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Summary 
The rotavirus replication cycle has not been fully characterised, one vital 
stage of virus replication involves large cytoplasmic occlusion bodies termed 
viroplasms. These are the sites of synthesis and replication of dsRNA, packaging of 
viral RNA into newly synthesized cores and the formation of double-shelled pre-
virions. The detailed mechanism by which these events occur is poorly understood but 
is thought to be mediated by the non-structural proteins localised to these structures. 
Rotavirus gene segment 11 expresses two proteins NSP5 and NSP6 which are 
found in alternate open reading frames. NSP5 exists is several isoforms which differ 
on their level of phosphorylation. It has been shown to be essential for virus 
replication and localises to the viroplasms. The smaller NSP6 protein is the most 
uncharacterised of all of the rotavirus proteins. It has however been shown to interact 
with NSP5 and has been tentatively suggested to be localised to the viroplasms. 
To further investigate these two proteins the pET expression system was 
utilised to obtain purified protein which was subsequently used to generate 
mono specific polyclonal antisera. Studies into the function and localisation of these 
proteins found that both localised to the viroplasms and their relative distributions 
within these structures were defined. NSP6 was found to be expressed at a low level 
throughout the course of a rotavirus infection and in contrast to other non-structural 
proteins, to have a high rate of turnover. The RNA binding ability of both NSP5 and 
NSP6 was investigated using quantitative filter binding assays and these showed both 
have sequence independent nucleic acid binding ability. Studies were also conducted 
into the mechanism of NSP6 expression from the second open reading frame of gene 
11, the results obtained being consistent with a leaky scanning mechanism of 
expression. 
xxii 
Introduction 
Chapter 1 
Rotaviruses and their replication 
1.1. Rotaviruses and diarrhoeal disease 
Rotaviruses are the major contributing factor to severe diarrhoea in children 
and young animals worldwide (Kapikian et al., 2001). The majority of children will 
have been infected with rotavirus by the age of 3 years old, both in the developed 
and developing world (Bern and Glass, 1994; Glass et al., 1996). Previous to the 
discovery of rotaviruses 10% to 30% of child diarrhoeal causative agents could be 
accounted for by known bacterial, parasitic or viral pathogens. It was not until 1973 
that rotaviruses were identified by electron microscopy (EM) as the cause of human 
childhood diarrhoea (Bishop et al., 1973). Since then rotaviruses have been 
identified as an important pathogens accounting for large costs both in economic 
terms and in terms of human lives. 
A study performed by Parashar and colleagues showed that rotaviruses cause 
approximately 2 million hospitalisations and between 352,000 and 592,000 deaths 
per year in children under the age of 5 years (Parashar et al., 2003). The disparity in 
the severity of illness caused by these viruses between a developed and a developing 
country is striking, with the study finding that 82% of these deaths occurred in the 
poorest countries (Figure 1.1). There is a 1 in 205 chance of a child under the age of 
5 dying from rotavirus induced diarrhoea in low income countries such as, India (a 
low World Bank Income Group is classified as spending <U.S. $756 of gross 
national product or GNP per capita), as compared to a 1 in 48,680 chance in a high 
income group country such as the United Kingdom (a high World Bank Income 
Group is classified as spending >U.S. $9,265 of GNP per capita). The availability of 
2 
re-hydration therapy, access to clean water and adequate hospital treatment are all 
key factors in determining the severity of disease (Parashar et al., 2003). 
Although mortality is far less in the developed world the financial burden of 
rotaviruses is still high, with an estimated 2.7 million rotavirus diarrhoeal episodes 
in the United States per year, which result in the hospitalisation of 50,000 children. 
The cost of direct medical care in the United States is an estimated at $274 million 
with a social cost of $1 billion (Tucker et al., 1998). 
3 
Figure 1.1 Global mortality attributed to rotavirus per annum 
Global distribution of the nwnber of annual death attributed to rotavirus infection, 
each dot represents 1000 childhood deaths per year. 
Adapted from Glass et al. , 1997 
4 
1.2. Classification 
1.2.1. Reoviridae 
Rotaviruses are members of the Reoviridae family, which consists of twelve 
genera: Fijivirus, Aquareoviridae, Cypovirus, Orbivirus, Phytoreovirus, 
Oryzaviridae, Orthoreovirus, Rotavirus, Seadomavirus, Mycoreovirus, Coltivirus 
and Idnoreovirus (Mertens, 2004; Mayo, 2005). The viruses in this family have 10, 
11 or 12 gene segments of dsRNA, encapsidated within a non-enveloped icosahedral 
virion of 60-100nm (Table 1.1). The Reoviridae family can be separated into two 
structurally distinct groups the turreted and the smooth-core viruses (Hill et al., 
1999). The core particles of the members of the Reoviridae have a T = 2 
organisation (T is the triangulation number). The turreted group of viruses genera 
include the Orthoreovirus, Aquareoviridae, Cypovirus, Fijivirus and Oryzaviridea, 
they all share an incomplete T = 13 layer which is penetrated by a turret-like 
structures (Hill et al., 1999). The other group includes Rotavirus, Orbivirus, 
Coltivirus and Phytoreovirus, these have a complete T = 13 forming channels with a 
five fold axis attached to subcores compose of 120 copies of a capsid protein 
(Grimes et al., 1998; Merten, 2004). 
Members of the Reoviridae family are important pathogens infecting a wide 
variety of different species including humans (rotavirus), animals (bluetongue virus 
and African horse sickness virus) and plants (rice dwarf virus) (Nibert and Schiff, 
2001). 
5 
Reoviridae genus No. of genome segments Hosts 
Turreteda 
Orthoreovirus 10 mammals, birds, reptiles 
Aquareoviridae 11 fish, mollusks 
Cypovirus 10 insects 
Fijivirus 10 ylants, insectsD 
Oryzaviridea 10 plants, insects!! 
Non turreteda 
Rotavirus 11 mammals, birds 
Orbivirus 10 mammals, birds, arthropodsD 
Coltivirus 12 mammals, arthropods!! 
Phytoreovirus 12 plants, insects!! 
Newlyassignedc 
Seadomavirus 12 mammals, insects 
Mycoreovirus 11-12 fungi 
Idnoreovirus 10 insects 
Table 1.1 Feature of members of the Reoviridae family 
a Proposed division of the Reoviridae based on the presence or absence of turret-like 
rrotein projecting around fivefold axes from innermost capsid layer. 
Served as vector for transmission to other hosts. 
C Newly assigned genera in family Reoviridae. 
Table reproduced and adapted from Nibert and Schiff, 2001 and Mertens, 2004. 
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1.2.2. Rotaviruses 
Rotaviruses have a tripled shelled virion, which measures 100nm in diameter 
and contains the 11 dsRNA genome segments (Figure 1.2) (Kapikian et al., 2001) 
which vary in size from 0.6 to 3.3 kilobases (Mattion et al., 1994). The genome 
segments encode only one protein with the exception of the smallest gene segment 
11 which is dicistronic (McCrae & McCorquodale, 1982; Mattion et al., 1991). The 
name rotavirus comes from the virion's distinctive appearance when viewed under 
the EM, where the wheel-like structures evident lead to the name derived from rota 
the Latin for wheel (Flewett et al., 1974). Rotaviruses share several universal 
characteristics including: an I 1 dsRNA genome, the size of their virions, the three 
concentric shells of the infectious particle, the presence of 60 spikes that protrude 
from the outer shell, the presence of an RNA dependent RNA polymerase and the 
other enzymes needed for ssRNA message production in the virion, the capacity for 
genetic reassortment and a morphgenic pathway that involves immature particles 
budding into the endoplasmic reticulum (ER) (Estes, 2001). 
Rotaviruses can be divided into groups; subgroups and serotypes, there are 
seven distinct groups of rotaviruses A to G, groups A to E were identified in the 
early 1980's on the basis of serology and RNA fingerprinting (Bridger et aI., 1982; 
Pedley et al., 1983; Bridger, 1994), groups F and G have been tentatively proposed 
based largely on serological evidence (reviewed by Saif & Jiang, 1994). Groups A, 
B and C have been found in both humans and animals, with group A being the major 
cause of disease in humans. To date groups D to G have only been isolated from 
animals, with group F and G only detected in birds. Group A viruses can undergo 
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Figure 1.2 Morphology of the rotavirus particle 
Negative stain transmission electron microscope image of rotavirus particles in cell 
culture, demonstrating the wheel- like nature of the virion (bar = 100 nanometer) . 
Source: F.P. Williams, U.S. Environmental Protection Agency 
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genetic reassortment with other group A viruses however, no reassortment of group 
A viruses has been detected with viruses from different groups (Yolken et ai., 1988). 
Group A viruses are the major cause of disease in children and young animals, 
whereas the group B viruses have been associated predominantly with adult 
diarrhoeal infections, the first outbreak being detected in 1983 in China (Su et al., 
1983; Hung et al., 1983). The virus causing this outbreak was named adult 
diarrhoeal rotavirus (ADRV) and was responsible for outbreaks of severe diarrhoea 
in numerous rural areas of China (Chen et al., 1985; Hung et al., 1987). In these 
outbreaks 85% of those infected were over 15 years old with the highest number 
infected over 30 years of age (Hung et al., 1987). Outbreaks of group B rotavirus 
have occurred in both India and Bangladesh; group B rotavirus has also been either 
serologically identified or isolated in Australia, Mexico, Japan, Thailand and the 
United Kingdom (Krishnan et al., 1999; Sanekata et al., 2001 and Mackow, 2002). 
Group C viruses were first identified in piglets with servre diarrhoea in 1980 
(Saif et al., 1980) and were later identified as human pathogens after isolation from 
human faecal samples which were obtained from several countries (Bridger et al., 
1986). A more recent study in rural Colombia found that up to 25% of the diarrhoeal 
cases found to be negative for the presence of group A rotaviruses were positive for 
group C rotaviruses (Gutierrez et aJ., 2003). 
The pattern of the gene segments separation by polyacrylamide gel 
electrophoresis (PAGE) can be used to some degree as an indication to which group 
a particular virus belongs, in a procedure termed electropherotyping (Estes et al., 
1994; Holmes, 1996). This technique was used to determine to which group isolates 
9 
of rotavirus belonged. However, within the group A viruses the electropherotype 
pattern was found not to compare with the antigenic specificity defined by 
neutralisation. Two viruses of the same electropherotype may belong to different 
serotypes and viruses of the same serotype may possess different electropherotypes 
(Kapikian et al., 2001). The gene segments can be put into size groups by which 
gene segments cluster together, for example in general the pattern for group A 
viruses is one of, four large segments, two medium size segments, three smaller 
segments and the two smallest segments (4-2-3-2). Several patterns have been 
observed in the group B rotaviruses including 4-2-1-1-1-1-1 for ADRV and 4-2-2-3 
from two isolates of porcine and bovine origin (Pedley et ai., 1983). 
Rotavirus groups have been further divided in the case of group A into 
subgroups based on the antigenic recognition of the VP6 protein that forms the 
middle shell of the virion. Epitopes on VP6 have been used to group virus isolates 
into one of four categories: subgroup I, subgroup II, subgroup I + II and non I, non II 
(Hoshino et al., 1987; Svensson et al., 1988). Monoclonal antibodies have 
subsequently been produced that specifically recognise sub group antigen I or II and 
the amino acids involved in these interactions have also been mapped (Greenberg et 
al., 1983; Lopez et al., 1994). 
In group A rotaviruses, virus isolates have also been divided into serotypes 
based on plaque reduction neutralisation assays using sera generated against the 
outer capsid proteins (Estes, 2001). The VP7 glycoprotein (0) has been found to be 
the major contributing factor in defining serotype, 14 0 serotypes have been 
identified to-date, with 10 isolated from humans (Hoshino & Kapikian, 1996). This 
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may in part be due to the larger amount VP7 proteins found in the virion. The VP4 
protein (protease sensitive protein or P) also stimulates the production of 
neutralising antibodies has been used to classify viruses into serotypes. A system of 
VP4 classification using sequence analysis and hybridisation analysis has 
distinguished 21 separate genotypes. More recently a system involving neutralisation 
assays has been developed that has identified 13 VP4 serotypes. For the most part 
these serotypes are in agreement with the separation by genotype (Kapikian et al., 
2001; Hoshino & Kapikian, 1996). To identify a specific virus first the P (VP4) 
number as determined by serotyping, then followed by the designated genotype 
number in brackets, after which the G (VP7) number is given, for example, the 
human Wa isolate is designated PIA[8]Gl using this system (Santos & Hoshino, 
2005). 
1.3. Epidemiology 
Rotaviruses are ubiquitous infections with greater than 90% of children by the age of 
3 years testing positive for antibodies to rotavirus, the highest incidence of infection 
occurring between 6 and 24 months (Huilan et aI., 1991). Rotaviruses are thought to 
be spread via the faecal-oral route, with 34.5% of all child diarrhoeal patients in a 
Washington D.C. hospital testing positive for the presence of rotavirus in their 
faeces (Brandt et al., 1983). The majority of rotavirus infections are asymptomatic 
and high titres of antibody to these viruses can be detected in adults suggesting 
continued subclinical infection through out life. The factors involved in the change 
from a susceptible age «5 years) for virus induced disease to a non-susceptible age 
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(>5 years) are unknown. However disease in the elderly has also been documented 
(Bern & Glass, 1994). 
In temperate climates like the United Kingdom rotavirus displays a seasonal 
pattern with peaks in the cooler months, the reasons for this cycling are unknown as 
this pattern of infection is reminiscent of an airborne virus but no evidence exists of 
a respiratory route of infection (Crowley et al., 1997). 
A large study of the distribution of G and P serotypes/genotypes of 45,571 
strains of rotavirus showed that 88.5% of rotavirus cases worldwide were caused by 
01, 02, 03 and 04 in conjunction with P[8] or P[4]. When the distribution of 
serotypes was divided by geographical location the four serotypes P[8]01, P(4]G2, 
P[8]03 and P[8]04 were found to cause up to 90% of rotavirus infections in North 
America, Europe and Australia. However, these serotypes only account for 68% of 
infections in South America and 50% in Africa. This is indicative of a dramatic 
change in 0 and P types across the globe. A clear example of which is the P[8]0 1 
serotype which represents 70% of all rotavirus infections in North America, Europe 
and Australia but only 30% of infections in South America and 23% in Africa. 
Overall a much wider variety of serotypes cause disease in South America, Asia and 
Africa with no clear serotype dominating on these continents (Santos & Hoshino, 
2005). 
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1.4. Structure of the rotavirus particle and genome 
1.4.1. Structure of the rotavirus virion 
The rotavirus virion is composed of three concentric shells, these are the core 
composed of VP1, VP2 and VP3 which encloses the dsRNA genome, the middle 
shell composed entirely of VP6 and the outer shell composed of VP7 which forms 
the smooth surface of the virus and VP4 which protrudes from the outer shell as a 
spike of roughly 100m (Figure 1.3) (Prasad et al., 1988; Prasad et al., 1994; Yeager 
et al., 1994). These particles are often referred to as being single layered, double 
layered or triple layered. The double layered and triple layered virions have a T = 13 
icosahedral structure. There are 132 channels in the virion which run from the outer 
shell to the inner core. There are three types of channel which are classified by their 
position and size; there are twelve type I channels which are 40A wide opening at 
the outer surface of the virion, and running down the icosahedral five fold axes. 
Sixty type II channels are fOWld at the six-coordinated positions surrounding the five 
fold axes. There are sixty, type III channels which are 55 A wide, 140 A deep and 
are found on the six-coordinated positions around the three fold axes. The type I 
channels have been postulated as being involved in the export of the messenger 
RNA formed within the core of the particle. The channels allow entry of nucleoside-
triphosphastes substrates for the RNA dependent RNA polymerase (RdRP) (Patton 
& Spencer, 2000). 
The single layered particle is composed of 120 copies of VP2 arranged into 
60 dimers on aT = 1 icosahedral lattice, and the major structural element of the core. 
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Figure 1.3 Structure of the rotaviru VIrion 
Panel A how a graphica l representation of the electropherotype of a group A 
rotavirus strain, indicating the protein coding assignment for each of the II genome 
segment. The po ition of each of the tructural protein in the virion is indicated on 
Panel B which shows a cryo EM reconstruction of a rotaviru particle with the three 
concentric layers composing the virion. 
Adapted by the rotavirus group Univer ily of Warwick from Pra ad et af., 1988 
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The two protein monomers arranged in the asymmetric units, are called T = 2 
icosahedral structures and have one monomer pointing towards the five fold axes 
and the other slightly offset from this. The N-terminus of the VP2 protein has been 
shown to have RNA binding capability (Labbe et ai., 1994) and it is the N-terminal 
region of the protein that points towards the viral genome where it is thought to 
interact with the dsRNA genome (Prasad et al., 1996; Jayaram et aI., 2004). Within 
the shell formed by the VP2 protein there is the dsRNA genome, which is thought to 
exist in a coil around one of the 12 copies of VPI and VP3 RNA dependent RNA 
polymerase (RdRP)-capping complex found at the five fold axes. The possibility that 
the icosahedral core T = 1 symmetry may restrict the number of copies of the RdRP-
capping complex to 12 has been proposed to be the reason why no members of the 
Reoviridae have more than 12 genome segments (Gouet et al., 1999; Patton & 
Spencer, 2000). 
The VP6 protein forms the middle shell of the whole particle surrounding the 
core; there are 780 molecules of VP6 arranged into trimers. The VP6 protein appears 
to be necessary for the transcriptional ability of the core structure (Prasad et al., 
1988). The addition of the VP6 layer increases structural integrity of the particle and 
the resulting double layered particle can survive in the environment for an extended 
period of time (Zeng et al., 1996). 
The outer layer is formed by VP4 and VP7, the VP4 protein forms spikes 
that protrude from the virion and VP7 which is a glycoprotein forms the surface of 
the particle. VP7 interacts with the VP6 layer and forms the outer surface on the 
virion, there are 780 copies of the protein which forms 260 trimers that give the T = 
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13 icosahedral shape of this shell (Estes, 2001). The VP4 protein which forms 60 
spikes extending from the outer surface has been implicated in cell attachment, cell 
penetration, haemaglutination, neutralisation and virulence (Estes, 2001). The spike 
is asymmetric and interacts with two VP7 molecules; at its base there is a large 
globular domain that interacts with the six VP6 molecules that surround the type II 
channel (Estes, 2001). VP4 is sensitive to proteolitic cleavage, splitting the VP4 
(88kDa) protein into VP5* (60kDa) and VP8* (28kDa) (Fiore et aJ., 1991). This has 
been shown to have a dramatic effect on infectivity; trypsinised virus has been 
shown to enter cells at much greater efficiency (Kaljot et al., 1988; Keljo et al., 
1988). 
1.4.2. Physiochemical properties of the virion 
The stability of the virus particle is dependent on the presence of calcium, 
which appears to stabilise the VP7 glycoprotein. In the presence of calcium 
chelating agents, such as EDT A and EGT A, the outer layer is stripped off leaving 
double layered particles. The outer layer formed by VP4 and VP7 has been shown to 
be essential for normal virus infectivity (Gajardo et al., 1997; Ruiz et al., 1996). 
Calcium has been detected within triple layered particles but not found in double 
layered particles (Shahrabadi & Lee, 1986). 
The middle shell can be removed to leave single layered particle by using 
chaotrophic agents such as sodium thiocynate or high concentrations of calcium 
chloride (Almeida et aJ., 1979; Cohen et al., 1979). Triple and double layered 
particles can be separated by caesium chloride (CsCI) or sucrose gradient 
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centrifugation. Triple layered particles separate at a density of 1.36 glcm3in CsC} 
and sediment at 520S to 530S in sucrose. The double layered particles have a density 
of 1.38 glcm3and sediment at 380S to 400S and the single layered particles have a 
density of 1.44 glcm3and sediment at 280S (Tam et al., 1976; Bican et al., 1982). 
The virus particle is very stable in the environment and can remain infectious 
at room temperature for months, however repeated freeze thawing has been shown 
to reduce virus titres (Narang et al., 1983). It has also been shown to be resistant to 
fluorocarbons, ether, chloroform and non-ionic detergents; which may result from 
the lack of a lipid membrane surrounding the virus (Estes et at., 1979). Treatment 
with SDS has been shown to destroy infectivity. Other disinfectants that have been 
shown to effect rotavirus infectivity are 95% ethanol, phenol, chlorine and formalin 
(Narang et at., 1983). 
1.4.3. The Rotavirus genome 
The rotavirus gene segments are all monocistronic with the exception of the 
smallest gene segment 11, which has been found to encode for two proteins (Estes & 
Cohan, 1989; Mattion et at., 1991). The genome segments range from 667bp to 
3302bp for the simian SAIl virus strain (Estes, 2001). The viral mRNA is highly 
(58% to 67%) A +V rich and contains a 5'-terminal cap structure (m7GpppO(m)GPy) 
but lacks a poly(A) tail (Imai et ai., 1983; McCrae & McCorquodale, 1983). The 
viral mRN As have untranslated regions (UTRs) flanking the open reading frames, 
whose sequences vary widely between individual genes except for short 5' and 3' 
consensus sequences. These short consensus sequences at the 5' and 3' termini are 
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5'-GGC-poly(NU)-3' and 5'-AUGUGACC-3' respectively (Desselberger & 
McCrae, 1994). The positive strand mRNA's of members of the Reoviridae serve 
two functions within the infected cell: they are used for the translation of viral 
proteins and also serve as a template for the synthesis of minus strand in the 
production of dsRNA (Nonoyama et at., 1974). Cis-acting regulatory elements have 
been found within the 3' conserved sequence on all 11 gene segments, these have 
been shown to be required for the replication of transcripts in a cell free system 
(Patton et al., 1996; Wentz et al., 1996). The signals concerned are thought to 
involve secondary/tertiary structures rather than primary sequences (Chen et al., 
2001). Viral transcripts that lack the 3' consensus sequence cannot serve as 
templates for the synthesis of dsRNA, however if the 3' consensus sequence is fused 
to an mRNA of non-viral origin this can then be replicated by the viral RdRP 
complex but at a lower level than wild type viral mRNA (Patton & Spencer, 2000). 
1.4.4. Genomic rearrangements 
Rearrangements of the rotavirus genome have been detected these are usually 
in the form of head to tail duplications (Estes, 2001). Rearrangement is often found 
in virus that has been passaged in tissue culture at a high multiplicity of infection 
(m.oj.) however, rearrangement has been detected in a wide variety of both human 
and animal primary isolates (Desselberger, 1996). Rotavirus strains which contain 
extra gene segments or larger than normal gene segments by gene concatemerisation 
have also been identified (Pedly et at., 1984; Scott et at., 1989; Ballard et at., 1992). 
Several studies have shown numerous deletion and mutations in gene segment 5 
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which encodes NSPl, these studies showed that this protein is not required for 
growth in tissue culture (Tian et at., 1993; Hau & Patton, 1994). Several gene 
segment 11 reassortants have been characterised. These are classified as long, short 
or super-short due to the electropherotype pattern produced. Rotaviruses usually 
have a long electropherotype pattern however duplications in the gene 11 sequence 
cause a shift to a shorter pattern and a switch between gene 10 and gene 11 due to 
the increase in size of the gene 11 sequence (Matsui et at., 1990). The short and 
super-short gene 11 sequences are caused by partial or full duplications Kojima et at 
(1996b) characterised a gene 11 reassortant in which the 664bp gene from the parent 
strain had been duplicated in a head to tail fashion creating a 1182bp gene and a 
super-short electrophoretic pattern. From determination of key nucleotide positions 
it was determined that the duplication must have occurred during plus strand 
synthesis rather, than minus strand synthesis (Kojima et at., 1996b). A region 
located between nucleotides 328 to 618 were found to in several strains was found to 
be duplicated extending the 3' UTR (Matsui et aI., 1990). A gene 11 rearrangment 
containing a complete duplication of the NSP5 coding region in a head to tail 
arrangement was characterised by Chnaiderman et at., (1998). The strain carrying 
this rearrangement was found to create larger plaques than the parental strain. The 
gene 11 segment by the use of reassortment was transferred from the parental 
porcine strain to an SA-ll background for further analysis. The SA-ll strain 
carrying the duplicated gene 11 also had an increased plaque size when compared 
SA-II indicating that the gene 11 strain introduced carried with it an increase in 
pathogenicity (Chnaiderman et at., 1998). This however was proposed to be due to 
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several point mutations within the NSP5 coding region rather than from the 
duplicated sequence (Chnaiderman et al., 1998; Chnaiderman et al., 2002). Further 
characterisation revealed that the point mutations removed several serine residues 
and was less hyperphosphorylated than normal NSP5. Also viral protein synthesis 
and the concentration mRNA in the strain carrying the rearranged gene 11 occurred 
at earlier time points that in SAIL Less dsRNA production was also noted leading 
to the hypothesis that NSP5 phosphorylation regulates the fate of mRNA to either 
protein synthesis or dsRNA production (Chnaiderman et al., 2(02). 
1.5. Protein coding assignments of the rotavirus proteins 
Rotavirus produces six structural and six non-structural genes, the coding 
assignments were originally elucidated for the UKtc virus by in vitro translation 
analysis using mRNA transcripts or denatured dsRNA (Figure 1.3) (McCrae & 
McCorquodale, 1982). The smallest gene segment, of the 11 dsRNA genome 
segments, encodes two proteins; all of the other genes are monocistronic. Gene 
segments are ordered by their migration by electrophoreses. 
The order of the gene segments varies among rotavirus strains and 
identification of the proteins coded has relied on techniques such as gene-specific 
probes, reassortant analysis, and sequence homology or on biochemical and 
immunological analysis in a cell free in vitro translation system (Dyall-Smith et al., 
1983; Gombold et al., 1985; Green et aI., 1987; McCrae & McCorquodale, 1982). 
An overview of rotavirus protein coding assignments can be seen in (Table 1.2). 
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Genome Protein Molecular Mature Protein Location Number of 
Segment product Mass kDa Modified Molecules 
per virion 
I VPl 125 Core ND 
2 VP2 94 Cleaved Core 120 
3 VP3 88 Core ND 
4 VP4 88 Cleaved Outer Shell 120 
VP5* +VP8* 
5 NSPI 53 Nonstructural 
6 VP6 41 780 
7 NSP3 34 N onstructural 
8 NSP2 35 Nonstructural 
9 VP7 38 Cleaved Outer Shell 780 
Glycosylated 
10 NSP4 28 Glycosylated Nonstructural 
11 NSP5 26 O-Glycosylated Nonstructural 
NSP6 12 Nonstructural 
Table 1.2 Coding assignments and features of rota virus proteins 
Table showing the 11 genome segments and the proteins encoded from them, 
together with their molecular size, modification, function and number found per 
virion. The apparent molecular weights are for SA II rotavirus polypeptides 
analysed by SDS-PAGE. ND = not yet detennined. 
Adapted from Kapikian, Hoshino & Chanock, 200 1 
21 
1.5.1. Rotavirus structural proteins 
1.5.1.1. VPl 
The largest of the rotavirus genes, gene segment I encodes VPl, which is a 
minor component of the viral core and has been proposed to be the RNA dependent 
RNA polymerase (RdRP) (Cohen et aI., 1989; Mattion et aJ., 1994). A number of 
studies have provided evidence for VPl being the viral RdRP. Using a recombinant 
baculovirus expression system to create rotavirus core-like particles the proteins 
necessary for RNA synthesis were assayed (Zeng et al., 1996). A core-like particle 
containing VPl, VP2 and VP3 was able to transcribe RNA, as was a core-like 
particle containing VPl and VP2. However, VP2 alone and a core-like particle 
containing VP2 and VP3 were not able to transcribe RNA. This indicates that VPl is 
essential for RNA production (Zeng et al., 1996). The VPl protein has the four 
sequence motifs that are shared between other proteins proposed to be RdRP (Cohen 
et al., 1989; Fukuhara et al., 1989; Mitchell et al., 1990). A further consistent 
observation is the fact that temperature sensitive mutants mapped to VP 1 cannot 
produce RNA at non-pennissive temperatures (Chen et al,. 1990). VPl has 
nucleotide binding ability, experiments perfonned using cross linking between VPl 
and the photosensitive nucleotide analog [a)2p] azido-adenosine triphosphate 
resulted in active VP6 particles losing their ability to transcribe RNA in the presence 
of light (Valenzuela et al., 1991). VPl is a component of the baculovirus-expression 
particles and replication intennediates that have replicase activity (Gelegos & 
Patton, 1989; Zeng et ai., 1996). VP 1 specifically recognises the 3' end of viral 
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RNA containing the cis-acting replication signals (Patton et al., 1996), in addition 
the RdRP activity ofVPl appears to be dependent on the presence ofVP2 (Patton et 
al., 1997). 
1.5.1.2. VP2 
VP2 is the major structural protein of the viral core, constituting 12% of the 
total virion protein, it encapsidates the dsRNA genome and the minor core proteins 
VPl and VP2 (Kumar et al., 1989). In a baculovirus expression system VP2 was 
shown to bind ssRNA and dsRNA in a sequence independent manner however, 
ssRNA binds with a much greater affinity, it was also shown to bind genomic RNA 
in purified single-shelled particles. The nucleic acid binding domain of the protein 
has been located between amino acids 1 and 132 (Labbe et al., 1994). Studies have 
shown that removal of the first 25 amino acids was sufficient to remove the RNA 
binding ability of VP2 (Boyle & Holmes, 1986; Labbe et al., 1994; Prasad et al., 
1996). Removal of the first 25 amino acids also abolished the ability of VP2 to 
encapsidate VPl and VP3 into core-like particles in a baculovirus expression system 
(Zeng et al., 1998). The importance of the N terminal region ofVP2 can also be seen 
by studying the primary and secondary sequence of this region which contains 
several motifs that are common among RNA binding proteins. There is a predicted 
helix-tum-helix secondary structure between amino acids 65 to 121, a series of 
heptad repeats of lysine and glutamic acid residues between amino acids 53 to 81 
and a RSKKEAKNA(AAKLA)VEIL motif which has been found in the RNA 
binding domain of several well characterized RNA binding proteins such as the 
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human RNA-dependent PlIeIF-2a protein kinase (Michel1 & Both, 1990, 
McCormack et ai., 1992; Labbe et al., 1994). VP2 has been shown to be able to 
independently self assemble into core particles, and the N-tenninus RNA binding 
domain does not appear to be essential for this property (Labbe et al., 1994). 
1.5.1.3. VP3 
VP3 is found in the core of the virion associated to the viral dsRNA genome 
(McCrae & Faulker-Valle, 1981). A baculovirus expression system expressing core-
like particles has shown that VP3 binds to the N-terminus of VP2, which in turn is 
the domain of VP2 which binds RNA (Labbe et al., 1994; Zeng et aI., 1998). VP3 is 
also a sequence independent RNA binding protein with affinity for ssRNA (Patton & 
Chen, 1999). It has been identified as the guanylyltransferase capping protein, which 
places 5' caps onto viral mRNA molecules (Liu et ai., 1992; Pizzaro et ai., 1991). 
This activity bas been demonstrated to be non specific with VP3 being able to cap 
any RNA initiating with both guanine and adenine residues. However, VP3 does 
preferentially bind uncapped RNA rather than capped RNA (Patton & Chen, 1999). 
Methyltransferase activity has also been detected showing the multifunctional 
properties of VP3 (Chen et al., 1999). 
Sequence analysis using RT-PCR of VP3 from mUltiple strains of rotavirus 
showed that there is a 94% sequence identity among human group A rotavirus VP3 
proteins and a 79% homology between mammalian VP3 sequences (Cook & 
McCrae, 2004). There appears to be a species specific conservation ofVP3 sequence 
with high homology found within viruses from one species but a high level of 
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sequence divergence between viruses of different species. Investigation into the 
sequences involved in the putative enzymatic site showed that the motifs 
KXTAMDXEXP at amino acid 385 and KXXGNNH at amino acid 545 were 
conserved in both group A and C rotaviruses (Cook & McCrae, 2004). 
1.5.1.4. VP4 
VP4 is part of the outer layer of the virion and forms the spikes that protrude 
from the virion surface (Pasad et ai., 1990). It is an 88kDa protease sensitive protein 
that is the P type neutralising antigen used for classification of rotavirus strains into 
serotypes (Offit & Blavat, 1986; Fiore et ai., 1991). VP4 is the haemagglutinin and 
has been purported to be the cell attachment protein (Kalica et aI., 1983; Crawford et 
ai., 1994; Ruggeri and Greenberg, 1991). It also interacts with the VP6 protein in the 
inner shell of the virion (Shaw et ai., 1993). 
Treatment of virus with trypsin has been shown have greater infectivity 
(Kaljot et ai., 1988; Keljo et ai., 1988) and this has been linked to the cleavage of 
VP4 to produce VP5* (60kDa) and VP8* (28kDa) (Fiore et ai., 1991). The VP4 
spike was initially thought to be a dimer of VP4 subunits however recent work has 
shown it to be a trimer, where two VP4 molecules form the rigid spike and a third 
molecule is left flexible. However it has been proposed that during entry the three 
cleaved VP5* molecules form a trimer of the membrane interaction domains, 
resulting from the release of the VP8* cleavage product and exposing the 
hydrophobic apex of the VP5* antigen domain (Dormitzer et ai., 2005; Lopez et ai., 
1991; Mattion et ai., 1994). It has been suggested that this hydrophobic domain may 
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then insert into the cell membrane causing it to fold back exposing the potential 
fusion domain which in turn leads to entry of the virus into the cell (Donnitzer et al., 
2005; Lopez et al., 1991; Mattion et al., 1994). In line with this hypothesis the VP5* 
cleavage product has been shown to be able to penneablise membranes (Denisova et 
al., 1999) 
VP4 and the VP8* cleavage product can both activate NF-kappaB through a 
TRAF2-NF-kappaB-inducing kinase signalling pathway (LaMonica et al., 2001). 
VP4 and VP8* both contain three TNFR-associated factor (TRAF) binding motifs. 
When expressed in vivo VP4 and VP8* both caused a 5 to 7 fold increase in NF-
kappaB activity and upregulated TRAF2-mediated NF-kappaB activation. This 
suggests that rotavirus actively changes cellular signalling and directly effect cellular 
transcriptional responses (LaMonica et al., 2001). 
1.5.1.5. VP6 
The hydrophobic VP6 protein fonns the middle shell of the rotavirus virion it 
is the major virion protein constituting 51 % of the total protein in the particle 
(Mattion et ai., 1994; Smith et al., 1989). It can spontaneously fonn trimers and this 
is its native form within virus particles (Estes et ai., 1987). These trimers can be 
dissociated and refonned by varying the pH (Tosser et aI., 1992). VP6 interacts with 
VP2, VP4 and VP7 and is highly antigenic and immunogenic (Estes et al., 1987; 
Gorziglia et ai., 1985; Sabara et aI., 1987). Deletion mutagenesis has mapped a 
region essential for trimerisation to amino acids 246 to 314 (Affranchino & 
Gonzalez, 1997). Proline 308 has also been shown to be important for the stability of 
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VP6 trimers (Shen et al., 1994). The N-terminal region has been proposed to be an 
important domain of VP6, possibly involved in transporting viroplasmic occlusion 
bodies (Mansell etaI1994). VP6 has been shown to interact with B-cells via surface 
immunoglobulins (Parez et al., 2004). 
1.5.1.6. VP7 
VP7 forms the smooth surface of the mature virion, it is a glycoprotein that 
contains N-linked high mannose oligosaccharides which are processed via trimming 
(Arias et al., 1982; Ericson et al., 1983 Kabcenell & Atkinson, 1985). MangGlcNAcz 
and MaIlt;GlcNAc2 oligosaccharides are found on the VP7 protein during viral 
replication and M<lll6GlcNAz and MansGIcNAc2 are found on the mature virus 
particle (Kabcenell & Atkinson, 1985; Kabcenell et al., 1988). The VP7 ORF is 326 
amino acids in length however the first initiation codon has a suboptimal Kozak 
consensus sequence which directs the initiation of translation. There is a second 
initiation codon 90 base downstream of the first which is in a much better Kozak 
consensus sequence. The initiation codons are both preceded by hydrophobic 
domains at amino acids 6 to 23 and 33 to 44 respectively; it is these domains that 
have been implicated in the transport of the VP7 protein to the endoplasmic 
reticulum (ER). A potential third in frame initiation codon is present in some but not 
all virus strains. A single glycosylation site at amino acid 69 is used in the SAIl and 
UKtc rotavirus strains but, other strains have three potential glycosylation sites of 
which only two are thought to be used (Kouvelos et al., 1984; Kelvelos et al., 1984; 
Sato et al., 1986; Estes & Cohen, 1989). The VP7 ER signal is located at the N-
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tenninus of the protein and is cleaved at amino acid 51, the amino tenninal residue 
of VP7 found in purified virus is blocked by pyroglutamic acid (Stirzaker et ai., 
1987). 
VP7 is glycosylated as it is inserted into the membrane of the ER; this 
insertion is directed by the signal sequence (Both et al., 1983; Ericson et al., 1983; 
Kahcenell & Atkinson, 1985). Two regions between amino acids 51 to 61 and 61 to 
111 have been implicated in retention of VP7 to the ER (Poruchynsky & Atkinson, 
1988; Poruchynsky et aI., 1985; Stirzaker et ai., 1987; Whitfeld et ai., 1987). A 
number of amino acids found between these regions at amino acids 57 to 63, with 
the sequence LPITGS, has been demonstrated to be highly conserved among 
rotaviruses (Matti on et al., 1994). The ITG has been shown via mutation analysis to 
be essential for ER retention (Maass & Atkinson, 1994). However, the exact process 
involved in VP7 ER retention is still not fully understood. 
VP7 fonns trimers and has been shown to interact with VP4 and NSP4 
within infected cells (Maass & Atkinson, 1990), these interactions and the presence 
of calcium appear to be crucial elements in the fonnation of the outer layer and the 
correct placement of VP7 into the mature virus particle (Donnitzer & Greenberg, 
1992; Poruchynsky & Atkinson, 1991; Poruchynsky et al., 1991; Shahrabadi & Lee, 
1986; Shahrabadi et al., 1987). Silencing of VP7 by siRNA does not affect double 
layered particle production but, no triple-layered particles were seen to be produced 
and enveloped double-layered particles were observed to accumulate in the ER 
lumen (Lopez et al., 2004). 
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1.5.2. Rotavirus non-structural proteins 
1.5.2.1. NSPI 
The NSP! protein is encoded by gene segment 5 and is a 58kDa protein that 
is poorly conserved among rotavirus strains (Dunn et al., 1994; Xu et aI., 1994; 
Kojima et al., 1996). However, the region between amino acids 42 and 72 in the N-
terminus of the protein has been found to be conserved over most rotavirus strains. 
This region is highly cystiene rich and has been predicted to form two zinc finger 
motifs (Hau et aJ., 1994, Brottier et aI., 1992). NSPl has been found to be non-
essential for virus growth in tissue culture, by using several mutant strains 
containing deletion of regions including the cystiene rich N-terminus of gene 5 (Tian 
et al., 1993; Hau & Patton, 1994; Okada et al., 1999; Taniguchi et al., 1996). NSPI 
knock down, using siRNA specific for gene 5, has also shown it to be non-essential 
for virus replication in tissue culture (Silvestri et al., 2004). Gene 5 reassortants have 
also been used to show that the N-terminus is the functional region of the protein 
(Tian et al., 1993; Hau & Patton, 1994). 
The NSP 1 protein is localised to the cytoplasm within the infected cells and 
has been shown to localise with the cytoskeleton when analysed by sub-cellular 
centrifugation (Hau & Patton, 1994). NSPI has specific affinity for the 5' end of 
viral mRNA which has been linked to the N-terminal cystiene rich region of the 
protein (Brottier et al., 1992; Hua et al., 1994). 
The NSPI protein has been shown to be an antagonist of the interferon (IFN) 
signalling pathway (Barro & Patton, 1993). NSP! binds to IFN regulatory factor 3 
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(IRF3) which responds to infections by phosphorylation, dimerisation and nuclear 
translocation where it causes activation and release of IFN. NSPI causes degradation 
of IRF3 via a proteasome-dependent pathway, this ability was mapped to the C 
terminus of NSP 1 (Graff et al., 2002; Barro & Patton, 2005). NSP 1 has been found 
to undergo rapid mutation when rhesus rotavirus (RRV) was serially passaged at 
high multiplicity of infection (MOl) leading to defective NSPI (Kearney et al., 
2004). 
1.5.2.2. NSPl 
NSP2 is a highly basic 35 kDa protein that is the most abundant viral protein 
found within the infected cell (Petrie et al., 1984). It self-assembles into stable 
octomers (Schuck et al., 2001) which is the functional form of the protein (Kattoura 
et al., 1994; Taraporewala et al., 2002). Crystal structure analysis of the NSP2 
protein has shown that the NSP2 monomer is composed of two separate domains, 
separated by a 25 A deep cleft (Jayaram et al., 2002). The N-terminal domain is 
mostly formed from a-helices and contains a 24 residue basic loop which is the 
proposed ssRNA binding site. The C-terminal domain forms a histidine triad (HIT)-
like fold which is common amongst nucleotidyl hydrolases, there is no primary 
sequence homology between NSP2 and other nucleotidyl hydro lases. The histidine 
triad, His 221, His 225 and His 110 located near the base of the cleft are thought to 
be the site ofNTP binding and hydrolysis. 
NSP2 has been localised to the viroplasms which are cytoplasmic occlusion 
bodies that form between 2-3 hours post infection. These have been shown to be 
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sites for the synthesis and replication of dsRNA, the packaging of viral dsRNA into 
newly synthesised cores and the steps of viral morphogenesis that result in the 
formation of double-shelled pre-virions (Petrie et al., 1984; Altenburg et al., 1980; 
Esparza et al., 1980; Patton & Gallegos, 1990; Patton et at., 1997; Wentz et al., 
1996). Early investigations using temperature sensitive mutants showed that NSP2 is 
essential for viroplasm formation and virus replication (Ramig & Petrie, 1984; 
Gombold et al., 1985), later studies using siRNA knock down of NSP2 have shown 
that loss of NSP2 leads to inhibition of viroplasm formation, genome replication, 
virion assembly, and synthesis of the other viral proteins (Silvestri et al., 2004). 
NSP2 has been shown to have sequence independent ssRNA binding ability, with 
octamers of protein binding RNA co-operatively to form higher ordered complexes 
(Kattoura et aI., 1992; Taraporewala et al., 2002). NSP2 has also been shown to 
have helix-destabilising activity, this unlike other helicases is Mg2+ and ATP 
independent (Taraporewala and Patton, 2001). It also possesses NTPase activity that 
is Mi+ dependent and can hydrolyse any NTP to NOP. Cross-linking assays have 
been used to show that NSP2 binds VPl and NSP5 in the infected cell (Kattoura et 
al., 1994; Afrikanova et al., 1998) 
1.5.2.3. NSP3 
NSP3 is a 36 kDa protein that is found distributed throughout the cytoplasm 
of the infected cell and which has been shown to form homodimers (Mattion et al., 
1992; Piron et al., 1999; Estes, 2001). NSP3 is composed of two separate domains, 
the N-terminal domain specifically binds the 3' consensus sequence of viral mRNA, 
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X-ray crystal structure analysis has shown that NSP3 fonns a heart shaped dimer 
with the mRNA buried deep within the cleft of the two monomers (Deo et aI., 2002). 
The dimerisation domain has been localised to between amino acids 163 to 237 
(Pi ron et al., 1999). 
NSP3 specifically binds to the 3' terminus of viral mRNA by the consensus 
sequence GACC (Poncet et al., 1993; Poncet et al., 1994). NSP3 is a functional 
homolog of poly A binding protein (PABP) (Both et al., 1984) and binds the 
translation initiation factor eIF4G with a higher affinity than P ABP (Groft & Burley, 
2002; Piron et al., 1998). The specific binding of NSP3 to viral mRNA and the 
subsequent displacement of P ABP in the translation initiation complex has been 
proposed to cause circularisation of the viral mRNA transcript and preferential 
translation. This in tum leads to host cell shut off and the inability for capped and 
polyadenylated cellular mRNA to be translated (Padilla-Noriega et al., 2002; Poncet 
et al., 1994; Vende et al., 2000). 
A novel cellular protein has been shown to interact with NSP3; RoXaN 
(rotavirus X protein associated with NSP3) has been identified as a 110 kDa protein 
that maybe involved in protein-protein interactions and RNA binding. A leucine-
aspartate repeat motif between amino acids 244 to 341 has been shown to interact 
with the dimerisation domain of NSP3; this interaction has been detected within 
virus infected cells (Vitour et al., 2004). 
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1.5.2.4. NSP4 
NSP4 is a 28kDa transmembrane glycoprotein localised to the ER with a 
vital role in virus morphogenesis (Ericson et aI., 1982; Kabcenell & Atkinson, 
1985). The protein is composed of three hydrophobic domains (HI - H3), two N-
linked high mannose glycosylation sites are located within the first hydrophobic 
domain and a predicted amphipathic a-helix that overlaps a folded coiled-coil 
region. The HZ domain contains a predicted transmembrane domain that spans the 
ER membrane the C-terminus is hydrophilic and extended (Chan et al., 1988). The 
polypeptide backbone of NSP4 also contains an uncleaved signal sequence (Both et 
al., 1983; Baybutt & McCrae, 1984). 
The C-terminus ofNSP4 has been proposed to be an intracellular receptor for 
double layered particles and to mediate their transport into the ER (Au et al., 1993; 
Taylor et al., 1992; Taylor et al., 1993). Evidence to support this comes from studies 
which show double-layered particles will only bud into ER containing NSP4 (Au et 
al., 1993; Meyer et al., 1989). The NSP4 protein has been predicted to form a 
homotetramer (Taylor et al., 1996) and be involved in the removal of the transient 
membrane from budded double-layered particles (Tian et al., 1996). Glycosylation is 
thought to be required for the removal of membranes by NSP4 (Suzuki et al., 1984). 
NSP4 also contains a VP4 binding domain suggesting that it may possess some 
function in the construction of the virions outer layer (Au et al., 1993; Tian et al., 
1996). Silencing of NSP4 expression using siRNA resulted in the incorrect 
distribution of a number of viral proteins and no production of double or triple 
layered particles (Lopez et al., 2004). 
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NSP4 among group A viruses, has very highly conserved sequence with 98% 
homology between strains (Lin & Tian, 2003). This highly conserved sequence 
identity is only found within rotavirus groups but, not seen between groups, with 
less than 10% sequence identity between group A and group B NSP4 sequences, but 
within the group B viruses there is a 93% sequence sequence identity (Guzman & 
McCrae, 2005). Despite this lack of primary sequence identity there is a high level 
of secondary sequence similarity and possibly epitope configuration as sera 
generated against purified group B protein was able to detect group A NSP4 by 
immunofluorescence in both infected and transfected cells (Guzman & McCrae, 
2005). 
NSP4 was the first viral endotoxin documented, its effects were first 
observed when purified NSP4 protein was introduced intraperitoneally and caused 
age-dependent diarrhoea in mice (Ball et al., 1996). NSP4 appears to stimulate the 
secretion of intra cellular calcium (Ca2+) and chloride ions (Estes, 2001), there is 
some evidence that NSP4 may act as a viroporin creating a Ca2+ channel leading to 
export of Ca2+ from the cell (Ruiz et al., 2005). The increased Ca2+ permeability of 
the plasma membrane leads to a progressive rise in cytosolic Ca2+ concentration 
(Michelangeli et al., 1991; Perez et al., 1999), Ca2+ stabilized the outer capsid of the 
virion and induces cell death. It has also been proposed that Ca2+ mediated secretory 
pathways of water and electrolytes maybe triggered by the increased Ca2+ 
concentration contributing to the onset of diarrhoea (Ruiz et al., 2000). 
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1.5.2.5. NSPS 
NSP5 is the larger of the two proteins expressed from the smallest segment 
of the rotavirus genome, gene segment 11 (Figure 1.4) (Dyall-Smith et al., 1981; 
Mattion et al., 1991). It is a dimeric, O-linked glycosylated protein that has been 
localised to the viroplasm in virus infected cells (Petrie et al., 1984; Gonzalez & 
Burrone, 1991; Gonzalez et al., 1998). The NSP5 protein has been shown to bind 
ssRNA and dsRNA with equal affinity in a sequence independent manner (Vende et 
al., 2002), and to interact with the viral proteins VPl, VP2 and NSP2 (Afrikanova et 
at., 1998; Berois et al., 2003). NSP5 is a highly serine/threonine rich (24%) protein 
that exists in several isoforms which vary on their level of phosphorylation, the 
phosphorylation of the protein causes retardation when analysed by SDS-PAGE 
electrophoresis and has lead to the identification of three separate species of 26, 28 
and 30-34 kDa (Welch et at., 1989; Afrikanova et al., 1996; Poncet et al,. 1997; 
Blackhall et al., 1997). It has been suggested that NSP5 has putative autocatalytic 
kinase activity potentially leading to autophosporylation of the protein (Welch et at., 
1989; Poncet et al., 1997; Torres-Vegas, 2000). NSP5 synthesis has been detected 2 
hours post infection however the 28 and 30-34 kDa isoforms were not detected until 
4 hours post infection (Blackhall et al., 1997; Blackhall et at., 1998). Current 
evidence suggests that NSP5 autocatalytic kinase activity probably only accounts for 
a small proportion of NSP5 phosphorylation. The generation of the 
hyperphosphorylsated form (30-34 kDa) has been shown to be up-regulated by the 
presence of NSP2 (Afrikanova et af., 1998). 
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Figure 1.4 Functional domains of rotavirus gene segment 11 
The gene II coding regions for P5 (green) and P6 (blue) are demonstrated on 
the diagram. The interaction domain ofN P5 proposed to bind P2 and P6, 
along with the region required for multimerization and hyperphosphoryltion are 
also indicated. 
Adapted from Torres-Vega el af., 2000 
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It is however still unclear as to how NSP2 causes up-regulation of NSP5 and several 
theories have been proposed i) the binding of NSP2 triggers an increase in the 
autocatalytic kinase activity of NSP5, ii) the NTPase activity of NSP2 generates 
phosphates that are transferred from NSP2 to NSP5 (Taraporewala et al., 1999; 
Vende et al., 2002), iii) the binding of NSP2 leads to conformational changes in 
NSP5 allowing cellular kinases to phosphorylate previously blocked residues on the 
protein (Blackhall et al., 1998; Eichwald et al., 2002). 
The NSP2 binding domain of NSP5 has been localised to the N-terminal 
region however a 33 amino acid N-terminal deletion mutant which could not bind 
NSP2 was still able to undergo hyperphosphorylation (Afrikanova et al., 1998), 
whereas a C-terminal deletion mutant lost this ability, the removal of just the 10 C-
terminal amino acids was enough to block hyperphosphorylation (Afrikanova et al., 
1998; Torres-Vega et al., 2000). Dimerisation of NSP5 has been shown to be 
dependent upon the 28 C-terminal amino acids, which contains no serine or 
threonine residues and is therefore not a site for phosphorylation, this suggests that 
NSP5 multimerisation is essential for hyperphosphorylation (Torres-Vega et al., 
2000). 
A number of phosphorylation sites have been detected within NSP5, four 
serine residues (Ser-153, Ser-155, Ser163, and Ser-165) contained in an acidic 
region have been found to have homology to casein kinase II (CK2) phosphorylation 
sites (Eichwald et al., 2002). In later experiments performed by Eichwald et al., 
(2004) using synthetic peptides, CK2 was not able to phosphorylate NSP5 substrates 
however, casein kinase I (CKI) was shown to cause the phosphorylation of the 
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synthetic peptides as well as bacterial expressed NSP5 mutants indicating that it was 
a strong candidate for the cellular kinase involved in NSP5 phosphorylation 
(Eichwald et al., 2004). 
A serine residue at position 67 was shown to be vital to 
hyperphosphorylation of NSP5 and a probable target for a cellular kinase. It appears 
to become accessible to hyperphosphorylation only in the presence of NSP2 or in 
mutants lacking the N-terminal 33 amino acids and/or a 50 amino acid region 
downstream of Ser-67 between amino acids 80 to 130. These regions may block Ser-
67 phosphorylation until NSP2 binding causes a conformational shift exposing the 
region between them containing Ser-67. Evidence suggests that phosphorylation of 
Ser-67 is the first crucial step in hyperphosphorylation and only after this step 
further phosphorylation events can occur (Eichwald et al., 2004). Mutants 
containing deletions of the N-terminal 33 amino acids and the 50 amino acid 
deletion from amino acids 80 to 130 were both able to undergo 
hyperphosphorylation when transfected alone. By contrast two other deletion 
mutants lacking either amino acids 33 to 80 or 130 to 180 were unable to be 
hyperphosphorylated when transfected alone, presumably due to the fact that the 
first deletion lacks Ser-67 and the latter one contains the regions thought to block 
Ser-67 phosphorylation. When either of the mutants that were able to undergo 
hyperphosphorylation was co-transfected with either of the mutants unable to show 
hyperphosphorylation then, hyperphosphorylation of both could be detected 
(Eichwald et al., 2004). This is evidence that the phosphorylation of Ser-67 is a 
critical step, after which, subsequent phosphorylation events can occur leading to 
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hyperphosphorylation. The C-terminus was shown to be essential for all 
hyperphosphorylation events to occur, strongly linking it to NSP5 dimerisation 
(Eichwald et al., 2004). One study has suggested that the level of NSP5 
phosphorylation may be linked to positive sense ssRNA being directed from 
translation to dsRNA replication (Chnaiderman et al., 2002). 
Co-transfection of NSP2 and NSP5 expressing plasmids leads to the 
formation of viroplasm-like occlusion bodies, hyperphosphorylation and both N and 
C terminal domains of NSP5 have been shown to be necessary for the formation of 
these structures (Fabbretti et al., 1999). The binding of NSP2 can be mimicked by 
the creation of N-terminal NSP5 fusion proteins, leading to the formation of 
viroplasm-like structures in the absence of NSP2. The formation of these viroplasm-
like structures was dependent on leaving the C-terminus of NSP5 unmodified 
however, hyperphosphorylation was not found to be essential for viroplasm-like 
structure formation (Mohan et al., 2003). One study has observed that the number of 
viroplasms in a virus infected cell decreases over time, whilst the size of the 
viroplasms increases and that the viroplasm was composed of NSP2 at its core with 
an outer ring ofNSP5 protein (Eichwald et al., 2004). 
NSP5 expression, like NSP2, has been shown to be essential for virus 
replication, siRNA and intracellular antibodies have both been used to knockdown 
the expression of NSP5 in virus infected cells leading to loss of viroplasm formation 
and viral replication (Vascotto et al., 2004; Lopez et al., 2005). 
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1.5.2.6. NSP6 
NSP6 is the least well characterized of all of the rotavirus proteins, it is 
encoded in a + 1 alternate reading frame in gene segment 11 which lies entirely 
within the NSPS ORF. NSP6 is a 92-98 amino acid protein depending on the strain 
and has been suggested to localise to viroplasms in virus infected cells (Matti on et 
al., 1991). Yeast two hybrid and co-immunoprecipitation experiments from cells co-
transfected with the NSPS and NSP6 ORF's, have shown it to interact with NSP5. 
This interaction has been localised to the C-terminal region ofNSP5 which has been 
shown to be involved in both NSP5 dimerisation and hyperphosphorylation (Torres-
vega et al., 2000). Sequence analysis of gene 11 from different virus isolates has 
revealed that not all of them appear to actually encode NSP6 protein. Two human 
virus isolates Mc323 (Kojima et ai., 1996) and SI2-C (Wu et al., 1998) do not 
possess the NSP6 start codon, while the Alabama strain of lapine virus (Gorziglia et 
al., 1989) and the porcine OSU strain (Gonzalez & Burrone, 1989) both appear to 
have truncated open reading frames for NSP6. Also group B and group C gene 
segment 11 sequences do not contain the NSP6 ORF. The group B gene 11 sequence 
shows low sequence identity compared to the group A gene 11 sequences. However 
there is 71.9% nucleotide sequence similarity between group B gene 11 sequences 
(Petrie et al., 1991). The lack of conservation of NSP6 in some rotavirus strains and 
low level of expression found within virus infected cells, has led to the suggestion 
that NSP6 may playa non-essential regulatory role during the virus replication cycle 
(Mattion et al., 1991; Torres-vega et al., 2000; Lopez et al., 2005). 
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1.6. The Rotavirus Replication cycle 
1.6.1. Rotavirus replication 
Rotaviruses replicate entirely within the cytoplasm and have a lytic lifecycle 
(Estes, 2001). The replication cycle when studied in monkey kidney cells produces 
the maximum virus yields in 10 - 12 hours (McCrae & Faulkner-Valle, 1981) 
however, in differentiated human intestinal cell lines replication appears to be much 
slower with maximum virus yield detected at 20 - 24 hours (Jourdan et al., 1997). 
The virus particle contains all the enzymes necessary for the generation of mRNA 
and dsRNA. The positive sense RNA transcripts, generated by these enzymes can 
act as mRNA or templates for minus-strand synthesis (Estes, 2001). All viral RNA 
synthesis appears to occur in large electron dense cytoplasmic occlusion bodies 
termed viroplasms (Silvestri et al., 2004). Double layered particles are formed 
within the viroplasms and an unusual feature of the rotavirus life cycle is the 
transient envelope stage gained by double-layered particles budding through the ER 
membrane after which the final outer layer of the virion is acquired. Progeny virions 
are released mainly, but not exclusively by cell lysis rather than through budding at 
the cell surface (Estes, 2001). The rotavirus replication cycle is summarised in figure 
104. 
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Figure I.S Rotavirus replication cycle 
The virus particle attaches to the host cell mediated by the cleavage of VP4 to VP5* 
and VP8*. Entry has been shown to be lipid raft dependent but virus particles have 
been detected by electron microscopy to enter the cell by coated pits and found 
internally in intracellular vesicles. Once internalised, the virus quickly loses its 
outershell and transcription is activated within the double-layered particles. 
Translation of viral mRNA is enhanced by the NSP3 protein which specifically 
binds viral mRNA and replaces P ABP in the initiation complex. The non-structural 
proteins NSP2, NSP5 and NSP6 form viroplasms within which VP 1, VP2, VP3 and 
VP6 have been localised. Secondary transcription, replication of the dsRNA genome 
and the formation of new double layered particles occur within the viroplasm. The 
VP7 and NSP4 proteins localise to the ER and via the NSP4 protein which acts as an 
intracellular receptor the double-layered particles bud from the viroplasm into the 
ER. Transiently enveloped virus particles are formed and subsequently triple layered 
particles. The mature triple layered virus particles then exits the cell by host cell 
lysis or by non-classical vesicular transport. 
Adapted from Estes, 2001, with cryoEM images taken from Schneider & Mohr, 
2003; Jayaram et ai., 2004; Pesavento et ai., 2005. 
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1.6.2. Attachment 
Rotavirus attachment and entry is a multistep process that involves the 
interactions of several molecules (Mendez et al., 1999; Lopez & Arias, 2004). Only 
triple layered particles have been shown to be infectious (Crawford et al., 1994; 
Jourdan et al., 1998). Virus attachment has been proposed to be by VP4 (Crawford 
et al., 1994; Ruggeri & Greenberg, 1991) or by its cleavage product VP5* (Zarate et 
al., 2000), however the proteolytic cleavage of VP4 to VP5* and VP8* is not 
required for cell binding (Clark et al., 1981; Fukuhara et al., 1988). Rotaviruses have 
a specific cell tropism in vivo infecting the mature enterocytes of the villi of the 
small intestine however; spread of the infection through the intestine has been 
observed (Mossel & Ramig, 2(03). 
Some animal rotaviruses have been shown to require sialic acid for 
attachment, as demonstrated using neuraminidase (NA) treated cells which showed a 
great reduction in rotavirus infection levels (Bastardo & Holmes, 1980). The 
infectivity of the majority of human isolates was not however blocked by NA 
treatment, these isolates being termed NA-resistant (Yolken et al., 1987; Fukudome 
et al., 1989; Ciarlet & Estes, 1999). NA-resistant strains may still use sialic acid for 
attachment as SA moieties that are internal in the oligosaccharide but are not 
affected by NA however, these experiments were perfonn in tissue culture and not in 
the gut environment (Delorme et ai., 200 I). The VP4 genotype appears to be the 
critical factor in conveying NA sensitivity (Ciarlet et al., 2002). Several SA 
containing cellular receptors have been identified for different rotavirus strains, such 
as the ganglioside OM3 for porcine strain OSU (Rolsma et al., 1998) and 
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ganglioside GMI in the case of the human strain KUN and MO (Guo et al., 1999). 
Recent work suggests that the binding of SA by VP4 causes a conformational 
change in the VP4 molecule leading to the trimeric VP5* form which may have 
further post attachment interactions with other cellular receptors (Pesavento et al., 
2005). 
Rotavirus appears to interact sequentially with several proteins and recently a 
model of rotavirus entry has been proposed (Figure 1.5) (Lopez & Arias, 2004). This 
suggests that the VP8 subunit of VP4 protein interacts with the SA containing 
receptor (Fiore et al., 1991; Fuentes-Panana et al., 1995). The binding ofVP8 to the 
SA receptor has been proposed to trigger a conformational change in VP4 to form 
the trimeric VP5* (Lopez & Arias, 2004). The binding of integrin a2pI has been 
implicated in attachment of some strains and observed to be involved in post 
attachment interaction events in others (Ciarlet et al., 2002; Graham et al., 2003; 
Londrigan et al., 2003). The interaction between a2p I has been localised to the DGE 
motif on VP4 an area located within the VP5* subunit and is proposed to be the 
second interaction after SA binding (Zarate et al., 2000; Lopez & Arias, 2004). Post 
attachment interactions appear to play a vital part in virus infection and after the 
initial interactions of VP5* and VP8* with SA and a2p t three other host cell 
proteins appear to be involved in virus infection. These are hsc70 and the integrins 
avp2 and axp3. The interaction of hsc70 with the virus is mediated by VP5* in a 
domain between amino acids 642 to 658 (Zarate et al., 2003; Guerrero et al., 2002). 
The interaction with avp2 and (lxP3 appears to be mediated by VP7 (Guerrero et al., 
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2000; Zarate et al., 2000; Graham et al., 2003). The order these latter interactions 
occurs in still remains unclear (Lopez & Arias, 2004). 
Ganglioside GMI subunits a2 and ~3 as well as hsc70 have all been 
associated with lipid rafts and virus particles have also been found to localised to 
these cholesterol rich membrane lipid domains during infection (lsa et al., 2004). 
Evidence for the involvement of lipid rafts in the attachment of rotavirus comes 
from experiments using inhibitors ofN-glycosylation and glycolipid synthesis which 
dramatically reduce the levels of virus infection (Guerrero et al., 20(0). 
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Figure 1.6 A model for rotaviru attachment to a host cell 
Cell membrane 
The suggested initial contact of the virus with the cell surface i between a sialic 
acid ( A)-conta ining cel l receptor and the VP8* domain of VP4 protein. This initial 
interaction of the viru with SA probably induces a conformational change on VP4, 
which allows the viru to subsequently interact with integrin a2p I, through the DGE 
domain on VP5*. Once these initial event have occurred three more interaction are 
thought to take place, these are between: (i) the KID domain of VP5 and the ligand-
binding domain of h c70, (ii) the C P region of VP7 and integrin avp3, and (iii) the 
GRP domain of VP7 and integrin axp2. The exact order of the e attachment event 
remains unclear but ultimately leads to entry, uncoating of the virus and activation of 
transcription of the double-layered particle een here in blue. 
Adapted from Lopez & Arias, 2004 
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1.6.3. Rotavirus entry and un coating 
Early electron microscopy studies suggested that rotavirus entry might be 
mediated by endocytosis, rotavirus particles were detected in coated pits and in a 
variety of vesicles (Perie et at., 1981; Quan & Doane, 1983). However, electron 
microscopy has also been used to show that trypsin treated virus entered the cells by 
direct membrane penetration whereas non-trypsinated virus entered cells by 
endocytosis in a process which did not lead to productive infection (Suzuki et at., 
1985). Later experiments using drugs that block the acidification of endosomes and 
the transport of endocytic vesicles had no effect on infectivity suggesting that 
endocytosis is not involved in virus entry (Fukuhara et ai., 1987; Ludert et ai., 1987; 
Kaljot et ai., 1988; Bass et ai., 1995; Cuadras et ai., 1997). By contrast the drug 
bafilomycin A 1 which inhibits the endosomal proton-ATPase pump did block 
rotavirus infection (Chemello et al., 2002) In addition solublised VP4 and VP7 have 
been shown to permiablise membranes (Charpilienne et al., 1997) as has the 
hydrophobic domains of the VP5* cleavage product (Denisova et ai., 1999; Dowling 
et ai., 2000). These observations have lead to the suggestion that an endosomal 
protein driven-ATPase pump may lead to a lowered Ca2+ concentration causing 
solublisastion of the outer capsid proteins and permeabilisation of the endosome and 
release of the double-layered particle into the cytoplasm (Chemello et at., 2002). Set 
against this is other evidence suggesting that endocytosis is not involved in virus 
entry. Drugs and dominant negative mutants which impair clathrin and caveolae-
mediated endocytosis were found to have no effect on the entry of rotaviruses. 
However, dominant negative cell mutants which do not express dynamin, a GTPase 
48 
known to be involved in membrane scission events could not be infected (Sanchez-
San Martin et al., 2004). These observations and the apparent dependence of lipids 
for viral entry may suggest that rotavirus may enter by a raft-dependent endocytosis 
pathway (Nabi & Le, 2003). 
Virus uncoating appears to be dependent on Ca2+ concentration changes 
which lead to the loss of the outer coat protein and activation of the virion associated 
RNA dependent RNA polymerase. This can also be achieved in vitro by the use of 
chelating agents such as EDT A (Cohen et al., 1979). 
1.6.4. Transcription 
Rotavirus transcription occurs within the double-layered particle after 
uncoating and requires ATP (Spencer & Arias, 1981). Under single step growth 
conditions with the SAIl strain of virus growing in monkey kidney cells the 
maximum levels of transcription can be detected at 9 to 12 hours post infection 
(Stacy-Phipps & Patton, 1987). The transcriptase complex fonned by VPl and VP2 
has been localised to the five fold axes of the VP2 shell (Prasad et ai., 1996). It has 
been proposed that there are 12 VPI-VP3 heterodimers one at each five axes fold 
anchored by interactions with VP2 (Luongo et al., 2000; Ramadevi et al., 1998; 
Sandino et al., 1994). The genome has been detected by cryo EM microscopy to be 
organised into ordered concentric layers within the core structure and it has been 
suggested that it winds around the replicase complex in a spiral (Gouet et al., 1999; 
Prasad et ai., 1996; Reinisch et al., 2000). Newly transcribed RNA exits the core via 
the type I channels in the VP2 layer (Lawton et al., 1997). Each of the transcriptase 
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units appears to function independently each possibly only transcribing a single 
strand of the genome, this independent nature can be seen in the observations that 
mRNA of each genome segment is not produced in equimolar amounts, whereas the 
dsRNA genome is made in equimolar amounts during its replication (Johnson & 
McCrae, 1989; Patton, 1990). There is some evidence to suggest that the RdRP 
complex can reengage the 5' -end of the template RNA after finishing transcription at 
the 3' -end, as the two are thought to be in close proximity to each other (Banerjee & 
Shatkin, 1970; Cohen, 1977; Spencer & Arias, 1981; Yazaki et al., 1986). The viral 
transcripts are all positive sense full length copies of the minus strand from the 
dsRNA template (McCrae & McCorquodale, 1983). There is also evidence that 
control of viral gene expression occurs at the transcriptional and translational level 
(Johnson & McCrae, 1989). 
1.6.5. Translation 
Rotavirus mRNA does not contain a polyadenylation signal and is not 
polyadenylated nevertheless, the final four bases of the rotavirus mRNA (GACC) 
have been shown to be a translational enhancer (Chizhikov & Patton, 2000). It has 
been suggested that the 5' and 3' termini of the mRNA's form stable pan handle 
structures during translation (Patton et aI., 1993; Patton et ai., 1996). The pan 
handles do not form perfect duplexes with the 3' termini and the importance of the 
single stranded nature of the 3' terminus has been shown in two ways. First, 
mutations of the 5' terminus create complementary base pairing with the 3' terminus 
which greatly reduces dsRNA synthesis. Alternatively the annealing of 
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complementary deoxyoligonucleotides to the 3' consensus sequence abolished 
dsRNA replication, whereas annealing of oligonucleotides to other parts of the 
mRNA had no effect on synthesis (Chen & Patton, 1998). The levels of viral 
mRNA's and proteins were measured in virus infected cells revealing that there was 
quantitative and temporal control of gene expression at both the transcriptional and 
translational levels (Johnson & McCrae, 1989). Evidence suggests that post-
transcriptional control of rotavirus gene expression is mediated by translational 
efficiency of individual viral mRNAs (Mitzel et al., 2003). 
Rotaviruses cause host cell shut off by blocking translation of cellular 
mRNA which leads to preferential translation of viral mRNA. The rotavirus non-
structural protein NSP3 has been found to be a functional homolog of P ABP and 
binds with a higher affinity to eIF4G (Both et al., 1984; Eiden, 1993; Quin et ai., 
1991 and Grofts & Burley, 2002). The NSP3 protein specifically binds to the 3' 
terminus of viral mRNAs by the consensus sequence UGACC and because it 
competes more effectively with P ABP for binding of the translation initiation 
complex, viral mRNA is preferentially translated. This leads diminished host cell 
protein synthesis as capped and polyadenylated cellular mRNA can no longer access 
the translational machinery (Poncet et ai., 1994). 
51 
1.6.6. Genome replication 
Plus and minus strand synthesis can both be detected at 3 hours post 
infection (Stacy-Phipps & Patton, 1987; McCrae & Faulkner-Valle, 1981), the level 
of minus strand synthesis peaks at 6 to 9 hours post infection in monkey kidney cells 
which is somewhat earlier than the maximum of plus sense strand. The delay in the 
maximum amount of plus strand production has been postulated as being due to the 
accumulation of proteins required for the assembly of transcriptase particles (Stacy-
Phipps & Patton, 1987). The synthesis of dsRNA is thought to occur within subviral 
particles after segment selection and packaging, meaning that genome assortment of 
viral mRNA must occur prior to RNA replication. During this process, each 
individual virion acquires a single copy of each individual genome segment. How 
this occurs and the mechanism and signals involved is unclear, however the 
consensus sequences found at the 5' and 3' tennini are thought to be involved in 
directing packaging of mRNA molecules (McCrae & McCorquodale, 1983). The 
UTR regions of each gene segment are found to be highly conserved and are thought 
to be involved in directing genome segment specific encapsidation (Clarke & 
McCrae, 1983; Desselberger & McCrae, 1994). 
Within the viroplasms three distinct species of replication intennediate (RI) 
have been detected, tenned the pre-core RI, the core RI and the double-layered RI. 
The pre-core RI appears to be composed of viral RNA plus VP 1 and VP3 and the 
non-structural proteins NSPI and NSP3 (Gallegos & Patton, 1989). The fact that 
only NSPI and NSP3 reproducibly co-purify with the precore RI suggests that these 
complexes maybe assembled on the cytoskeleton (Patton, 1995). 
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The core RI contains all of the structural proteins found within the rotavirus single 
shelled core particle (VPl, VP2 and VP3) as well as containing the non-structural 
proteins NSP2 and NSP5. The double-layered RI is identical to the core RI with the 
exception that it also contains the VP6 protein (Gallegos & Patton, 1989). 
Recent evidence suggests that mRNA is primarily produced within the 
viroplasms and that no pathways exist for the importation of mRNA into the 
viroplasms, which if correct points to the presence of two separate species of 
positive sense RNA those that exit from the viroplasms which act as mRNA and 
those that are retained within the viroplasms that are utilised as templates for minus 
strand synthesis and the formation of dsRNA (Silvestri et al., 2004). 
Cis-acting signals involved in genome replication have been localised within 
the 26 3'-terminal non-coding region in vitro (Chen et al., 1994). Deletion mutants 
were analysed to define the minimal promoter for minus strand synthesis which was 
found to be the seven 3' terminal nucleotides 5'UGUGACC-3' (Wentz et al., 1996; 
Patton et al., 1996). The 5' UTR and the initial part of the 3' UTR have been shown 
to contain sequences that stimulate RNA replication. They are thought to act by 
complementary binding to create a pan handle structure which promotes RNA 
replication (Chen & Patton, 1998). The single stranded nature of the 3'-terminus in 
this structure has been shown to be essential for minus strand synthesis (Chen et al., 
2001). Complementary oligonucleotides to non-conserved sequences present either 
at the 5' or 3' termini blocked replication of their specific target gene but not that of 
other viral genes, indicating that non-conserved sequences in the rotavirus segment 
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tenninal regions contain gene specific infonnation that promotes RNA replication 
(Barro et al., 2001). 
1.6.7. Virus assembly and release 
Rotaviruses are thought to assemble sequentially with the VP2 layer being 
applied to the pre-core followed by the VP6 layer to fonn double-layered particles 
(Patton & Gallegos, 1990). Both these processes occur within the viroplasms 
(Richardson et al., 1986). 
The double-layered particles move from the viroplasms by budding into the 
ER, a process that leaves a transient membrane around the double-layered particle. 
Rotavirus maturation is dependent on the Ca2+ concentration (Shahrabadi & Lee, 
1986) and double-layered particles will not bud into the ER in the absence of Ca2+ 
(Shahrabadi et al., 1987). 
VP7 and NSP4 are localised within the ER and are co-translationally 
glycosylated before insertion into the ER membrane (Ericson et al., 1983; Kabcenell 
& Atkinson, 1985). The C-tenninus of NSP4 has been proposed to be the 
intracellular receptor for double-layered particles and mediate their transport into the 
ER (Au et al., 1993; Taylor et ai., 1992; Taylor et al., 1993), NSP4 has also been 
implicated as being involved in the removal of the transient membrane from budded 
double-layered particles (Tian et al., 1996) a process that involves NSP4 
glycosylation (Suzuki et al., 1984). It is within the ER that the outer layer of VP4 
and VP7 is assembled to give mature virions in a process that is not fully understood 
(Estes, 2001). 
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Once mature virions have been assembled they are released by host cell lysis 
(Altenburg et al., 1980; McNulty et al., 1976). However, a large fraction of this viral 
yield remains associated with cell debris after lysis, suggesting a possible role for the 
cellular cytoskeleton in virus assembly and transport (Musalem & Espejo, 1985). 
1.7. Effect on host cell 
Rotaviruses infect mature enterocytes of the villi of the small intestine 
leading to shortening and atrophy of the villi, distended cisternae in their ER, 
mitochondrial swelling and sparse irregular microvilli (Moon, 1994). Malabsorption 
of damaged intestinal villus enterocytes has been thought to be the major 
contributing factor to rotavirus induced diarrhoea. However, studies on piglets and 
mice detected diarrhoea ahead of detectable damage to the villi (Ward et al., 1996; 
Shaw et al., 1995). This observation has led to the suggestion that the enteric 
nervous system (ENS), activated by intestinal inflammation is a major contributing 
factor in the onset of diarrhoea by triggering secretion of electrolytes and water from 
the small intestine (Lundgren et al., 2000). The intestinal inflammation observed 
may be related to the toxic effects of the NSP4 protein which causes an increase in 
Ca2+ penneability of the membrane (Tian et al., 1994). 
Host cell shut off has been detected in infected cells by 4 hours post infection 
(McCrae & Faulker-Valle, 1981) and recently the NSP3 protein has been shown to 
be involved in the shut off of cellular translation (Padilla-Noriega et al., 2002). The 
membranes of infected cells also display increased permeability to calcium, sodium 
and potassium at 4 hours post infection (Michealgeli et al., 1991). 
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1.8. Vaccine development 
The mortality and economic cost of rotavirus related disease has prompted 
efforts to develop an effective vaccine. Several problems have been encountered in 
the development of a vaccine, the complex nature of the protective immune response 
against infection, the great antigenic diversity of rotaviruses, the variety of animal 
reservoirs, and the short lived nature of the protective immunity (Offit, 1994; Conner 
et al., 1994). Most efforts have concentrated on the generation of live attenuated 
strain vaccines in order to stimulate local intestinal immunity as evidence has 
suggested that protection is related to the generation of IgA antibodies (Offit, 1994; 
Kapikain et aI., 2001). 
Initial vaccine efforts focused on a Jennerian approach using an attenuated 
antigenically related virus derived from a non-human host (Kapikian, 1994). The 
first three vaccines generated by this method had varying ranges of efficacy with 
between 0 and 76% protection against any rotavirus diarrhoea and 0 to 100% against 
severe disease (Parashar et aI., 1998). In order to improve the efficacy of the vaccine 
a modified Jennerian approach was developed, in this approach a human/animal 
recombinant virus was constructed expressing all of the four major serotype VP7 
molecules (Parashar et al., 1998). 
The Rotashield™ vaccine was launched in 1998 by Wyeth Lederle and was a 
rhesus-human reassortant tetravalent (RR V-TV) rotavirus vaccine. The vaccine was 
approved by the food and drug administration (FDA) in the USA and recommended 
by both the Advisory Committee on Immunization Practice (ACIP) and the 
American Academy of Paediatrics for vaccination to begin on children in the USA. 
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Over the following nine months 1.2 million doses were given to an estimated 
600,000 children (Glass et ai., 2005). In July of 1999 the Center of Disease Control 
(CDC) reported that 15 cases of intussusception had been identified by the vaccine 
adverse events reporting system (V AERS) (CDC, 1999). Later that month the 
vaccine was suspended and by October had been withdrawn from the market by 
Wyeth Lederle (Glass et al., 2005). 
Since the withdrawal of the Rotashield® vaccine two new live attenuated 
vaccines are under development. Merck are developing RotaTeq® which is a 
pentavalent human-bovine reassortment and OlaxoSmithKline (OSK) are 
developing RotaRix® a monovalent attenuated human serotype 01 strain (Glass et 
al., 2005). 
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1.9. Aims of Study 
The aim of this thesis was to investigate the function(s) of the gene products 
of gene 11, the smallest of the rotavirus gene segments. Features of the NSP5 and 
NSP6 proteins were studied in vitro and in vivo in order to elucidate greater 
understanding of these two rotavirus non-structural proteins of unknown function. 
58 
Materials and Methods 
Chapter 2 
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2.1. Suppliers 
General chemicals were supplied by BDH Laboratory Suppliers, Fisher 
Scientific Equipment (Loughborough, Leicestershire), Merck Ltd., (Poole, Dorset) 
and Sigma-Aldrich Company Ltd, (Gillingham, Dorset), all were of an analytical 
and/or molecular biological grade. Double distilled water was always used 
throughout this study. Unless otherwise stated equipment and reagents were 
obtained from the following suppliers: 
Applied Biosystems (Warrington, Yorkshire) 
BigDye Terminator (v3.1) Ready Reaction Cycle Sequencing Kit. 
Bio-Rad Laboratories (Hemel Hempstead, Hertfordshire) 
Ammonium persulphate, N,N-methylene-bis-acrylamide, TEMED, sodium dodecyl 
SUlphate (SDS). 
Difco Laboratories (Basingstoke, Hampshire) 
Bacto-agar, Bactor-tryptone, Yeast extract. 
Fermentas UAB (Vilnius, Lithuania) 
Prestained Protein Ladder 10-180 KDa. restriction and modification enzymes. 
Fuji Photo Film Company Ltd (Tokyo, Japan) 
Fuji medical X-ray film. 
60 
GE Healthcare, Amersham Biosciences (Amersham, Buckinghamshire) 
Hybond™ Nitrocellulose membranes, DAPI, Glutathione Sepharose 4B, RNAguard 
™ RNase inhibitor (porcine), esS] Methionine (37TBq/mmol), a-ezp] VTP 
(30TBq/mmol), Amplif/M fluorographic reagent. 
Gibco-BRL Life Technolnologies Ltd. (Renfrewshire) 
Restriction and modification enzymes, Taq DNA polymerase, 1 Kb DNA marker, T4 
RNA ligase. 
Harlan Sera Labs (Bicester UK) 
Monospecific anti-NSP5 sera. 
Invitrogen Corporation, R&D Systems Ltd (Abingdon, Oxfordshire) 
TA CloningTM System, restriction and modification enzymes, Taq DNA polymerase, 
1 kb DNA ladder, Lipofectamine™ 2000 Reagent, G418. 
Immune Systems Ltd. (ISL), (UK) 
Monospecific anti-NSP6 sera 
Molecular Probes Europe BV (Leiden, The Netherlands) 
Alexafluor 466 and 594 secondary antibodies 
Isoproply-J3-D-thigalactopranoside (lPTG), Guanidine Hydrochloride. 
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New England Biolabs (UK) Ltd (Hitchin, Hertfordshire) 
Restriction enzymes. 
Novagen, Merck Biosciences Ltd., (Beeston, Nottinghamshire) 
Restriction grade Factor Xa, Protease Inhibitor Cocktail II, PET 42b cloning kit, 
pET15 vector, 
Promega (UK) Ltd, (Southampton) 
Taq DNA polymerase, Reverse Transcriptase. 
TNT® quick coupled Transcription/translation system. 
Qiagen Ltd, (Crawley, West Sussex) 
Gel extraction kit, DNA miniprep, QIA quick Gel extraction kit, QIAprep Spin Mini 
prep kit. 
Roche Diagnostics Ltd, (Lewis, East Sussex) 
Complete, Mini, EDT A-free protease inhibitor cocktail tablets. 
Sigma-Aldrich Company Ltd (Gillingham, Dorset) 
Butanol (molecular biology grade), trypsin, kanamycin, ampicillin, SigmaSpin™ 
Maxiprep kit, FITC conjugated goat anti-rabbit Immunoglobulin, High capacity 
Nickel Chelate Affinity Matrix (Ni-CAM) resin. 
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Strata gene (UK) 
PhrGFP-C vector, phrGFP-N vector. 
Whatman International Ltd (Maidstone, Kent) 
Filter paper Grade 5 (70mm) 
Department of Biological Sciences, University of Warwick - Media Preparation 
LB broth, LB agar, MEM, G-MEM, DMEM, penicillin-streptomycin, Versene, 
trypsin, phosphate buffered saline (PBS), lOX TBE, lOX protein running buffer, 
lOX protein transfer buffer. 
2.2. Materials 
2.2.1. Standard buffers and solutions 
SX SDS-PAGE loading buffer: 0.312M Tris-HCL (PH 6.8) 5% (w.v) SDS, 25% 
(v/v) f3-mercaptoethanol, 25% (v/v) glycerol, 0.25% (v/v) bromophenol blue. 
SDS-PAGE Staining solution: 0.1% Coomassie blue, R 50% Methanol, 10% 
glacial Acetic acid. 
SDS-PAGE Destaining solution: 5% Methanol, 10% glacial Acetic acid. 
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4X Bis-Tris sample buffer: 4.0g Glycerol, 0.689g Trisma base, 0.666g Tris-Hel, 
0.8 g SDS, 6mg EDT A in 10mi solution. 
5 X Agarose gel loading buffer: 5X TAE/TBE, 50% (v/v) glycerol, 0.01% (w/v) 
bromophenol blue, 0.01% (w/v) xylene cyanol ff. 
Chloroform/lsoamyl alcohol: 96% chloroform, 4% (v/v) iso-amyl alcohol. 
Luria Broth (LB): 1 % (w/v) bactotryptone, 0.5% (w/v) NaCl, 0.5% (w/v) yeast 
extract. 
LB agar: LB containing 1.5% (w/v) bacto-agar 
Phosphate buffer saline (PBS): 137mM NaC!, 2.7mM KCL, 4.3mM Na2HP04, 
l.4mM KH2P04. 
Phenol/chloroform/Isoamyl alcohol: 50% (v/v) Tris buffered phenol, 48% (v/v) 
chloroform, 2% (v/v) iso-amyl alcohol. 
T AE (IX): 40mM Tris Acetate, 2mM EDT A pH 8.0. 
TBE (IX): 89mM Tris. base, 89 mM boric acid, 2mM EDT A pH 8.0. 
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TE: 10mM Tris. HCL pH 8.0, ImM EDT A. 
Tissue Culture Media: Sterile PBS, Trypsin (0.25% in Tris-Saline), Versene 
(0.02% in PBS), L-glutamine (200mM), 5% NaHC03, penicillin and streptomycin 
sulphate (lOO,OOO,OOOU/IOOg in 200ml PBS), and tissue culture media including: 
Dulbecco's modification of Eagle's minimal essential medium (DMEM), Glasgow's 
modification of Eagle's minimal essential medium (GMEM) plus non-essential 
amino acids (NEAA; O.89g L-alanine, 1.1Sg L-asparagine'H20, 1.33g L-aspartic 
acid, 0.7Sg glycine, 1.45g L-glutamic acid, 1.15g L-proline and 1.05g L-serine/litre) 
and IX, 2X and GMEM minus methionine, valine, leucine and NaHC03. 
Preparation of the above was by the media preparation staff of the Department of 
Biological Sciences, University of Warwick. Foetal Calf Serum purchased from 
Gibco BRL. 
2.2.2. Bacterial Strains. 
The Bacterial strains E.coli INVaF' was obtained from the invitrogen TA 
Cloning™ System TA. The pET system host strain E. coli BLR (DE3) was obtained 
from Dr. D. Stott, University of Warwick. 
2.2.3. Bacterial Growth Conditions. 
The E. coli strains and BLR (DE3) were grown in LB media in the presence 
of absence of appropriate antibiotic. Liquid media was converted to solid media by 
the addition of agar (1Sg/L) prior to autoclaving. 
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2.2.4. Oligonucleotide Primers for peR 
Primer name Sequence Details 
NSP6 ORF PCIneo 5' 5- 5' primer to insert NSP6 
GCGCTCGAGACCATGAA ORF into the PClneo 
TCATCTTCAACAGCGTCA 
vector AC-3' 
NSP6 ORF PClneo 3' 5'- 5' primer to insert NSP6 
GCGTCTAGATCACTTTAA ORF into the PCIneo 
TTCCTTTA TT AAAG-3' 
vector 
NSP5 His tag 5' 5'- 5' primer used for the 
GCGCATATGCACCACCA addition of a 6 histidine CCACCACCACATGTCTCT tag for the NSP5 ORF CAGTA TTGACGTGAC-3 
NSP5 His tag 3' 5'- 3' primer used for the 
CTGCAGGTGACCTCTCA addition of a 6 histidine GGTCAGACCTACA- 3' tag for the NSP5 ORF 
NSP6 His tag 5' 5'- 5' primer used for the 
GCGCATATGCACCACCA addition of a 6 histidine CCACCACCACATGAATC tag for the NSP6 ORF ATCTTCAACAGCGTCA-3 
NSP6 His tag 3' 5'- 3' primer used for the 
CTGCAGGATGAATCTAG addition of a 6 histidine GTTCGCATTCACT-3' tag for the NSP6 ORF 
NSP6 ORF phrGFP-Nl 5'- 5' primer used to insert 
5' GGAATTCCTCGAGGGCT the NSP6 ORF into the 
TTTAAAGCGTCTCAGTCG phrGFP-Nl vector 
-3' 
NSP6 ORF phrGFP-Nl 5'- 3' primer used to insert 
3' GCGTCTAGACTGCAGGT the NSP6 ORF into the CACATAAGCGCTTTCTAT phrGFP-Nl vector TCTTG-3' 
Actin ORF PClneo 5' 5'- 5' primer used to insert 
GCAGGCTAGCATGGATG the actin ORF into the ATGATATCGCCGCGCT -3' PCIneo vector 
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Actin ORF PClneo 3' 5'- 3' primer used to insert 
GCGGCTCGAGCTAGAAG the actin ORF into the CATTTGCGGTGGA-3' PClneo vector 
Genell-CAT Step 1 5'- First 5' primer used for 
TCTTCTAGTATTTATAAA the addition of the 5' of AATGGAGAAAAAAATCA gene 11 to the 5' of the CTGGATATAC-3 ' 
CATORF 
Gene II-CAT Step 2 5'- Second 5' primer used 
GACGTGACGAGTCTTCC for the addition of the 5' 
TTCTATTTCTTCTAGTAT 
of gene 11 to the 5' of TT ATAAAAA TGATGGA-
3' theCATORF 
Gene II-CAT Step 3 5' -GCGGCG CTC GAG Third 5' primer used for 
ATG TCT CTC AGT ATT the addition of the 5' of GAC GTG ACG AGT CTT gene 11 to the 5' of the CCT TCT ATITC-3' 
CATORF 
Gene II-CAT Step 4 5'- Forth 5' primer used for 
GCGCTCGAGGGCTTTTA the addition of the 5' of 
AAGCGCTAAAGTGATGT gene 11 to the 5' of the CTCTCAGTATTGACGTGA 
CGAGTC-3' CAT ORF and for 
insertion into the PCIneo 
vector 
Gene II-CAT 3' primer 5'TATTCT AGA TTACGCC 3' primer used for the 
CCGCCCTGC-3 ' amplification of the 
gene It-CAT fusion for 
cloning into the PClneo 
vector 
Gene 11 PClneo 5' 5'- 5' primer to insert 
GCGCTCGAGGGCTTTTA gene 11 sequence into the 
AAGCGCTACAGTG-3' PCIneo vector 
Gene 11 PClneo 3' 5'- 3' primer to insert 
GAATCTAGACTGCAGGT gene 11 sequence into the CACAAAACGGGTGTGGG PCIneo vector G-3' 
NSP5 ORF PClneo 5' 5'- 5' primer to insert NSP5 
GCGCTCGAGTACAGTGA ORF into the PCIneo 
TGTCTCTCAGTAT-3' 
vector 
NSP5 ORF PCIneo 3' 5'- 3' primer to insert NSP5 
GCGTCTAGAACCTCTCA ORF into the PClneo GGTCAGACCTACA-3 ' 
vector 
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NSP5 phrGFP-Nl 5' 5'- 5' primer used to insert 
CGCGAGCTCATGTCTCTC the NSP5 ORF into the AGTATTGACGTG-3' phrGFP-Nl vector 
3' primer used to insert NSP5 phrGFP-Nl 3' 5'-
GCCAAGCTTCTACAAAT the NSP5 ORF into the CTTCGATCAATTGCAT -3' phrGFP-NI vector 
ORFI 5' Cia I 5'- 5' primer used to clone 
CCTATCGATGTCTCTCAG ORFI intoTA2.1 TATTGACGTGACGAGTC before insertion into the T-3' 
pET -42b vector 
5'- 3' primer used to clone ORFI3' 
CTGCAGGTGACCTCTCA ORFI into TA 2.1 GGTCAGACCTACA-3 ' before insertion into the 
pET -42b vector 
ORF2 5' Cia I 5'- 5' primer used to clone 
CAGATCTGGCCATCGAT ORF2 into T A 2.1 GAATCATCTTCAA-3 ' before insertion into the 
pET -42b vector 
5'- 3' primer used to clone ORF23' 
CTGCAGGATGAATCTAG ORF2 into TA 2.1 GTTCGCATTCACT-3 ' before insertion into the 
pET -42b vector . 
Genell a22g 5' 5'- 5' primer used for ~lte 
GCGCTACAGTGGTGTCT directed mutagenesIs of CTCAGTAT-3' gene 11 ATG start c?don 
Genell a22g 3' 5'- 3' primer used for s.lte 
ATACTGAGAGACACCAC directed mutagenesls of TGTAGCGC-3' gene 11 ATG start codon 
Gene 1 1 t25g 5' 5'- 5' primer used for site 
GCTAGCCTCGAGATGGC directed mutagenesis to 
TCTCAGTATTGAC-3' improve kozak 
consensus sequence at 
ORFl start codon 
3' primer used for site Genell t25g 3' 5'-
GTCAATACTGAGAGCCA directed mutagenesis to 
TCTCGAGGCTAGC-3 ' improve kozak 
consensus sequence at 
ORFl start codon 
Genell-CAT-PClneo 5'- 5' primer used for site 
GAGGGCTTTTAAAGCGC directed mutagenesis to gI9a, a20c, g2Ic, t25g TACAACCATGGCTCTCA improve kozak 5' GTA TTGACGTGACG-3' 
consensus sequence at 
ORFI start codon 
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Genell-CAT-PCIneo 5'- 3' primer used for site 
gI9a, a20e, g2Ic, t25g CGTCACGTCAATACTGA directed mutagenesis to 
3' GAGCCATGGTTGTAGCG improve kozak CTTTAAAAGCCCTC-3 ' 
consensus sequence at 
ORFI start codon 
Genell t23c 5' 5'- S' primer used for site 
GCTAGCCTCGAGACGTC directed mutagenesis of 
TCTCAGTATTGAC-3' gene 11 ATG start codon 
Gene 1 1 t23c 3' 5'GTCAATACTGAGAGAC 3' primer used for site 
GTCTCGAGGCT AGC-3' directed mutagenesis of 
gene 11 ATG start codon 
2.3. Cell Culture 
2.3.1. Cell lines. 
The tissue culture cell line used in this study was BSCI African Green 
Monkey Kidney epithelial ECACC No 85011422 (ECACC: European Collection of 
Cell Cultures) cells were grown in GMEM supplemented with 5% FCS growth 
medium and L-glutarnine (2mM), penicillin (IOOU/ml) and streptomycin 
(1 OO~g/ml). 
2.3.2. Maintenance of tissue culture cells 
Mammalian cell lines were maintained at 37°C in a 5% C02 incubator in a 
humidified atmosphere (150cm2 flasks) using the appropriate media. When 
confluent, the cells were passaged as follows: cells were detached by rinsing the 
monolayer twice with versene followed by incubation with trypsinlversene (l :5) and 
disaggregation. Cells were re-seeded at a ratio of 1 :4. All manipulations were 
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performed under sterile conditions in a Class II Laminar Flow Cabinet using 
standard aseptic techniques. 
2.3.3. Freezing and recover of cell stocks 
Cell stocks were prepared by suspending the cells from a 150cm2 flask in 2ml 
of 8% (v/v) dimethylsulphoxide (DMSO) and 30% FCS in GMEM. Freezing vials 
were cooled slowly to -70% before immersion in liquid nitrogen for long term 
storage. Cell stocks were recovered by rapidly thawing at 37°C and adding the 
contents of one vial to a 150cm2 flask containing pre-warmed medium. The medium 
was changed or the cells passaged the following day. 
2.4. Antibody Production 
2.4.1. Anti-NSP5 
Monospecific anti-NSP5 serum was generated by Harlan Sera Labs 
(Bicester, UK). A single guinea pig was pre-bled and tested for rotavirus antibodies 
by indirect immunofluorescence. When the animal tested negative, it was injected 
i.m. with 200111 containing 251lg of purified His-NSP5 in PBS in the presence of 
Freud's complete adjuvant. The animal was sacrificed at day 30 and a final bleed 
taken. 
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2.4.2. Anti-NSP6 
Monospecific anti-NSP6 was generated by ISL Ltd. A New Zealand White-
Barrier rabbit was pre-bled and tested for rotavirus antibodies by indirect 
immunofluorescence. When the animal tested negative, it was injected 
intramuscularly (i.m.) with 500J,t1 containing 200J,tg of purified NSP6 in PBS in the 
presence of Freud's complete adjuvant. The animal was boosted with the same dose 
14 days later and five 5 ml bleeds were taken at 14 day intervals. The animal was 
sacrificed and a final bleed taken at day 70. 
A second monospecific antisera was generated by Harlan Sera Labs 
(Bicester, UK). Two rats were pre-bled and tested for rotavirus antibodies by 
indirect immunofluorescence. When the animals tested negative, it was injected i.m. 
with purified His-NSP6 100 J,tl containing 20 J,tg of purified His-NSP6 in PBS in the 
presence of Freud's complete adjuvant. The animal was boosted with the same dose 
7 days later and again 7 days after that followed a 200 J,tl test bleed taken 7 day after 
the final boost. The animals were sacrificed at day 35 and a final bleed taken. 
2.5. Tissue Culture based assays and analysis 
2.S.1. Virus Strains 
The tissue culture adapted Compton UK (Uktc) strain of bovine rotavirus (0 
serotype 6) was provided by Prof. M.A. McCrae. 
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2.5.2. Transfection 
For transient transfections BSC-l cells were grown to 80% confluence in 12 
well plates and transfected with 1.6~g DNA and 2~1 Lipofectamine 2000 
(Invitrogen). At 8 hours post transfection the DNA mix was removed and the cells 
overlaid with 2ml OMEM 1 % FCS and incubated for a further 40 hours. For 
experiments requiring transfection of a plasmid followed by infection with UKtc 
rotavirus the cells were infected at an m.o.i. of 3 at 48 hours post transfection and 
then fixed 8 hours post infection. 
2.5.3. Immunofluorescence microscopy and antibodies 
Expression of green fluorescent protein (OFP) was monitored by confocal 
microscopy. Transfected cells were washed once with phosphate buffered saline 
(PBS) and then fixed in 100% methanol at -20°C for 20 minutes and then washed 
twice with PBS. Transfected cells that were subsequently infected were fixed using 
the same procedure at 8 hours post infection. The intracellular distribution of NSP5 
was monitored by indirect immunofluorescence. For this, confluent BSC-l cells 
grown in 6 well tissue culture dishes were infected with the UKtc strain of bovine 
rotavirus at an m.o.i. of 3 and incubated for 2, 4, 6, 10, 16, or 24 hours p.i. To stain 
for NSP5 coverslips were blocked in 1 % bovine serum albumin (BSA) in PBS for 1 
hour, washed 3 times in PBS and then incubated with guinea pig anti-NSP5 serum 
(1:100) in PBS 1% BSA for 1 hour. The coverslips were then washed 3 times with 
PBS and incubated with (1: 100) Alexafluor 594 conjugated goat anti-guinea pig 
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serum (Molecular probes) and mounted for confocal microscopy using vector shield 
mounting media (Vector Laboratories). 
2.5.4. Pulse-chase analysis 
Confluent BSC-l cells grown in 6 well tissue culture dishes were infected 
with the UKtc strain of bovine rotavirus at an m.o.i. of 3. To analyse the time course 
of NSP6 synthesis cells were incubated in methionine free medium until it was 
replaced with 200~Ci of esS] methionine diluted in methionine free medium. Pulse 
labelling for 1 hour intervals was carried out starting at 1 hour post infection. For 
pulse-chase studies, cells were incubated for 3 hours after infection in methionine 
free GMEM and then radio-labelled for 5 hours in GMEM containing approximately 
200~Ci of 35S methionine. Where appropriate a two hour chase was carried out by 
incubating radio-labelled cells in GMEM containing 50X the nonnal methionine 
concentration. Radio-labelled cells were harvested into 500~1 of RIPA lysis buffer 
(50mM Tris-HCI buffer pH 7.4, 150mM NaCI, ImM EDTA, 1% Triton XlOO, 1% 
Sodium deoxycholate, 0.1 % SDS and 1 tablet per 10ml of Complete mini EDT A 
free protease inhibitor cocktail (Roche). 
2.5.5. Immunoprecipitation 
Immunoprecipitations were carried out by mixing 250J,l1 of radio-labelled 
cell lysate with an equal volume of 2X IP-3 buffer (20mM Tris-HCI buffer pH 8.0, 
100mM NaCI, ImM EDTA, 1% NP-40, 1% sodium deoxycholate) and adding 20~1 
of hyper-immune guinea pig anti-NSP5 or rabbit anti-NSP6 serum. After 2 hours of 
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incubation at 4°C, 5mgl100J,l1 of pre swollen protein A-sepharose CL-4B beads 
(Amersham) were added and incubation continued for a further 2 hours at 4°C. The 
beads were concentrated by centrifugation and resuspended in IP-2 buffer (20mM 
Tris-HCI buffer pH 8.0, 100mM NaCI, ImM EDTA, 1% NP-40, 1% Na-
deoxycholate, 20mg BSA). They were then washed sequentially in IP2 buffer 
containing 1M NaCl, IP-3 buffer (2X) and IP-l buffer (20mM Tris-HCI buffer pH 
8.0, 100mM NaCI, ImM EDTA, 1 % NP-40). Finally the beads were resuspended in 
40J,l1 of Tris-HCI pH 8.0 and lOJlI cracking buffer (50mM Tris-HCI pH 8.0, 10% 
SDS, 2.5% ~-mercaptoethanol, 50% glycerol and 0.01% bromophenol blue) added. 
Samples were then boiled for 5 minutes and proteins fractionated by PAGE on a 
14% gel. After electrophoresis the gel was fixed for 30 minutes (30% methanol-1O% 
acetic acid), soaked in Amplify (GE Healthcare) for 30 minutes, dried and 
fluorographed at -70°C. 
2.6. Molecular Biology techniques 
2.6.1. Quantification of DNA 
DNA was quantified by spectrophotometry. Absorbance readings was taken 
at 260nm where an absorbance of 1.0 was taken as indicating a concentration of 
50J,lglml for double stranded DNA or 20J,lg/ml for a single stranded DNA primer. 
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2.6.2. Agarose gel electrophoresis 
DNA samples were analysed on agarose gels containing between 0.8% and 
1.5% agarose and lflg/ml ethidium bromide in IX TAEffBE. DNA samples and 
IKb ladder were prepared by the addition of 115 volume of 5 X TAErrBE agarose 
gel loading buffer before being loaded into the prefonned wells. Electrophoresis 
was perfonned at 70mA in 1 X T AEITBE running buffer for 60 - 90 minutes. Bands 
were visualized using Grab-IT (Ultraviolet Products Ltd., Cambridge), an annotating 
image capture system and printed on a digital graphic printer. 
2.6.3. Phenol/Chloroform extraction 
An equal volume of phenol/chloroform/isoamyl alcohol was added to the 
DNA solution and mixed by vortexing. The phenol/chlorofonnlisoamyl alcohol 
fraction was separated from the aqueous phase by centrifugation for 1 minute in a 
microcentrifuge. The upper phase was removed and the lower phase discarded. The 
process was repeated and the resulting DNA solution was ethanol precipitated. An 
additional extraction using chloroform/isoamyl alcohol was perfonned before 
ethanol precipitation if additional purity was required. 
2.6.4. Ethanol precipitation of nucleic acids 
DNA was precipitated from solution by the addition of sodium acetate pH 
5.2 to a final concentration of 0.3M and 2.5 volumes ofice-cold 100% ethanol. After 
precipitation for 30 minutes - 1 hour at -20°C, DNA was pelleted by centrifugation 
in a microcentrifuge for 20 minutes at 15,000 rpm. The pellet was washed with 70% 
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(v/v) ethanol, dried under vacuum and resuspended in 50mM Tris-Hel pH 8.0 or TE 
buffer. Otherwise, one volume of isopropanol was used in place of 2.5 volume of 
ethanol to precipitate DNA. 
2.6.5. Dephosphorylation of vector DNA 
The 5' phosphate groups were removed from DNA using bacterial alkaline 
phosphatase (BAP) under the conditions recommended by the manufacturer. BAP 
was inactivated and removed by phenol/chloroform extraction 
2.6.6. Restriction enzyme digestion of DNA 
Restriction enzyme digests were performed under the manufacturer's 
recommended conditions using the supplied lOX buffer solutions. 
2.6.7. Blunt-ending of DNA 
Protruding 5' extensions were removed using Mung Bean Nuclease under the 
conditions recommended by the manufacturer or filled using the Klenow fragment 
of E. coli DNA polymerase I (Sambrook et al., 1989). 
2.6.8. Recovery of DNA from agarose gel 
DNA bands were excised from agarose gels under UV light using a sterile 
scalpel blade. The DNA was recovered using the QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturer's instructions. 
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2.6.9. Ligation of DNA fragments 
DNA fragments were ligated into dephosphorylated DNA vector molecules. 
Ligation was allowed to precede at 15°C overnight and contained insert DNA, 
vector DNA, 1.5111 lOX ligation buffer (0.66M Tris-HCL pH 7.6, 50mM MgC}z, 
50mM DTT, 100mM ATP) and 1 unit T4 DNA ligase in a total volume of 15).1.1. 
The DNA ligation mixture was ethanol precipitated and the vacuum dried pellet 
resuspended in 50111 of distilled water. 
T A cloning of PCR products into PCR2.1 (Invitrogen) was performed as per 
manufacturer's instructions using supplied reagents. 
2.6.10. peR amplification of viral genes 
A standard PCR was performed in a final volume 251-11. This contained 
200ng of template DNA, 0.5).1.M primer mixture, 1 X PCR mixture (2.8).1.1 lOX peR 
buffer, 200).l.M dNTPs, 4.5mM MgCh, sterile water), and 2.5 units Taq polymerase. 
The solution was overlaid with 501-11 liquid paraffin and subjected to I cycle of 94°C 
for 5 min and 53°C or 55°C for I min. 45 sec., 3 cycles of 72°C for 3 min., 95°C for 
45 sec., and 53°C or 55°C for 1 min. 45 sec., 30 cycles of 72°C for 3 min., 95°C for 
45 sec., and 53°C or 55°C for 45 sec, and 1 cycle 72°C for 10 min. 31-11 of reaction 
mixture was then analysed by 0.8% agarose gel electrophoresis. In some cases, 
adjustments of the thermal cycling parameters were necessary to improve 
amplification specificity and target DNA yield. 
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2.6.11 RT-PCR reactions 
RT-PCR reactions were perfonned using RMY reverse transcriptase. 600ng of viral 
dsRNA, 200ng of each primer and 0.5)11 of RNA guard (Amersham) was made up to 
a final volume of 30~1. This dsRNA-primer mix was then incubated at 95°C for 2 
minutes followed by 40°C for 4 minutes. A 2X reaction mixtures containing 5)11 
10% Triton X, 50111 25mM MgCh, 50111 lOX Taq polymerase PCR buffer, 16)11 
1.5mM dNTP mix, 2111 RNA guard, 125)11 dH20 and 1.5~1 AMY reverse 
transcriptase was prepared. 30fll of the 2X reaction mix was then dispensed into 
each RT-PCR reaction. The combined reaction mix and dsRNA-primer mix (final 
volume 60)11) was then incubated for 60 minutes at 42°C. At the end of the 60 
minute incubation O.5fll Taq DNA polymerase was added to each reaction. 
Following this the reactions were mixed and subjected to 40 cycles of 95°C for 1 
min, 45°C for 1 min and noc for 3 minutes. Following this 1 cycle at noc for 10 
min was perfonned. 
2.6.12 CAT assays 
The detection of CAT was perfonned using a Roche kit all procedures were carried 
out as per the manufacturer's instructions. 
2.6.13 In vitro transcription and translation 
The In vitro transcription and translation assays were perfonned using the TnT 
Quick couple In vitro transcription and translation system from Promega. All 
reactions were carried out as per the manufacturer's instructions 
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2.6.14. Preparation of competent cells for electroporation 
Electro-competent E.coli cells were prepared by washing 200ml of mid log 
phase bacteria (ODs9o = 0.4 - 0.5) twice with sterile ice-cold water. The bacteria 
were resuspended in 15ml of ice-cold water, washed again and resuspended in 0.5ml 
sterile ice-cold water. 
2.6.15. Transformation of DNA into bacteria by electroporation 
50JlI of electro-competent bacteria were mixed with IOI!I salt free ligated 
DNA or control DNA and pulsed in a BioRad Gene Pulse at 2.5kV with 25JlF set as 
capacitance and 200.0 set on the pulse controller. Cells were immediately diluted 
into to 0.7ml LB and allowed to recover by shaking for 30 min at 37°C. The 
bacteria were then plated onto selective agar plates containing appropriate antibiotics 
and incubated overnight at 37°C. Recombinant clones were identified by restriction 
enzyme analysis of mini-prep DNA 
2.6.16. Small scale preparation of plasmid DNA from bacteria (mini-prep) 
Individual bacterial colonies were picked from agar plates into lOmI LB 
medium containing appropriate antibiotics and incubated overnight with continuous 
shaking at 37°C. For restriction enzyme analysis the plasmid DNA from 1.Sml of 
culture was prepared using an alkaline lysis technique (Sambrook et ai, 1989) and 
the DNA pellets resuspended in 50JlI 50mM Tris-HCl pH 8.0. For sequence 
analysis the plasmid DNA from 5ml of culture was isolated using the QIAprep Spin 
Miniprep Kit (Qiagen) according to manufacturer's instructions. 
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2.6.17. Large scale preparation for plasmid DNA from bacteria (maxi-prep) 
10ml of LB containing appropriate antibiotics was inoculated with a single 
colony and incubated overnight with continuous shaking at 37°e. The overnight 
culture was subcultured into 1 L of LB plus appropriate antibiotics and incubated 
OIN at 37°C with shaking. Maxipreps were carried out using a SigmaSpin ™ 
Maxiprep kit (Sigma-Aldrich) as per manufacturer's instruction. 
2.6.18. Vectors. 
The pET expression vector pET42b was obtained from Novagen 
(Nottingham) and pET-I 5 was originally obtained by the rotavirus laboratory from 
Dr. D. Roper, University of Warwick. The pET-42b ™ vector was obtained from 
Novagen and pET4215b was created by Keun-Taik Chung (University of Warwick). 
The pET-His-NSPS and pET-His-NSP6 plasmids were constructed by first cutting 
the pET42b vector (Novagen) with the restriction enzymes NdeI and Pst! to remove 
the GST tag region of the plasmid. The coding region of NSP5 and NSP6 were then 
amplified with specific primers containing an NdeI restriction site followed by 6 
histidine residues at the 5' terminus and a Pst! restriction site at the 3' terminus of 
the ORF's. This PCR product was then cleaved with these restriction enzymes and 
ligated into the prepared pET42b vector. 
The GFP-NSP6 and GFP-NSP5 plasmids were constructed by using PCR to 
generate a product of the NSP5 and NSP6 ORF's with Sad at the 5' terminus and 
HindIII at the 3' terminus. The multicioning site of the vector phrGFP-Nl 
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(Stratagene, La jolla, California, USA) and the PCR products cleaved with Sad and 
HindIII and the two eDNA's ligated. 
The cellular gene actin, Gene I 1 of the UKtc strain of bovine rotavirus, 
NSP5 ORF, NSP6 ORF, Genell-CAT construct and Gene 7 of the UKtc strain of 
bovine rotavirus were all amplified using PCR with primers that introduced an XhoI 
restriction site at the 5' terminus and an XbaI restriction site at the 3' terminus. 
These PCR products were then ligated into the multicloning site of the PClneo 
(Promega) vector using these restriction enzyme sites. The PClneo vector and the 
CAT-PCIneo vector were both obtained from Dr A.C. Marriott, University of 
Warwick. The vectors containing gene segment 4 and the 5'-terminal 100 
nucleotides of gene segment 5 were constructed by K.T. Chung of Warwick 
University (unpublished data). The Luciferase T7 control DNA vector from the 
TNT® Quick coupled transcription/translation system (Promega) was used for the 
expression of Luciferase. 
2.6.19. DNA Sequencing 
DNA was sequenced by the Molecular Biology Service, University of 
Warwick using the dideoxy method (Sanger et al., 1977) with BigDye Terminator 
(v3.1) Ready Reaction Cycle Sequencing Kit (Applied Biosystems (ABI), 
Warrington UK) and carried out on a GeneAmp PCR System 9700 (ABI). Raw 
sequence data was generated by capillary electrokinetic injection using an ABI 
prism Genetic Analyzer 3100 (ABI) and collected using ABI Prism 3100 Genetic 
Analyzer Data Collection Software version 1.1 (ABI) and edited using ABI Prism 
Sequencing Analysis Software version 3.7 (ABI). Sequences were then analysed 
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using Chromas (viAS, Conor McCarthy, Griffith University Australia) and the 
DNAStar (DNAStar 5, DNAST AR Inc., Madison, WI) software packages. 
2.6.20. Transformation of Bacterial Cells by Heat Shock 
INVaF' cells (Invitrogen) were transformed with plasmid DNA by heat 
shock following the manufacturers instructions and plated on LB agar plates 
containing the appropriate antibiotics. 
2.7. RNA Binding Assays 
2.7.1. RNA Filter binding assay 
2.5cm discs of Hybond ECL nitrocellulose (GE Healthcare) were boiled for 
30 minutes in deionised water and then placed into a vacuum manifold. SOOIlI of 
filter binding buffer (FBB) (20mM HEPES buffer, 100mM NaCI, 5mM EDT A, 
1 mM OTT) was passed through them before addition of the lOOll1 samples. 
Purified NSP5 or NSP6 at varying concentrations was incubated at 30°C in duplicate 
in FBB with an excess (50OnM) of 32p UTP labelled ssRNA produced using a 
megascript RNA transcription kit (Ambion). After 30 minutes incubation samples 
were filtered through the nitrocellulose. Filters were washed twice with 500lli of 
FBB, air dried, and the amount of RNA bound measured using a scintillation counter 
(Tri-CARB 2900TR liquid scintillation analyzer Packard Bioscience Company). To 
investigate the effect of NaCI concentration on RNA binding the assay was 
performed using FBB supplemented with various concentrations of NaCl. RNA 
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competition assays were carried out using a fixed amount (500nM) of radio-labelled 
ssRNA and increasing amounts of cold competitor ssRNA, dsRNA or dsDNA. Cold 
competitor nucleic acid was added at 0%, 25%, 50%, 100%, 200% and 500% of the 
concentration of radio-labelled ssRNA (500nM = 100%). 
2.7.2. Gel mobility shift assay 
A transcription plasmid carrying the 5' -terminal 100 nucleotides of bovine 
rotavirus (UKtc) gene 5 was used to produce a radio-labelled ssRNA probe for gel 
mobility shift assays. 500nM of probe was incubated with varying amounts of NSP6 
protein in gel mobility buffer (20mM HEPES buffer, 100mM NaCI, 5mM EOTA, 
ImM OTT, 20% glycerol) at 30°C for 30 minutes. Samples were then analysed on a 
1 % TBE agarose gel run at 10 milliamps for 1 hour. The gel was dried and subject to 
autoradiography at -70°C using an intensifying screen. 
2.8. Protein Analysis 
2.8.1. Mass spectroscopy 
Mass analysis of purified NSP5 and NSP6 was performed using MALDI-MS 
(matrix assisted laser desorption/ionization mass spectrometry) (Matilda, 
Micromass). As confirmation LC-ESI (liquid chromatography electrospray 
ionization) MS/MS (Micromass Q-Tofl, Waters) was used. 
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2.8.2. Determination of Protein Concentration 
Protein concentrations were colourimetrically detennined using the Lowry 
Protein Assay Method (Lowry et al., 1951). 
2.8.3. SDS-PAGE 
Protein samples were resolved by SDS-polyacrylamide gel electrophoresis as 
described by Laemmli et al (1970). 
2.8.4. Visualisation of Proteins 
Proteins separated by PAGE were visualized with Coomassie blue 0250 as 
described in Ausbel et al (1998). 
2.8.5. Western Blotting 
14% SDS-PAGE gels were used to separate proteins and then Western 
blotting was performed using an Amersham ECL advance kit and carried out using 
the manufacturers recommended conditions. 
2.9. Protein Purification 
2.9.1. Expression of recombinant proteins 
Vectors containing the tagged coding regions of NSP5 and NSP6 were 
transformed into the BLR strain of Escherichia coli. An overnight (OIN) culture was 
diluted 1:100 in Luria-Bertani (LB) media and incubated with shaking at 37°C until 
84 
the optical density (ODS90) was between 0.5 and 1. Expression of the pET constructs 
was then induced by addition of O.lmM IPTG and incubation with shaking 
continued for a further 4 hours at 37°C. Bacterial cells were recovered by 
centrifugation at 6,370g for 10 min using a JAlO rotor (Beckman). 
2.9.2. Lysis of cells by French press 
Recovered cells were suspended in lOmI of PBS and disrupted by being 
passed twice through a French press at 10,000 psi according to the manufacture's 
instructions (American Instrument Company, Silver Spring, Maryland, USA). 
2.9.3. Recovery of soluble and insoluble fractions 
Soluble and insoluble protein fractions were separated by centrifugation at 
39200g (Beckman JA20 rotor) for 30 minutes. The insoluble fraction was recovered 
by washing the insoluble pellet twice in 20ml of 20mM Tris HCI pH7.5 before being 
resuspended in 6M guanidine hydrochloride and left to solubilise for at least 4 hours. 
2.9.4. Glutathione-Agarose column 
This soluble fraction of recombinant GST fusion protein was purified using 
glutathione agarose (GSH-agarose). The soluble GST-fusion was loaded onto a 5ml 
of column GSH-agarose equilibrated with PBS, pH 7.5 at a flow rate of Imllmin and 
washed with same buffer. The binding proteins were then eluted with 10mM Tris-
HCI, pH 8.0, lOmM reduced glutathione. The eluted proteins were monitored at 
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280nm using a Pharmacia LKB UV MIl monitor and conected using a Pharmacia 
FRAC-loo fraction collector. 
2.9.5. Metal Cbelating column 
Denatured His tagged proteins suspended in 6M guanidine hydrochloride 
was then purified using FPLC. 8M urea at pH8.0 was used to equilibrate a Ni++ 
chelating column. Solublised protein was then passed over the column which was 
washed first with 8M urea at pH 8.0 and then with 8M urea pH 6.0. The bound His 
tagged protein was then eluted from the column by dropping the pH by addition of 
concentrated HCI to pH 4 and finally to pH 3.5. The eluted proteins were monitored 
at 280 nm using a Pharmacia LKB UV MIl monitor and collected using a Pharmacia 
FRAC-loo fraction collector. 
2.9.6. Stepwise refolding of purified protein 
Denatured protein was eluted from the Ni++ chelating column in 8M urea pH 
3.5. The eluted protein was then refolded by stepwise dialysis against 20mM Tris-
HCI buffer. The NSPS protein was refolded from a solution of 8M urea pH 10, 
adjusted from the 8M urea pH 3.5 elution buffer by addition of 10M NaOH, and 
refolded in a stepwise gradient from 20mM Tris HC} pH 10 to 20mM Tris HCI pH 
7.5. The NSP6 protein was refolded from the 8M urea pH 3.5 in a stepwise gradient 
from 20mM Tris HCI pH 4 to 20mM Tris HCI pH 7. 
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2.10. Computer Analysis 
2.10.1. Sequence Alignments 
DNA and protein sequence alignments were performed electronically in 
MegAlign, DNAStar Inc. (Technelysium, Queensland, Australia). 
2.10.2. Plasmid Maps 
Graphical representation of plasmids, including genes and restriction enzyme 
locations were generated using Clone Manager, SciED Central, v7.02. 
2.10.3. Calculation of dissociation constants 
Dissociation constants were calculated using the Prism 4 software (GraphPad 
Software). Graphs were produced plotting the amount of probe bound versus the 
concentration of protein in picomoles (PM) and then the dissociation constants 
extrapolated from the line of best fit. 
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Results 
Chapter 3 
Purification of the Rotavirus 
NSP5 and NSP6 proteins 
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3.1. Aims 
The aims of the work described in this chapter were: i) Construct expression 
vectors containing the ORF's of rotavirus gene 11, ii) Purify the expressed NSP5 
and NSP6 proteins iii) Generate polyclonal monospecific sera to the purified 
proteins. 
3.2. Introduction 
3.2.1. Recombinant protein expression and purification 
The development of recombinant protein expression and purification has led 
to great advances in the understanding of protein structure and function. It has 
enabled the development of in vitro assays of protein function, in order to determine 
properties, such as RNA binding and enzymatic activity, as well as enabling the 
determination of a protein's structure by X-ray crystallography and NMR 
spectroscopy. Following characterisation of a gene sequence it can be used to create 
purified protein via a number of methods. The range of techniques by which purified 
protein can be obtained has become very diverse, including many possible species 
for expression and the exploitation of many features of proteins to secure 
purification. The two most common systems for protein expression use E. coli and 
baculoviruses as hosts (Kingston & Brent, 2002). 
The E. coli system uses a plasmid carrying the coding sequence of the 
protein of interest transformed into the bacteria, expression is generally controlled 
by a chemical inducer such as IPTG. When a bacterial culture has reached the 
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optimal optical density the inducer is added and expression of the protein begins, its 
concentration can reach up to 50% of the total cell protein following induction. The 
advantages of this system are that it is straight forward to use, can produce a large 
amount of protein in a short time and is very cost effective. There are however a 
number of disadvantages, including the lack of appropriate post translational 
modification and the formation of occlusion bodies; the latter are insoluble 
aggregates of mis-folded protein which occur due to the high levels of protein 
expression. The formation of occlusion bodies is not necessarily a draw back as they 
can be exploited for protein purification by solublising the protein using detergents 
and then removing the detergents via dialysis after the purification process to refold 
the protein (Amersham Biosciences, 2003a). 
The baculovirus expression system uses homologous recombination between 
the baculovirus genome and a transfer or shuttle vector carrying the gene of interest 
to facilitate protein expression. The transfer vector which contains the gene of 
interest flanked by sections of a non-essential viral gene and a linear copy of the 
viral genome are co-tranfected into insect cells. This allows for homologous 
recombination to occur creating infectious virus that will express the inserted gene 
of interest when used to infect more insect cells. The recombinant viruses are plaque 
purified with a marker gene such as beta galactosidase to aid in their identification. 
After the recombinant virus has been isolated and grown to a sufficient titre, the 
virus can be used for protein expression. Expression in the baculovirus system is 
carried out in insect cells and is subsequently much more likely to be correctly post 
translationally modified, an advantage of this system. However, there are several 
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disadvantages of the baculovirus system including the higher costs than that of the E. 
coli system, the longer setup time and the post translational modifications are not 
always exactly as in mammalian cells, this being particularly relevant for 
glycosylation (Amersham Biosciences, 2003a). 
After expression the next step is to purify the protein of interest from other 
proteins in the cells being used for expression. The protein can be separated using 
specific features of that particular protein, for example its size, charge, 
hydrophobicity or its affinity for a ligand. This separation is commonly achieved by 
liquid chromatography (Amersham Biosciences, 2003b). 
To facilitate purification, fusion proteins are often made between the protein 
to be purified and a protein or protein fragment that has a known (reversible) affinity 
to a specific ligand. These fusions are referred to as tags and can range in length 
from very short such as, a 6 histidine (His) residues to large proteins such as, 
glutathione-S-transferase (GST). The tags are exploited by employing what is 
termed affinity chromatography (Kingston & Brent, 2002; Amersham Biosciences, 
2003b). 
3.2.2. pET vector system 
The pET vector system provides a powerful approach for the expression of 
recombinant proteins in E. coli. It takes advantage of the highly selective nature of 
the bacteriophage T7 RNA polymerase and its associated promoter sequence, 
coupled with the high translational efficiency of the T7 gene 10 translation initiation 
signals, such that after only a few hours of induction, the induced target protein can 
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constitute the majority of the protein present in the bacterial cell. A further 
advantage of employing T7 transcription and translation signals is the tight 
regulation that it affords, allowing the target gene to remain transcriptionally silent 
in the uninduced state. The pET vectors also contain an affinity tag positioned in 
frame with the expressed ORF so that it can be used to purify the protein. The 
constructed plasmid is initially transformed into a strain of E. coli that does not carry 
the T7 RNA polymerase gene thereby removing possible problems of plasmid 
instability due to leaky expression of toxic proteins. Expression of the target fusion 
protein can then be achieved by using one of two methods (i) the non-expressing E. 
coli host can be infected with the bacteriophage ",CE6 which carries the T7 RNA 
polymerase gene, (ii) the pET vector can be transformed into an E. coli strain 
carrying the T7 RNA polymerase gene in a chromosomal cassette under the control 
of lacUV5. Expression can then be induced via the addition of IPTO and further 
incubation of the bacterial culture. Following induction the bacterial cells can be 
lysed and the fusion protein purified by exploiting the affinity tag and appropriate 
affinity chromatography (Novagen, 2003). 
3.2.3. Expression vector pET42b 
The pET vector pET -42b was selected for expression of the rotavirus 
proteins. Following insertion into this vector the viral proteins expressed would 
carry both OST and His tags (Figure 3.1). Either of these tags could potentially be 
utilised to secure purification by affinity chromatography. 
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Eagl 
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Figure 3.1 The pET42b(+) expression vector 
Sphl 
BstAPI 
Hpal 
Asci 
Stul 
BsrGI 
EcoRI 
BamHI 
EcoRV 
Ncol 
PshAI 
Re triction map of the pET42b(+) clon ing vector showing th 220aa G T_tag rM 
selected restriction enzyme site and the T7 expre ' ion region. AI 0 indicated i the 
multicloning region of the vector. A unique Psh I re triction enzyme in the 
multicloning region when cleaved produces a blunt end cloning site allowing the 
in ert ion of the protein of intere t directly after a Factor Xa protea e site. The Factor 
Xa cleavage site can be u d for the removal of the G T affini ty tag after 
puri lication. 
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Proteins carrymg a OST tag will bind strongly to glutathione immobilised on 
agarose and after the other proteins in the mixture have been washed away, the 
interaction can be reversed by the addition of buffer containing glutathione releasing 
the tagged protein of interest (Figure 3.2). An additional feature of pET42b is the 
presence of a unique PshA1 restriction enzyme site within the multicloning region of 
the vector. Following cleavage with this enzyme a blunt end cloning site is produced 
and if the A TO start codon of the gene of interest can be inserted such that, it is in-
frame with the vectors tags then it will follow directly after a Factor Xa protease 
cleavage site (Figure. 3.1) (Novagen, 2003). Following affinity purification the tags 
used in purifying the protein can be removed by cleavage with Factor Xa. This 
allows an authentic purified protein to be produced. The cleaved purification tags 
can then be removed from the protein of interest by rerunning the sample over the 
same affinity column as that used previously in purification. The affinity tags will 
again bind to the column whilst the protein of interest will pass straight through 
allowing its collection (Novagen, 2004). 
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Glutathione-
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tag 
Figure 3.2 Affini ty chromatography of a GST tagged protein 
GST tagged protein was passed over the glu tatione coated agaro e and due to the 
affinity of GST for glutath ione becomes bound whereas untagged protein pass 
through the resin. The bound GST tagged protein can then be eluted u ing a washing 
buffer containing g lutathione. 
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3.3. Results 
3.3.1. Strategy for the amplification and insertion of the NSP5 and NSP6 coding 
sequences into pET42b 
Access to purified viral proteins was essential to this project for use in both 
RNA binding assays and for the generation of polyclonal hyper immune sera to 
exploit in characterising the expression and function of the two proteins. To achieve 
this objective the Novagen pET vector expression system was employed. The 
cloning strategy for the insertion of the ORF's of NSP5 (ORFI) and of NSP6 
(ORF2) into pET42b involved using PCR to introduce a Clal restriction enzyme site 
immediately upstream of the ATO start codon of each of the ORF's. Following 
cleavage with the ClaI enzyme the 5' overhang left by the enzyme was removed 
using Mung Bean Nuclease digestion to produce a blunt ended copy of the ORF 
starting with the initiation A TO codon which could then be cloned on to the blunt 
end of the vector following its cleavage with PshAI (Figure 3.3). 
The first step in generating the required clones was to generate a copy of the 
rotavirus UKtc strain gene 11 sequence. The RT-PCR was performed using RMV 
reverse transcriptase and Taq DNA polymerase so that standard T A cloning could be 
performed using an Invitrogen one step TA cloning kit (Invitrogen, 2004). Taq DNA 
polymerase inserts single adenosine overhangs at the 5' and 3' termini of the PCR 
products (Invitrogen, 2004). Exploiting this feature a linearised cloning vector 
(pCR2.1) with single base thymidine overhangs could be used in a straight forward 
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A 
5' ORF 1 Oligonucloetide 
Cia I restriction site 
t 
CAGATCTGGCCATCGATGTATCTCAGTATT 
B 
PCR Product cleaved with Cia I 
C 
CGATGTATCTCAGTATT 
TACATAGAGTCATAA 
PCR product after digestion with Mung Bean Nuclease. 
D 
pET -42b cloning site 
ATGTATCTCAGTATT 
TACATAGAGTCATAA 
PshAI Blunt Cloning Site 
PshAI 
r-----' 
, t I 
ATT QAG QQA CQC GQG Tee ] E Q ~ 
Factor xa tPshAl vector 
vector insert 
ATT GAG GQA CQC XX 
J E It' nsert codon 
Figure 3.3 Strategy for cloning rotavirus ORF's into pET41b(+) 
Flow-chart showing the insertion of the ORFI PCR product into pET-42b vector. A) 
ORFI PCR oligonucleotide showing Cia I restriction site. B) Cleaved PCR product 
with 5' overhang. C) Digestion of 5' overhang with Mung Bean Nuclease. D) 
Cleavage of pET -42b vector with PshAI ready for insertion of blunt ended PCR 
products. 
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ligation between the amplified viral gene and the vector. This one step reaction 
removes the need for restriction enzymes digestion and amplicon purification. The 
pCR2.l vector is a 3.9 kb plasmid supplied in linear form with single T overhangs 
ready for cloning. Recognition sites for the restriction enzyme EcoRI flank either 
side of the insertion site such that, this enzyme can be used to excise any insert as a 
single fragment provided no internal EcoRI sites were present within the insert. The 
dsRNA extracted from rotavirus UKtc strain virus particles were used as a template 
in the RT-PCR. Primers for gene segment 8 were used as a positive control for the 
gene 11 RT -PCR. Figure 3.4 shows a sample from each of these reactions in which 
the bands for gene 8 and gene 11 can be seen at 1.0 kb and 663 bp respectively 
(Figure 3.4). The gene 11 cDNA was then ligated into the pCR2.1 cloning vector 
which was transformed into the INVaF' strain of E. coli. Miniprep DNA from a 
selection of the clones was digested with EcoRI to release the cloned inserts, this 
showed that gene 11 had been successfully cloned (Figure 3.5). The clones were 
sequenced to select those that contained no Taq errors so that they could be used as a 
template for the NSP5 and NSP6 ORF PCR reactions. 
PCR was performed with primers for the ORF's of NSP5 and NSP6 
containing a Clal restriction enzyme site (Figure 3.6a and 3.6b). The 3' primers for 
these PCR's contained a PstI restriction enzyme site which was also found in the 
multicloning site of the pET -42b vector. Digestion of the amplified DNA with this 
restriction enzyme was used to ensure that the cDNA inserts would be ligated into 
the pET 42b vector in the correct orientation. The PCR products were gel purified 
and cut with Clal and Mung Bean Nuclease treated to form a blunt 5' end. 
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Following this treatment and gel purification Pst! was used to cleave the 3' end of 
the cDNA. A ligation was performed between this cDNA and the pET -42b vector 
which had been previously cleaved with PshAl and Pst! this ligation resulted in 
creation of the pET42b-ORFl (Appendix 1.6) and pET42b-ORF2 (Appendix 1.7) 
plasmids which were then transformed into INVaF' E. coli. Respective plasmids 
from this transformation were miniprepped for sequencing to ensure the ORF were 
correctly inserted and that no mutational changes had been introduced during the 
sub-cloning. The plasmids were then transformed into the BLR strain of E. coli 
which contained the T7 RNA polymerase gene. BLR E. coli colonies from this 
transformation were grown up OIN and minipreps performed to identify those 
carrying plasmids containing the NSP5 and NSP6 ORF's (Figure 3.7a and 3.7b). 
These plasmids were again sequenced to verify that no mutational changes had been 
introduced. 
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3054bp -----+ 
2036bp -----+ 
1636bp -----+ 
101 8bp -----+ 
506bp -----+ 
396bp -----+ 
A B c 
Figure 3.4 One step RT-PCR of rotavirus gene 11 from purified dsRNA of the 
UKtc strain of bovine rotaviru 
An RT -peR was carried out a de cribed in the Materials and Method. The 
products were fractionated on a 1% agaro e gel tained with ethidium bromide and 
vi ualised using UV light. Track A) DNA marker ize ladder, track B) Gene 8 
po itive con trol one step RT-P R from rOLaviru UKtc train d RNA and track C) 
Gene II one tep RT-PCR from rotav iru UKtc strain dsR A. Migration of the 
DNA ize markers are indicated on the left hand ide of the gel. 
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3054bp -----+ 
2036bp -----+ 
1636bp -----+ 
101 8bp -----+ 
506bp -----+ 
396bp -----+ 
ABeD EFGH IJKL 
Figure 3.5 Restriction enzyme analysis of the putative gene 11 cDNA clones 
A cD A copy of gene II was generated u ing RT-P R carried out as de cribed in 
the Material and Method. This cD A was cloned into the pCR2.1 vector using the 
In vitrogen TA cloning kit a de cribed in the Material and Method. ingle 
colon ie were harve ted and grown OIN at 37°C before being miniprepped as 
de cribed in the Materials and Method. The re LIlting pia mid 0 A was cut with 
EcoR I to creen for potential in ert . The re triction digest were then fractionated 
on a 1% agarose gel tained with ethidium bromide and vi ualized u ing UV light. 
Track A) 0 A size marker ladder, tracks B-K) Miniprepped colonie from the gene 
II -pCR2.1 tran formation cut with Eco RI , track L) DNA size marker ladder. 
Migration of the 0 A ize markers are indicated on the left hand ide of the gel. 
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A 
AB 
B 
3054bp-. 
2036bp-. 
1636bp-. 
10 18bp-. 
506bp-. 
396bp-. 
344bp-' 
298bp-' 
A Be 
Figure 3.6 peR amplification of ORFI (Panel A) and ORF2 (Panel B) from 
rotaviru gene 11 UKtc train 
Panel A) PCR wa carried out to generate a cD A of ORFI as de cribed in the 
Materials and Method . The product were fractionated on a 1% agarose ge l stained 
with eth idium bromide and vi uali ed u ing UV ligh t. Track A) D A ize marker 
ladder, track 8) PCR product of P5 ORF u ing primer conta ining a CIa I 
re triction enzyme sequ nce. Migration of the D ize marker are ind icated n 
the left hand ide of the gel. 
Panel 8) PCR wa carried out to generate a cD A of ORF2 a de cribed in the 
Materials and Method . The products were fract ionated on a 1% agaro e ge l tained 
with ethidium bromide and vi ualized using V li gh t. Track A) D A ize marker 
ladder) PCR product of P6 ORF u ing primer containing CIa I restriction ite 
equence at 2mM MgCI ~ and track C) P R product of P6 ORF u ing primer 
containing Clal re triction ite equence at 3mM Mg b. Migration of the D A size 
marker are indicated on the left hand ide of the gel. 
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A 
3054bp ----. 
2036bp----' 
1636bp ----. 
10 18bp----. 
506bp----. 
396bp----. 
344bp----. 
298bp ----' 
ABC 
B 
3054bp ----. 
2036bp----. 
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ABC D 
Figure 3.7 Re triction analy is of putative ORF'l (Panel A) and ORF'2 (Panel 8) 
clone in pET42b 
Panel A) A cD A copy of ORF I wa ligated into the p T42b vector a de cribed in 
the Materials and Method. ingle colonie were harve ted and grown 0 at 37° 
before being miniprepped a de cribed in the Material and Methods. The re ulting 
pia mid D A cut with Kpnl and PsI I to creen for potential in el1 . The restriction 
digest wa then fractionated on a 1% agarose gel tained with ethid ium bromide and 
vi ualized using UV light. Track A) D A ize marker ladder, track B) pET42b 
uncut and track C) pET42b cut with Kpnl and PsI!. Migration of the 0 A ize 
markers are indicated on the left hand side of the gel. 
Panel B) cD A copy of ORF2 wa ligated into the p T42b vector a de cribed n 
the Materials and Method. ingle colonie were harve ted and grown 0 at 37° 
before being miniprepped a de cribed in the Material and Method. The resulting 
plasmid D A cut with Kpnl and Ps/l to creen for potential in ert . The re triction 
dige t was then fractionated on a 1% agaro e gel tain d with ethidium bromide and 
vi ualized using UV light. Track A) D ize marker ladder, track B) p T42b 
uncut and track C) pET42b cut with Kpnl and Psl l. Track A) Invitrogen I kb D A 
ladder, tracks B-O) pET42b-ORF2 cut with Kpnl and PSI!. Migration of the D 
ize markers are indicated on the I ft hand ide of the gel. 
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3.3.2. Sequence analysis of rotavirus gene 11 UKtc strain 
Sequencing of the gene 11 clones obtained following RT-PCR of genomic 
dsRNA extracted from the UKtc strain of bovine rotavirus produced some 
interesting findings. When the published sequence of the UKtc gene 11 (Ward et al 
1985) is compared to that of other virus strains several differences were evident, 
differences at certain nucleotides that set the UKtc strain apart from the other strains. 
At nucleotide 17 in the 5' untranslated region there is an adenine in the UKtc strain 
while in all other rotavirus gene 11 sequences have a cytosine at this position with 
the exception of two human strains which have a thymine. The most significant 
difference however lies at the start of the coding region where in the UKtc sequence 
another adenine is found in place of a cytosine giving a TAT codon and a tyrosine 
amino acid. All other rotavirus gene 11 sequences have a TCT codon and a serine at 
this residue (Figure 3.8a). 
The sequence of the UKtc gene 11 obtained in this study had cytosines in these 
positions and not adenines, as is found in the published sequence (Figure 3.8b). 
Sequence alignments generated using BLAST software showed that the sequences 
obtained in this study did show greater homology to that of the UKtc sequence 
indicating that it was not a gene 11 from another rotavirus strain that had been 
cloned. Figure 3.8 panel B shows the alignment of the first 30 nucleotides of nine 
sequences all from different clones and several different transformations against the 
published sequence of UKtc gene 11. This shows that the sequences from RT -PCR 
performed in this investigation have the same changes from the published sequence 
as seen in other 
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G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C Majority 
---------- --------+-------------------+-------------------+-
10 20 30 
----- -------------+----------- --------+-------------------+-
G G C T T ':' T A A A G C G C T A A A G T G A T G T A T C T C genell UK c 
G G C T T ';' T A A A G C G C T A C A G T G A T G T C T C T C human NSP5 
G G C T T T - A A A G C G C T A C A G T G A T G T C T C T C bovine gene 11 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C human gene lIa 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C human gene llb 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C human gene lIc 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C simian gene 11 
G G C T T T A A A A G C G C - A T A G T G A T G T C T C T C human gene lId 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C porcine gene lla 
G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C porcine gene llb 
B 
G G C T T T T A A AGe G C T A C A G T GAT G T C T C T C Majority 
------------------+------------- ------+-------------------+-
10 20 30 
------------------+--------------- ----+-------------------+-
1 G G C T T T T A A A G C G C T A A A G T G A T G T A T eTC published UKLc 
1 G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C RT-PCR colony 1 
1 G G C T T T T A A A G C G C T A C A G T GAT G T C T C T C RT-PCR colony 2 
1 G G C T T T T A A A G C G C T A C A G T G A T GT e T C T C RT-PCR colony 3 
1 G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C RT-PCR colony 4 
1 G G C T T T T A A A G C G C T A C A G T G A T G T C T C T C RT-PCR colony 5 
1 G G C T T T T A A A G C G C T A C A G T GAT G T C T C T C RT-PCR colony 6 
1 G G C ':' T T T A A A G C G C T A C A G T G A T G T C T C T C RT-PCR colony 7 
1 G GeT T T T A A A G C G C T A C A G T GAT G T C T C T C RT-PCR colony 8 
G G C T T T T A A A G C G C T A C A G T GAT G T C T C T C RT-PCR colony 9 
Figure 3.8 Comparative sequence analysis of the first 30 nucleotide of the 
published sequence for gene 11 of the UKtc train and that obtained in Uti 
study 
Panel A) Sequence alignment of the fir t 30 nucleotide of rotaviru gene II 
egment from the UKtc train and everal different train of rotaviru . Differences 
between the published UKtc equence and the other g ne II equence are marked 
in red. 
Panel 8) Sequence alignment of rotavirus UKtc strain gene segment II published 
sequence and the first 30bp of gene segment II RT-P R products from RNA 
extracted from whole viru cloned into Invitrogen vector pCR2.I. Difference 
between the UKtc train gene egment II and the cloned RT-PCR product 
equences are marked in red . 
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rotavirus gene 11 sequences. This analysis clearly indicates that there were several 
nucleotide errors in the original sequencing of the UKtc strain gene 11. The 
sequence for this gene as detennined in this study had a greater sequence identity to 
other rotavirus strains than was previously thought. The four nucleotide changes 
detected from the published sequence are both non-coding and coding occurring at 
nucleotides, al7c, a26c, cl64t and t653a (Figure 3.9). These changes result in two 
amino acids changes in the NSP5 protein, the a26c causes a change at position 2 in 
the amino acid sequence from a tyrosine to a serine and the change c 164t results in 
the amino acid sequence at position 48 changing from a serine to a phenylalanine 
(Figure 3.1 Oa). Only one amino acid change was found in NSP6 and this was due to 
the nucleotide change c 164t which results in a change at position 29 from a proline 
to a serine (Figure 3.1 Ob). All of the above changes cause the gene segment 11 
sequence of UKtc to become far similar to that found in other strains of rotavirus. 
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GGCTTTTAAAGCGCTACAGTGATGTCTCTCAGTATTGACGTGACGAGTCTTCCTTCT 
GGCTTTTAAAGCGCTAAAGTGATGTATCTCAGTATTGACGTGACGAGTCTTCCTTCT 
ATTTCTTCTAGTATTTATAAAAATGAATCATCTTCAACAGCGTCAACTCTTTCTGGA 
ATTTCTTCTAGTATTTATAAAAATGAATCATCTTCAACAGCGTCAACTCTTTCTGGA 
AAATCTATTGGTAGGAGTGAACAATATGTTTCACCAGATGCAGAAGCGTTCAGTAAA 
AAATCTATTGGTAGGAGTGAACAATATGTTTCACCAGATGCAGAAGCGTCCAGTAAA 
TACATGCTGTCGAAGTCTCCAGAAGATATTGGACCATCTGATTCTGCTTCAAACGAT 
TACATGCTGTCGAAGTCTCCAGAAGATATTGGACCATCTGATTCTGCTTCAAACGAT 
CCACTCACCAGCTTTTCGATTAGATCAAATGCAGTTAAGACAAATGCAGACGCTGGC 
CCACTCACCAGCTTTTCGATTAGATCAAATGCAGTTAAGACAAATGCAGACGCTGGC 
GTGTCTATGGATTCATCAGTACAATCACGACCATCAAGTAACGTTGGGTGCGATCAA 
GTGTCTATGGATTCATCAGTACAATCACGACCATCAAGTAACGTTGGGTGCGATCAA 
GTGGATTTCTCCTTTAATAAAGGAATTAAAGTGAATGCGAACCTAGATTCATCTATA 
GTGGATTTCTCCTTTAATAAAGGAATTAAAGTGAATGCGAACCTAGATTCATCTATA 
TCAGTGTCAACAAATTCAAGAAAGGAGAAGTCCAAAAATGACCATAAAAGTAGGAAA 
TCAGTGTCAACAAATTCAAGAAAGGAGAAGTCCAAAAATGACCATAAAAGTAGGAAA 
CACTACCCTAGAATTGAAGCAGAATCCGACTCAGATGATTACGTACTTGACGATTCA 
CACTACCCTAGAATTGAAGCAGAATCCGACTCAGATGATTACGTACTTGACGATTCA 
GACAGTGATGATGGCAAATGTAAAAACTGTAAATATAAAAGGAAGTATTTCGCACTG 
GACAGTGATGATGGCAAATGTAAAAACTGTAAATATAAAAGGAAGTATTTCGCACTG 
AGAATGAGAATGAAGCAAGTTGCCATGCAATTGATCGAAGATTTGTAGGTCTGACCT 
AGAATGAGAATGAAGCAAGTTGCCATGCAATTGATCGAAGATTTGTAGGTCTGACCT 
GAGAGGTCACTAGGGAGCTCCCCACACCCGTTTTGTGACC 
GAGAGGTCACTAGGGAGCTCCCCACTCCCGTTTTGTGACC 
Figure 3.9 Comparison between the published gene 11 nucleotide sequence and 
that determined in this study 
Alignment of the UKtc strain gene II published sequence [rom Ward et al. , 1985 
(red) and the RT-PCR product of UKtc strain gene II sequence generated in thi 
study (blue). Four ingle nucleotide change between the e equences are 
highlighted in green. 
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A 
Mr LSIDVTSLPSISSSIYKNESSSTASTLSGKSIGRSEQYVSPDAEASSKYMLSK 
SPEDIGPSDSASNDPLTSFSIRSNAVKTNADAGVSMDSSVQSRPSSNVGCDQV 
,~, f." _,I 
DFSFNKGIKVNANLDSSISVSTNSRKEKSKNDHKSRKHYPRIEAESDSDDYVL 
DDSDSDDGKCKNCKYKRKYFALRMRMKQVAMQLIEDL 
Published UKtc strain NSP5 sequence 
B 
MNHLQQRQLFLENLLVGVNNMFHQMQKR PVNTCCRSLQKILDHLILLQTIHSPAFR 
MNHLQQRQLFLENLLVGVNNMFHQMQKRSVNTCCRSLQKILDHLILL TIHSPAFR 
LDQMQLRQMQTLACLWIHQYNHDHQVTLGAIKWISPLIKELK 
LD MQLRQMQTLACLWIHQYNHDHQVTLGAIKWISPLIKELK 
Published UKtc strain NSP6 sequence 
NSP6 sequence determined in this study 
Figure 3.10 Comparison ofthe published P5 and NSP6 amino acid equence 
and those determined in thi tudy 
Panel A) shows the UKtc train SP5 amino acid sequence from both the published 
sequence from Ward et aI. , 1985 (in black) and the RT -peR sequence obtained from 
this study (in red). 
Panel 8) haws the UKtc strain NSP6 amino acid sequence from both the publi hed 
equence from Ward el al .. 1985 (in black) and the RT-P R sequence obtained from 
thi tudy (in blue). 
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3.3.3. Expression of GST-NSPS and GST-NSP6 
E. coli carrying the relevant plasmids was cultured on a large scale to allow 
an induction test to assay their ability to express the fusion proteins. Figure 3.11 a 
shows that much of the GST-NSP5 fusion protein, with its expected size of 
approximately 60 kDa, was found in the soluble fraction of the induced E. coli 
lysate. By contrast figure 3.llb shows that the bulk of GST-NSP6 protein which had 
the expected size of 40 kDa was found to be in the insoluble fraction. Insoluble 
proteins cannot be directly purified, however a variety of methods are available to 
try and increase the solubility of such expressed proteins. 
Protein insolubility can result from the rate at which it is synthesised 
following induction consequently lowering the growth temperature can increase the 
solubility. To investigate this possibility the induction of GST -NSP6 was performed 
for 4 hours at both 30°C and 37°C (Figure 3.12). Small amounts of GST-NSP6 were 
produced from the 30°C sample however the fusion protein was still insoluble. 
Several other protocols were investigated with the aim of solubilising the expressed 
protein including induction at room temperature, lowering of the concentration of 
IPTG added for induction and transforming the pET42b-ORF2 plasmid into 
alternative strains of E. coli containing the T7 RNA polymerase. However, none of 
these resulted in the production of soluble GST-NSP6. 
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Figure 3.11 Expression of GST tagged NSPS and NSP6 from pET42b vectors 
The BLR strain of E. coli containing either pET42b-ORFI or pET42b-ORF2 was 
grown in 200ml LB at 37°C until the 00590 reached between 0.5 and 1. Each culture 
was then split into two and one half induced with a final concentration of ImM 
IPTG. Both the uninduced and induced cultures were incubated for a further 4 hours 
at 37°C. The cells were recovered by centrifugation using a Beckman JAlO rotor at 
6370g for 15 minutes at 4°C and lysed by use of a French press at 20,000 psi. The 
soluble and insoluble fractions were then separated by centrifugation in a Beckman 
JA20 rotor at 39200g for 30 minutes at 4°C. Insoluble proteins were solublised by 
incubation in 8M urea for 4 hours at room temperature. Samples of all fractions were 
fractionated on a 14% SOS-PAGE gel that was electrophoresed and stained with 
Coomassie blue as described in the Materials and Methods. 
Panel A) Showing induction test for GST -NSP5. The yellow arrow indicates the 
position of the expressed GST -NSP5 fusion protein. Track A) Protein size markers 
10-180 kDa, track B) Insoluble fraction from an uninduced culture, track C) 
Insoluble fraction from an induced culture, track 0) Soluble fraction from an 
uninduced culture and track E) Soluble fraction from an induced culture. Migration 
of the protein size markers are indicated on the left hand side of the gel and the 
position of the OST-NSP5 protein is indicated by the yellow arrow. 
Panel B) Showing induction test for OST-NSP6 the yellow arrow indicates the 
position of the expressed OST -NSP6 fusion protein. Track A) Protein size markers 
10-180 kDa, track B) Insoluble fraction from an uninduced culture, track C) 
Insoluble fraction from an induced culture track D) Soluble fraction from an 
uninduced culture and track E) Soluble fraction from an induced culture. Migration 
of the protein size markers are indicated on the left hand side of the gel and the 
position of the OST -NSP6 is indicated by the yellow arrow. 
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Figure 3.12 GST-NSP6 induction at 30°C and 37°C 
GST -NSP6 fu ion 
¢::J protein (40kDa) 
track C 
A 200ml cu lture of E. coli carrying the pET42b-ORF2 pia mid was grown at 37°C 
until the 00590 was between 0.5 and I. The culture was plit into two equal halve 
and induced with a final concentration of ) mM IPTG. One half wa incubated at 
30° for 4 hours and the other incubated at 37°C for 4 hour. The cell were 
recovered by centri fugation using a Beckman JA 10 rotor at 6370g for 30 minute at 
4°C and Iy ed by use of a French pre at 20,000 psi. The soluble and in oluble 
fraction were then separated by centri fugation u ing a Beckman JA20 rotor at 
39200g for 30 minute at 4°C and in oluble protein olubli ed in 8M urea a 
described in the Materials and Methods. ample were analysed by 0 -PAGE and 
tained with ooma sie blue a de cribed in the Material and Method. Tra k A) 
In olubl fraction of cu lture induced at 30° , track B) oluble fraction of ulture 
induced at 30°C, track ) In oluble fraction or culture induced at 37°C and track D) 
oluble fraction of culture induced at 37°C. The po ition of the G T-N P6 i 
indicated by the yellow arrow. 
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3.3.4. Purification of GST -NSP5 
Expression of the GST -NSP5 fusion protein in the soluble fraction of 
bacterial lysates should have allowed for its easy purification. Induced bacterial 
lysates containing expressed GST -NSP5 was loaded onto a glutathione-agarose 
(GSH-agarose) purification column equilibrated with PBS. After washing the 
column with PBS the bound GST -NSP5 was eluted using 20mM Tris HeL, pH 8.0, 
containing lOmM glutathione. Unexpectedly little or no GST-NSP5 fusion protein 
was present in the eluted fractions with most of the protein appearing to be either 
GST or GST-NSP5 break down products (Figure 3.13). In addition to the GST tag, 
the GST -NSP5 fusion protein also contained a 6xHis tag and because of the poor 
yield eluted from the GSH-agarose the possibility of using this second protein tag 
for purification was investigated by passing the soluble fraction over a Ni++ metal 
chelating column. The column was equilibrated with PBS containing lOmM 
imidazole and the GST-NSP5 passed through it and allowed to bind. After washing 
to remove non-bound material the GST -NSP5 fusion protein was eluted with 
500mM imidazole. The eluted protein contained only a small quantity of GST -NSP5 
fusion protein and large amounts of non-specifically bound E. coli proteins (Figure 
3.14). In an attempt to improve yields to a useful level a new GSH-agarose column 
elution buffer containing 75mM HEPES pH7.4, 150mM NaCI, 20mM reduced 
glutathione, 5mM OTT and O.l%Triton X-IOO was used giving better results and a 
usable amount of GST -NSP5 fusion protein being purified. There was still evidence 
of GST-NSP5 break down products in the eluted fractions but less than in previous 
attempts (Figure 3.15). This partially purified fusion protein was cut with Factor Xa, 
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the authentic cut NSP5 released by proteolytic cleavage and the OST tag are almost 
equivalent in size and it was not possible to separate the two by SDS-PAOE. The 
cleaved protein products were again passed over the OSH-agarose column, the NSP5 
protein should have passed straight through the column whereas the cut OST tag 
should remain bound to the column. The flowthrough was collected and the column 
washed to remove all non-bound material, the bound OST tag was then eluted from 
the column as previously described. However little or no protein was found to flow 
through of the column indicating that the authentic NSP5 protein could not be 
isolated using this protocol (Figure 3.16). 
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Figure 3.13 Purification of GST-NSP5 fusion protein using GSH-agarose 
affinity chromatography 
Fractions eluted after GST -NSP5 fus ion protein wa passed through a g lutathione-
agarose (GS H-agarose) co lumn were fractionated on a 10% SD polyacrylamide gel 
that wa stained with Coomassie blue as described in the Materials and Methods. 
Track A) Protein size markers 10- 180 kDa, track 8) first G T-N P5 fract ion eluted 
from GSH-agarose, C) second GST -NSP5 fract ion eluted from GSH-agarose D) 
third G T-NS P5 frac ti on e luted from G H-agaro e and E) Protein size marker 10-
180Kda. Migration of the protein size markers are indicated on the left hand ide of 
the ge l and the position of the G T-NSP6 is indicated by the ye llow arrow. 
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Figure 3.14 Purification of GST-NSP5 by Ni++ metal chelation chromatography 
The oluble fraction of Iy ed bacteria induced to e pre PS fu ion protein from 
the pET42b-N PS vector was pa sed over a Ni-++ metal chelating column 
equilibrated with PB containing 10mM imidazole. Protein wa elut d from the 
column u ing SOOmM imidazole. The eluted protein wa then fractionated on a 10% 
o -polyacrylamide gel which was tained with Cooma ie blue a de cribed in the 
Material and Method Track A) Protein ize marker 10-180 kDa, track B) olubl 
fraction before application to the column and track ) luted fraction from Ni-++ 
metal chelating column. Migration of the protein ize marker are indicated on the 
left hand ide of the gel and the po ition of the N PS fu ion i indicated by the 
yellow arrow. 
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Figure 3.15 Chromatography of GST-NSPS on GSH-agarose under stringent 
elution conditions 
A GSH-agarose column was equilibrated with PBS. The soluble fraction of a Iy ed 
bacterial culture induced to express GST-NSP5 fusion protein was applied to the 
column which was subsequently wa hed with 3 column volumes of PBS. The bound 
protein wa then eluted in 75mM HEPES pH7.4, 150mM Na I, 20mM reduced 
glutathione, 5mM DTT and 0.1 % Triton X-I 00. The eluted fractions were then 
fractionated on a 10% D polyacrylamide gel which was stained with oomas ie 
blue as de cribed in the Materials and Methods. Track A) Protein size markers 10-
180 kDa and track B) Eluted G T -N P5. Migration of the protein ize marker are 
indicated on the left hand side of the gel and the po ition of the NSP5 fusion is 
indicated by the yellow arrow. 
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Figure 3.16 Factor Xa cleavage of GST-N PS 
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The G T -N P5 obtained by G H-agaro e chromatography wa ubjected to 
enzymatic cleavage by the Factor Xa. Factor Xa wa added to a final concentration 
of 0.2U/ f.l1 a de cribed in the Materials and Method. Thi reaction mixture wa 
incubated for 4 hour at 37° . The cleaved protein wa then pa cd through H-
agaro e following thi bound G T wa eluted in 75mM H PE pH 7.4, 150mM 
a I, 20mM reduced glutathione, 5mM DTT and 0.1 % Triton X-I 00. The protein 
now through wa sub equently fractionated on a 14% D polyacrylamide gel 
which wa tained with ooma ie blue a de cribed in the Material and Method. 
Track A) Protein ize marker 10-180 kDa, track 8) T - P5 b fore cleavage 
with Factor Xa, track ) G H-agaro e column flow through containing authentic 
N P5 protein and track D) luted fraction from the G H-agaro e column containing 
cleaved T tag. Migration of the protein ize marker are indicated on the left hand 
ide of the gel and the po ition or the N P5 fu ion and free G T are indicated by the 
yellow arrow. 
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3.3.5. Purification of GST -NSP6 
Several methods can be employed to purify proteins from the insoluble 
fraction which involve dissolving the proteins in strong detergents. This denatures 
the proteins and as the affinity for OST to glutathione is dependent upon the proteins 
conformation the OST tag cannot be used for purification using these methods. To 
try and circumvent this problem a modification of a method used by Frangioni and 
NeeI using sarkosyl and Triton X-IOO was employed (Frangioni & Neel, 1993). 
Sarkosyl is an ionic detergent that can be used to solublise the insoluble protein. 
Triton X-IOO is a non-ionic detergent that has been found to sequester sarkosyl into 
its micelles and is known to be tolerated by GSH-agarose when used during OST 
fusion protein binding (Smith & Johnson, 1988). Using a combination of these two 
detergents it was discovered that the insoluble OST fusion protein could be 
solublised and rendered in such a state that it was now able to bind the OSH-agarose. 
A range of sarkosyl concentrations were used in order to find the concentration that 
gave the maximum protein solublisation but at the minimum concentration of 
sarkosyl. A solution with a 1 % concentration of sarkosyl was found to be optimal 
(Figure 3.l7a). A range of solutions were made by addition of Triton X-IOO of 0%, 
0.5%, 1 % and 2% which were then applied to the OSH-agarose column to check for 
refolded protein binding. Only a small amount of OST -NSP6 protein was eluted 
from the column (Figure 3.17b), most of the protein washed through the column and 
did not bind. 
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Figure 3.17 Purification of GST-NSP6 via sarkosyl solublisation and TritonX-
100 treatment 
Panel A) Shows a solublisation assay for insoluble GST-NSP6 with addition of 
differing amounts of sarkosyl. The insoluble fraction containing the GST-NSP6 
fraction was isolated from a 500ml culture. This was resuspended in STE buffer 
(IOmM Tris-HCI pH 8.0, 150mM NaCI 5mM OTT and ImM EDTA). The fraction 
was split into six, where a different amount of sarkosyl was added to each to give a 
final concentration of 0%, 0.25%, 0.5%, 1 %, 2% and 4%. This was done to 
determine the minimum concentration of sarkosyl needed in order to solublise the 
maximum amount of GST-NSP6 protein. Samples of each were resolved on a 10% 
SDS polyacrylamide gel which was stained with Coomassie blue as described in the 
Materials and Methods Track A) Protein size markers 10-180 kDa, track B) 0% 
sarkosyl added to GST-NSP6 insoluble protein, track C) 0.25% sarkosyl added to 
GST-NSP6 insoluble protein, track D) 0.5% Sarkosyl added to GST-NSP6 insoluble 
protein, track E) 1 % sarkosyl added to GST -NSP6 insoluble protein, track F) 2% 
sarkosyl added to GST-NSP6 insoluble protein, track G) 4% sarkosyl added to GST-
NSP6 insoluble protein and track H) Protein size markers 10-180 kDa. Migration of 
the protein size markers are indicated on the left hand side of the gel and the position 
of the NSP6 fusion is indicated by the yellow arrow. 
Panel B) Shows the effect of addition of differing amount of Triton X-IOO on 
purification of sarkosyl solublised GST -NSP6. The insoluble fraction of a 500ml 
culture was treated with STE buffer containing 1 % sarkosyl. The solublised GST-
NSP6 solution was then split into four and to each a different amount of triton X was 
added to give the final concentrations of 0%, 0.5%, 1 % and 2%. These samples were 
then applied to a GSH-agarose column to look for refolded protein binding to the 
column which could then be eluted. The eluted fraction from these attempts at 
purification were resolved on a 10% SDS polyacrylamide which was stained with 
Coomassie blue as described in the Materials and Methods, along with the 1 % and 
2% Triton X-I00 samples flow through from the column. Track A) Protein size 
markers 10-180 kDa, track B) 0% Triton X-IOO GST-NSP6 eluted fraction, track C) 
0.5 % Triton X-IOO GST-NSP6 eluted fraction, track D) 1% Triton X-IOO GST-
NSP6 eluted fraction track E) 2% Triton X-IOO GST-NSP6, track F) 1% Triton X-
100 GST-NSP6 flow through of unbound protein from column, track G) 2% Triton 
X-IOO GST-NSP6 flow through of unbound protein from column and track H) 
Protein size markers 10-180 kDa. Migration of the protein size markers are indicated 
on the left hand side of the gel and the position of the NSP6 fusion is indicated by 
the yellow arrow. 
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An alternative method of purification was attempted for NSP6 making use of 
the 6xHis tag which can be used for purification of denatured proteins on a Ni++ 
chelating column. The insoluble fraction containing the insoluble NSP6 fusion 
protein was dissolved in Guanidine hydrochloride (Gu-HCI) denaturing all of the 
insoluble protein. The Ni++ chelating column was equilibrated with 8M urea, pH 8.0 
and subsequently used to bind and elute the GST -NSP6 under denatured conditions. 
The denatured GST-NSP6 was eluted in 8M urea pH 3.5 and then refolded by 
stepwise dialysis against 20mM Tris-HCI to a pH of 7 (Figure 3.18). Once the 
protein had been refolded it was treated with the Factor Xa protease in order to 
remove the tag region at the N-terminus of the NSP6 protein. However, as was 
found with the GST-NSP5 fusion protein all that was recovered using this method 
was degradation products and no authentic NSP6 could be isolated. This meant that 
this method could not be used for the purification ofNSP6. 
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Figure 3.18 Purification of insoluble G T-NSP6 fusion protein from Ni++ 
chelating column 
The insoluble fraction from a culture induced to xpress G T- P6 was denatured 
in 6M Gu-HCI and pas ed over a i++ chelating column equilibrated with 8M urea 
pH 8.0. The column wa then washed with 8M urea pH 8.0 until all protein flow 
through wa removed. Th column was then wa hed with 3 column volume of 8M 
urea pH 6.0 followed by 3 co lumn volume of 8M urea pH 4.0. Finally protein was 
eluted by washing with 3 column volume of 8M urea pH 3.5 a de crib d in the 
Materials and Method. This protein wa then refolded by tepwise dialy i again t 
20mM Tri to a pH of 7.0 a de cribed in the Material and Method. The purified 
protein were then fractionated on a 14% 0 polyacrylamide gel which wa tained 
with ooma sie blue as de cribed in the Mat rial and Methods. Track A) Protein 
ize marker 10-180 kDa and track 8) T - P6 eluted from Nt+- chelating 
column und r denatured condition and refolded by tepwi e dialy i again t 20mM 
Tri to a pH of 7.0. Migration f the protein ize marker are indicated on the I ft 
hand ide of the gel and the po ition of the P6 fu ion i indicated by the yel low 
arrow. 
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3.3.6. Expression and purification of pET4215-His-NSPS and pET4215-His-
NSP6 expressed from the pET4215 vector 
A new approach of purification was required to circumvent the problems 
encountered during GST tagged protein purification. The plasmid pET 4215 was 
developed within the rotavirus lab at the University of Warwick (Chung, 2004). This 
vector was based upon the pET42b vector but contains the His tag region from the 
pET 15 vector. This created a fusion construct in which the protein expressed from 
this vector contained a His tag followed by a linker region ending in the factor Xa 
cleavage site (Figure 3.19). The ORF's for NSP5 and NSP6 were excised from the 
pET42b vector by enzymatic cleavage with KpnI and Pst!, and ligated into the 
pET4215 vector which had also been cut with these restriction enzymes (Figure 
3.20). The pET4215-0RFI (Appendix 1.9) and pET4215-0RF2 (Appendix 1.10) 
constructs were first transformed into the INVaF' E. coli strain and then into the 
BLR E. coli strain containing T7 RNA polymerase. The pET4215-His-NSP5 and 
pET4215-His-NSP6 fusion proteins were both found to be in the insoluble fraction 
of the induced bacteria (Figure 3.21 a and 3.21 b). The purification of the two proteins 
from the insoluble fractions was undertaken using denatured purification and 
stepwise refolding. The pET4215-His-NSP5 protein and pET4215-His-NSP6 protein 
were eluted in 8M urea pH 3.5 and refolded by stepwise dialysis against 20mM Tris-
HCl (Figure 3.22a and 3.22b). The pET4215-His-NSP5 protein was refolded from 
pH 10 to pH 7.5 and the pET4215-His-NSP6 protein was refolded from pH 4 to pH 
7. The purified proteins were then subjected to Factor Xa digestion to remove the 
His tag and linker region. When the proteins were cleaved with Factor Xa a large 
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amount of protein degradation was observed preventing efforts to purify the cleaved 
protein. 
Although this protein could not be used for functional assays the tagged 
purified pET4215-His-NSP5 and pET4215 His-NSP6 were successfully used to 
generate polyclonal sera to these proteins. The pET4215-His-NSP5 was used to 
generate guinea pig anti-NSP5 sera (Harlan sera labs, UK) as described in the 
Materials and Methods and the pET4215-His-NSP6 was used to generate rabbit anti-
NSP6 sera (ISL Ltd, UK) as described in the Materials and Methods. 
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Figure 3.19 Restriction map of pET4215 and schematic of His linker region 
Panel A) DNA equence of the region of pET4215-0RF I encoding the 6xHi tag 
and the linker region before the ORF of P5. Down tream of the 6xHi tag i a 22 
amino acid linker region which i followed by a Factor Xa cleavage ite. Restriction 
enzyme site are indicated in blue and the amino acid equence can be een in green 
below the nucl otide triplet codon which enc de th m. The Hi tag and N P5 tart 
codon are both indicated in red. 
Panel B) Repre entation of p T4215 con tructed in the rotaviru laboratory ( hung, 
2004). The vector wa con tructed by removing the T tag from pET42b and 
replacing it with the Hi tag from the p T 15 vector. 
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Figure 3.20 Restriction enzyme analysis of putative pET4215-0RFl and 
pET4215-0RF2 clone 
A cDNA copy of gene II ORF I and ORF2 wa generated u ing peR carried out a 
described in the Material and Methods. The e cDNA were cloned into the pET421S 
vector as de cribed in th Material and Method. ingle colonies were harve ted 
and grown OIN at 3r before being miniprepp d a de cribed in the Mat rial and 
Methods. The resulting plasmid DNA cut with Kpn l and PstI to creen for potential 
insert. The re triction dige twa then fractionated on a 1% agarose gel stained with 
ethidium bromide and visualized using UV light a de cribed in the Materials and 
Methods. Track A) DNA size marker ladder, track 8) pET42IS-0RF I cut with Kpnl 
and Psll and track C) p T421S-0RF2 cut with Kpnf and P. II. Migration of the D A 
ize marker are indicated on th left hand ide of the gel. 
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Figure 3.21 Expression of His tagged NSP5 and NSP6 from pET4215-0RFl 
and pET4215-0RF2 
BLR E. coli containing either pET4215-0RFl or pET4215-0RF2 were cultured in 
500ml LB at 37°C until the 00 reached between 0.5 and 1. IPTG was added to a 
final concentration of 1 mM and cultures incubated for a further 4 hours. The cells 
were recovered by centrifugation and lysed by French press. The soluble and 
insoluble fractions were then separated by centrifugation and insoluble proteins 
solublised in 8M urea as described in the Materials and Methods. Both soluble and 
insoluble fractions from the induced cultures were then fractionated on a 14% SOS 
polyacrylamide gel which was stained with Coomassie blue as described in the 
Materials and Methods. 
Panel A) Showing the induction test of His-NSP5 from pET4215-0RFl. Track A) 
Protein size markers 10-180 kDa, track B) Soluble fraction and track C) Insoluble 
fraction. Migration of the protein size markers are indicated on the left hand side of 
the gel and the position of the NSP5 fusion is indicated by the yellow arrow. 
Panel B) Showing the induction test of His-NSP6 from pET4215-0RF2. Track A) 
Protein size markers 10-180 kDa, track B) Insoluble fraction and track C) Soluble 
fraction. Migration of the protein size markers are indicated on the left hand side of 
the gel and the position of the NSP6 fusion is indicated by the yellow arrow. 
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Figure 3.22 Purification of His tagged NSP5 and NSP6 from pET421S-0RFl 
and pET421S-0RF2 
The insoluble fractions from cultures induced to express pET421S-His-NSPS and 
pET4215-His-NSP6 were denatured in 6M Gu-HCI and passed over a Ni++ chelating 
column equilibrated with 8M urea pH 8.0. The column was then washed with 8M 
urea pH 8.0 until all protein flow through was removed. The column was then 
washed with 3 column volumes of 8M urea pH 6.0 followed by 3 column volumes 
of 8M urea pH 4.0. Finally protein was eluted by washing with 3 column volumes of 
8M urea pH 3.5 as described in the Materials and Methods. The proteins were eluted 
from the column in 8M urea pH3.5 and refolded by stepwise dialysis against 20mM 
Tris-HeI. pET4215-His-NSP5 was refolded stepwise from 20mM Tris-Hcl pH 10 to 
pH 7.S and pET4215-His-NSP6 was refolded by stepwise dialysis against 20rnM 
Tris-Hel pH 4 to pH 7 as described in the Materials and Methods. The purified 
proteins were then fractionated on a 14% SDS polyacrylamide gel which was stained 
with Coomassie blue as described in the Materials and Methods. 
Panel A) pET4215-His-NSP5 purified and refolded by stepwise dialysis against 
20mM Tris-Hel 7.5. Track A) Protein size markers 10-180 kDa, tracks B-D) 
pET4215-His-NSPS eluted fractions from Ni++ chelating column. Migration of the 
protein size markers are indicated on the left hand side of the gel and the position of 
the NSP5 fusion is indicated by the yellow arrow. 
Panel B) pET4215-His-NSP6 purified and refolded by stepwise dialysis against 
20rnM Tris-Hel pH 7.5. Track A) Protein size markers 10-180 kDa, tracks B-C) 
pET4215-His-NSP6 eluted fractions from Ni++ chelating column. Migration of the 
protein size markers are indicated on the left hand side of the gel and the position of 
the NSP6 fusion is indicated by the yellow arrow. 
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3.3.7. Expression and purification of direct His tagged NSP5 and NSP6 proteins 
The His tagged proteins expressed from the pET4215 vector had a large 
linker region between the His tag and the ORF's which could possibly interfere with 
the folding of the protein and increase instability leading to degradation during 
purification. To circumvent the problems encountered during purification of NSP5 
and NSP6 with large tags and to remove the necessity for cleavage of these tags by 
Factor Xa, peR was used to fuse a His tag directly to the 5' terminus of the two 
proteins. The 5' primer for these peR's contained a unique restriction site of NdeI 
followed by the 6xhistidine residues and the start of the ORF. The 3' primer 
contained a PstI restriction site. The pET42b vector was cut using these two 
restriction enzymes to completely remove the OST tagging domain. The gel 
extracted peR products were cut with these restriction enzymes before being ligated 
into the open vector to create direct fusion His-NSP5 and His-NSP6 (Figure 3.23) 
Single colonies were then grown and minipreps performed in order to assess which 
contained the NSP5 and NSP6 ORF inserts (Figure 3.24a and 3.24b). 
Induction tests showed that the protein expressed from these constructs were 
found in the insoluble fraction and both proteins were purified using a Ni++ chelating 
column as described above (Figure 3.25a and 3.25b). Following elution the His-
NSP5 and His-NSP6 proteins were refolded by stepwise dialysis against 20mM Tris-
Hel. His-NSP5 was refolded from 20mM Tris-Hel pH 10 to pH 7.5 and the His-
NSP6 protein was refolded from 20mM Tris-Hel pH 4 to pH 7 (Figure 3.26a and 
3.26b). This one step purification method created highly pure protein that required 
no further modification and could be used in functional assays. The purified NSP5 
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was found to exist as two discrete bands of 26 and 28 kDa when analysed by SDS-
PAGE (Figure 3.26a). Mass spectrometry based N-terminal sequence analysis was 
used to establish that both of these bands were NSP5. Previous reports have 
indicated that different iso-forms ofNSP5 can be generated byautophosphorylation 
of the protein (Afrikanova et al., 1994; Blackball et al., 1998). The purification of 
NSP5 in two forms at 26 and 28 kDa might suggest that this has taken place in the 
bacterially expressed NSP5. 
The purified NSP6 obtained with this protocol was also used to generate rat 
anti-NSP6 monospecific antisera (Harlan sera labs, UK) as described in the 
Materials and Methods. 
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Figure 3.23 Strategy for cloning the NSPS and NSP6 ORF's into a modified 
pET42b expression vector 
Panel A) Schematic representation showing the insertion of PCR products of NSP5 
and NSP6 ORF with a 6xHis tag at their 5' termini into a pET42b vector which 
lacked it's tagging region. The PCR products and the pET42b vector were cut with 
NdeI and Pst! restriction enzymes, gel purified and ligated as described in the 
Materials and Methods. 
Panel B) DNA sequence chromatogram of pET -His-NSP5 construct showing the 
junction between the pET vector NdeI restriction site and the 6xHis tag ligated into 
the plasmid. The NdeI restriction site, 6xHis tag and the NSP5 start codon are 
identified at the top of the chromatogram. 
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Figure 3.24 Restriction enzyme digestion analysis of the creation of pET42-
HisORFl and pET42-HisORF2 
A cDNA copy of gene II ORF I and ORF2 with direct 6xHis fusion tag wa 
generated using P R carried out as described in the Materials and Method. This 
cDNA was cloned into a modified pET42b vector as described in the Materials and 
Methods. Single colonies were harvested and grown OIN at 37°C before being 
miniprepped as described in the Materials and Method. The resulting plasmid DNA 
cut with Nde l and Pst) to screen for potential in erts. The re triction digest wa then 
fractionated on a 1% agarose ge l tained with ethidium bromide and vi ualized using 
UV light as described in the Materials and Methods. 
Panel A) Tracks A-K pET42-HisORF I colony screen u ing the Nde) and Psll 
re triction enzymes to determine the presence of in ert . Track A) DNA ize marker 
ladder, tracks B- K) Miniprepped colonies from the pET42-HisORF I ligation cut 
with Nde ) and Pstl. Migration of the DNA ize marker are indicated on the left 
hand side of the gel. 
Panel B) Tracks A-C pET42-HisORF2 colony creen using the Ndel and Psll 
re triction enzymes to determine the pre ence of in ert . Track A) DNA size marker 
ladder, tracks B-C) Miniprepped colonie from the p T42-Hi ORF2 ligation cut 
with Nde l and P II. Migration of the DNA size marker are indicated on the left 
hand side of the gel. 
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Figure 3.25 Expression of His tagged NSPS and NSP6 
BLR E. coli cultures induced to express His-NSP5 or His-NSP6 in 500ml were 
incubated at 37°C until the 00 reached between 0.5 and 1. IPTG was then added to 
a final concentration of ImM and the cultures were incubated for a further 4 hours. 
Cells were recovered by centrifugation and lysed by French press. The soluble and 
insoluble fractions were then separated by centrifugation and insoluble proteins 
solublised in 8M urea as described in the Materials and Methods. Samples were 
fractionated on a 14% SDS-PAGE gel which was stained with Coomassie blue as 
described in the Materials and Methods. 
Panel A) Expression of NSP5 with a His fusion tag. Track A) Protein size markers 
10-180 kDa, track B) Total cell protein of induced culture, track C) Media fraction 
of induced culture, track D) Soluble fraction and track E) Insoluble fraction. 
Migration of the protein size markers are indicated on the left hand side of the gel 
and the position of the NSP5 fusion is indicated by the yellow arrow. 
Panel B) Expression of NSP6 with a His fusion tag. Track A) Protein size markers 
10-180 kDa, track B) Total cell protein of induced culture, track C) Media fraction 
of induced culture, track D) Soluble fraction and track E) Insoluble fraction. 
Migration of the protein size markers are indicated on the left hand side of the gel 
and the position of the NSP6 fusion is indicated by the yellow arrow. 
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Figure 3.26 Purification of His tagged NSPS and NSP6 
SDS-PAGE analysis of purified His-NSP5 and His-NSP6 protein eluted from NiH 
chelating column stained with Coomassie blue. 
Panel A) His-NSP5 purified and refolded Track A) Protein size markers to-180 kDa, 
tracks B-D) His-NSP5 eluted fractions from NiH chelating column. Migration of the 
protein size markers is indicated on the left hand side of the gel and the position of 
the NSP5 fusion is indicated by the yellow arrow. 
Panel B) His-NSP6 purified and refolded Track A) Protein size markers 10-180 kDa, 
tracks B-D) His-NSP6 eluted fractions from NiH chelating column. 
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3.4. Discussion 
Work presented in this chapter has shown the cloning, expression and 
purification strategies used in order to obtain purified NSP5 and NSP6. In the 
process of cloning the NSPS (ORFl) and NSP6 (ORF2) coding sequences into the 
required vectors several changes from the published UKtc bovine rotavirus strain 
gene 11 sequence were identified, some of which lead to changes in the amino acid 
sequences of NAPS and NSP6. These changes make the gene 11 sequence of the 
UKtc strain more homologues with other rotavirus gene 11 sequences. 
The original strategy was to utilise a GST tag and purification on GSH-
agarose. However this was not possible because the GST-NSP6 protein was 
expressed in the insoluble fraction and the GST -NSP5 protein degraded when cut 
with Factor Xa to remove the GST tag after purification. 
The second expression strategy employed was to use a vector that contained 
a His tag on the end of a large linker region for purification. Although large amounts 
of the His tagged proteins were obtained using this approach. removal of the 6xHis 
tag and the linker region was problematic leading to highly degraded protein. 
However it did generate purified protein that was used to generate monospecific 
antisera against the NSP5 and NSP6 protein. 
To produce highly pure protein required for functional assays peR was used 
to fuse a 6xHis tag directly onto the amino terminus of NSP5 and NSP6. This 
approach allowed single step purification of NSP5 and NSP6. The purified NSP6 
protein was again used to generate monospecific antisera. The purified NSP5 protein 
was seen to exist in two forms migrating at 26 and 28 kDa in PAGE. Both forms 
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were confirmed by mass spectrometry to be NSP5 possibly indicating that 
autophosphorylation was occurring during E. coli protein expression. 
The work in this chapter has demonstrated the means by which purified 
protein and mono specific antisera were produced to the two rotavirus proteins NSP5 
and NSP6 for use in future experiments. 
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4.1 Aims 
The aims of the work described in this chapter were to examine the 
expression and intracellular localisation of the NSP5 and NSP6 proteins encoded by 
rotavirus gene 11. 
4.2 Introduction 
NSP5 and NSP6 proteins have both been localised to the viroplasm of 
infected cells and shown to be expressed throughout the rotavirus infection (Petrie et 
al., 1884; Mattion et al., 1991). The NSP6 protein was detected as a 12 kDa protein 
expressed at low levels (Mattion et al., 1991; Torres-vega et ai., 2000). The NSP5 
protein was found in infected cells as three isoforms differing in their level of 
phosphorylation. These isoforms are found at 26, 28 and 30-34 kDa when analysed 
by SDS-PAGE (Welch et al., 1989; Afrikanova et aJ., 1996; Poncet et al,. 1997; 
Blackhall et aJ., 1997). NSP2 has been shown to upregulate the phosphorylation of 
NSP5 from the 26 and 28 kDa isoforms to the hyperphosphorylated 30-34 kDa 
isoform (Afrikanova et al., 1998). A number of studies have indicated that NSP5 has 
some level of autophosphorylation activity but was unable to form the 
hyperphosphorylated isoform by this means (Blackball et al., 1997; Blackball et al., 
1998). 
The formation of viroplasm-like structures in the absence of a rotavirus 
infection has been observed in cells transfected with plasmids expressing NSP5 and 
another rotavirus protein NSP2 (Fabbretti et al., 1999). A number of deletion 
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mutants were used to determine that the N-terminus of NSP5 was essential for 
binding of NSP2 (Frabbretti et al., 1999). 
The exact distribution of NSP6 still remains unclear, Mattion et al stated that 
when their anti-NSP6 sera was used in immunofluorescence experiments the NSP6 
was found in discrete foci smaller than that of the NSP5, which they claimed were 
potentially the viroplasms (Mattion et ai., 1991). Nothing more is known about the 
expression of NSP6, other than it has been immunoprecipitated from cells infected 
with the YM and SAIl rotavirus strains and that co-imunoprecipitation ofNSP5 and 
NSP6 was achieved by using cells transfected with the open reading frames of the 
two proteins (Mattion et al., 1991; Torres-Vega et ai., 2000). 
4.3 Results 
4.3.1. Expression of the NSPS and NSP6 proteins in vitro 
A coupled in vitro transcription/translation system was used to investigate 
expression levels of the proteins transcribed from the rotavirus UKtc strain gene II. 
A gene 11 cDNA was sub-cloned into the expression vector PClneo positioning it 
downstream of the T7 promoter (Figure 4.1). This construct was used in the in vitro 
transcription/translations system to express the two viral proteins which were radio-
labelled by the addition of 35S Methionine to the reaction mixture. Autoradiography 
was used to detect the radio-labelled NSP5 and NSP6 proteins. The NSP5 protein 
appeared as expected, at the 26 - 28 kDa and NSP6 was detected at 12 kDa in much 
smaller amounts (Figure 4.2). 
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In order to verify that the protein detected at 12 kDa was indeed NSP6 and 
not simply a prematurely terminated fragment of NSP5, the ORF2 of gene 11 (Le. 
the NSP6 coding region) was cloned separately into the PCIneo vector. Using this 
construct a large amount of NSP6 protein was produced at 12 kDa, which was not 
detected when only the PCIneo vector was used in the expression system (Figure 
4.2). 
4.3.2. Hyperphosphorylation of NSPS in the coupled in vitro 
transcription/translation system 
The protein expressed from the genell-PCIneo construct in the coupled in 
vitro transcription/translation system was incubated overnight at 20°C. The 
incubated NSP5 protein was able to form the higher hyperphosphorylated form 
which could be seen at the 30-34 kDa band of protein (Figure 4.3). However, a 
control sample left at 4°C overnight did not form the hyperphosphorylated NSP5 
isoform. This indicates that hyperphosphorylation of NSP5 can occur in the absence 
of NSP2 either by the presence of cellular kinases in the reaction mixture or by a low 
level ofNSP5 autophosphorylation over an extended incubation period. 
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Figure 4.1 Schematic diagram of the structure of gene 11 in the PClneo 
expression vecto r 
The rotavirus gene II was amplified f rom the pET42b-genell plasmid by PCR 
using primers that introduced an Xho l restriction site at the 5' termini and an Xba l 
re tricti on site at the 3' termini . The PCR product and the PIneo vector were both 
cut w ith these restriction enzymes and gel purified. The two cDNA's were ligated 
and transformed into E. coli as described in the Materi als and Method . 
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Figure 4.2 Expression of NSPS and NSP6 from gene 11 and detection of the 
NSP6 protein expressed from a coupled in vitro transcriptiOn/translations 
system 
Panel A) Gene 11 of the UKtc strain of rotavirus was cloned into the PClneo 
expression vector (genell-PClneo). In vitro transcription/translation using this viral 
eDNA construct was carried out as described in the Materials and Methods. The 
protein products were analysed by PAGE as described in the Materials and Methods. 
After drying, the gel was autoradiographed as described in the Materials and 
Methods. The migration positions of the molecular weight size markers are indicated 
on the left hand side of the autoradiogram and the positions of NSP5 and NSP6 are 
indicated by arrows on the right hand side. 
Panel B) The NSP6 coding region was cloned into the PCIneo expression vector 
(NSP6-PClneo). In vitro transcription/translation reaction was carried out as 
described in the Materials and Methods. The protein products were analysed by 
PAGE as described in the Materials and Methods. After drying, the gel was 
autoradiographed as described in the Materials and Methods. Track A) shows 
protein expression from the PeIneo plasmid and track B) shows protein expression 
from the Genell-PClneo construct. The migration positions of the molecular weight 
size markers are indicated on the left hand side of the autoradiogram. 
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Figure 4.3 Hyperphosphorylation of the NSP5 in the coupled in vitro 
transcr-iption/tra nsla tions system 
Protein expressed from the gene II-PClneo con truct in the coupled in vitro 
tran cription/translation sy tern was incubated O/N at either 20°C or 4°e. 
In vitro transcription/translation u ing thi vira l eDNA construct was carried out as 
described in the Materials and Methods and the reaction mixture plit into two equal 
halves one of wh ich wa incubated OIN at 4°C and the other at 20°e. The protein 
products were analysed by PAGE a de cribed in the Material and Method. Arter 
drying the gel wa autoradiographed as described in the Materials and Methods. 
Track A) show the proteins present after OIN incubation at 4°C and track 8) shows 
the proteins after OIN incubation at 20°e. The migration po ition of the molecular 
weight size markers are indicated on the left hand ide of the autorad iogram and the 
po ition of N P6 and the different phosphorylated i oforms of NSP5 are indicated 
by arrow on the right hand ide. 
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4.3.3. Detection of NSPS and NSP6 by immunofluorescence 
Immunofluorescence experiments on cells infected with the UKtc rotavirus 
strain were undertaken using polyclonal antisera generated from purified NSP5 and 
NSP6. Cells were infected at an m.o.i. of 3 and fixed 12 hours post infection. The 
polyclonal monospecific antisera were then used as the primary antibody in indirect 
immunofluorescence studies. The hyperimmune NSP5 antisera detected large 
punctate occlusion bodies of the viroplasms in the cytoplasm (Figure 4.4). As 
expected no specific staining for NSP5 was seen with the preimmune sera. However 
the NSP6 antisera did not give any specific fluorescence above background at any 
time post infection (data not shown). 
4.3.4. Viroplasm formation within the infected cell 
The localisation of NSP5 to the viroplasms was first reported in early studies of 
rotaviruses (Gallegos & Patton, 1989). A time course study was perfonned to 
investigate the intracellular distribution of NSP5 and the viroplasms it fonns, cells 
were fixed at time points of 2, 4, 6, 10, 16, and 24 hours post infection and stained 
with NSP5 antisera (Figure 4.5). The results indicated that there were few 
viroplasms evident at the earliest time point but this number rose dramatically over 
the following 2 hours. At 6 hours post infection the number appeared to decrease, 
possibly as a result of viroplasms coalescing. Consistent with this interpretation was 
the fact that the size of the viroplasms began increasing at approximately this time. 
At 16 hours, large occlusion bodies could be seen that were much fewer in number 
than at earlier time points. The last time point, 24 hours, showed little change from 
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Figure 4.4 Localisation of NSPS in virus infected cells by indirect 
immu nofluorescence 
Confluent monolayers of BSC] cells were infected with the UKtc strain of rotavirus 
at an m.o.i. of 3. At 16 hours post infection the cells were fixed using methanol at _ 
20°C. The fixed cells were then stained with either panel A) guinea pig pre-immune 
sera or panel B) a I :200 dilution of guinea pig anti NSP5 sera. This was followed by 
staining with the secondary antibody goat anti guinea pig Alexa fluor 594 (red). 
Nuclei were stained with DAPI (blue) and fluorescence was detected using confocal 
microscopy as desclibed in the Materials and Methods. Size of scale bar is indicated 
on images. 
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Figure 4.5 Time course of viroplasm formation in virus infected cells 
Confluent mono layers of BSC I cells were infected with the UKtc strain of rotavirus 
at an m.o.i. of 3. The cells were then fixed using methanol at -20°C at several time 
points panel A) 2 hours post infection, panel B) 4 hours post infection, panel C) 6 
hours post infection, panel D) 10 hours post infection, panel E) 16 hours post 
infection and panel F) 24 hours post infection. 
The fixed cells were then stained using a I :200 dilution of guinea pig anti 
NSP5 sera, followed by staining with the secondary antibody goat anti guinea pig 
Alexa fluor 594. Nuclei were stained with DAPI and fluorescence was detected 
using confocal microscopy as described in the Materials and Methods. Size of scale 
bar is indicated on images. 
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that evident at 16 hours however there was a small increase in the number of 
viroplasms, possibly due to secondary rounds of replication from newly synthesised 
core particles. 
4.3.5. Morpbology of the NSP5 protein within tbe viroplasm 
In the later time points as the viroplasms began to increase in size, ring 
structures were observed. However in the lower confocal slices there appeared to be 
a base to these rings indicating more of a cup shape to the distribution of the NSP5 
protein. By viewing individual images of a confocal series which pass through a 
viroplasm it was possible to view this cup shape of the viroplasm (Figure 4.6). Also 
the impression gained from studying the viroplasms was that most of the viroplasms 
appeared to be localised to the lower half of the cells i.e. towards the side attached to 
the tissue culture flask. 
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Figure 4.6 Morphology of NSPS within the viroplasm 
Horizontal stack of a confocal series showing NSP5 distribution within viroplasms. 
Confluent monolayers of BSC 1 cells were infected with the UKtc strain of rota virus 
at an m.o.i. of 3. The cells were then ftxed using methanol at -20°C at 16 hours post 
infection. The ftxed cells were then stained using a 1 :200 dilution of guinea pig anti 
NSP5 sera, followed by staining with the secondary antibody goat anti guinea pig 
Alexa fluor 594. Nuclei were stained with DAPI and fluorescence was detected 
using confocal microscopy as described in the Materials and Methods. Size of scale 
bar is indicated on images. 
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4.3.6. Detection of the NSP6 protein in virus infected ceOs 
Two polyclonal antisera were generated against the purified NSP6 protein (as 
stated in the previous chapter), one in a rabbit and the second in a rat. NSP6 
expression could not be detected above background using immunofluorescence with 
either of these sera and Western blot on infected cell lysate did not detect the 
presence of any NSP6 protein. However the sera could be used to detect purified 
His-NSP6 protein by Western blot analysis (Figure 4.7). 
Immunoprecipitation of radio-labelled protein was the only method by which 
NSP6 could be detected in virus infected cells. Infected cells were labelled with 35S 
methionine for 5 hours beginning at 3 hours post infection. These cells were then 
lysed and immunoprecipitation performed using either the NSP5 or NSP6 sera. The 
immunoprecipitated proteins were separated on a 14% SOS-PAGE gel and proteins 
detected by autoradiography. The immunoprecipitation detected both NSP5 and 
NSP6, but the level of NSP6 detected was significantly lower than that of NSP5 
(Figure 4.8). Several large bands appeared to be non-specifically precipitated by 
both sera. These non-specific bands were also precipitated using monospecific sera 
to VP7 (Figure 4.9a) and when using only the protein A sepharose beads in a 
precipitation without any sera (Figure 4.9b). No NSP5 or NSP6 proteins were 
precipitated from uninfected cells or by using beads alone, demonstrating the 
specificity of the two sera. 
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Figure 4.7 Detection of purified NSP6 protein by Western blot 
100ng ofpw-ified NSP6 protein was lUn on a 14% SDS-PAGE gel and transferred to 
a nitrocellulose ECL membrane as described in the Materials and Methods. A 
Western blot was carried out using the Amersham ECL Western blot kit as described 
in the Materials and Methods. The Western blot was probed with 1: 1 0,000 dilution 
of rabbit anti NSP6 sera and with the secondary HRP-conjugated goat anti rabbit at a 
di lution of 1 :20,000. The NSP6 protein was then detected by exposw-e to X-ray film . 
The migration positions of the molecular weight size markers are indicated on the 
left hand side of the Western blot and the positions of the His-NSP6 is indicated by 
arrows on the right hand side. 
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Figure 4.8 Immunoprecipitation of NSP5 and NSP6 from virus infected cells 
Confluent monolayers of BSCI cells were infected with the UKtc strain of rotavirus 
at an m.o.i. of 3. The cells were overlaid with methionine free DMEM and incubated 
at 37°C for 3 hours to deplete the methionine pool. The medirun was then removed 
and replaced with methionine free DMEM containing approximately 200).1Ci of 35S 
methionine and incubated for a further 5 hours. Cells were harvested in 500).11 of 
RIP A lysis buffer. Immunoprecipitation was then performed using either the guinea 
pig anti NSP5 polyclonal sera or the rabbit anti NSP6 polyclonal sera as described in 
the Materials and Methods. The precipitated proteins were fractionated on a 14% 
SDS-P AGE gel and detected by autoradiography as described in the Materials and 
Methods. Track A) Immunoprecipitation using NSP5 pre immune sera, track B) 
Immunoprecipitation using NSP5 hyper immune sera, track C) lmmunoprecipitation 
using NSP6 pre immune sera and track D) Immunoprecipitation using NSP6 hyper 
immune sera. The migration positions of the molecular weight size markers are 
indicated on the left hand side of the autoradiogram and the positions of NSP5 and 
NSP6 are indicated by arrows on the right hand side. 
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Figure 4.9 Autoradiograms showing immunoprecipitation of NSP6 and VP7 
showing the presence of non-specific bands and immunoprecipitation of 
uninfected and infected cells using protein A sepharose beads ooly or with 
NSP6 polyclonal antisera 
Confluent monolayers of BSCI cells were infected with the rota virus UKtc 
strain at an m.oj. of 3. The cells were overlaid with methionine minus DMEM and 
incubated at 37°C for 3 hours to deplete the methionine pool. The medium was then 
removed and replaced with methionine free DMEM containing approximately 
200).1Ci of 35S methionine and incubated for a further 5 hours. Cells were harvested 
in 500).11 of RIP A lysis buffer as described in the Materials and Methods. 
Panel A) Immunoprecipitation was then performed using either rabbit anti VP7 
polyclonal antisera or rabbit anti NSP6 polyclonal antisera on uninfected or infected 
cells as described in the Materials and Methods. Track A) Uninfected cell whole 
lysate, track B) Immunoprecipitation of uninfected cells using VP7 antisera, track C) 
Immunoprecipitation of uninfected cells using NSP6 antisera, track M) position of 
molecular weight markers, track D) Infected cell whole lysate, track E) 
Immunoprecipitation of infected cells using VP7 antisera and track F) 
Immunoprecipitation of infected cells using NSP6 antisera. The migration positions 
of the molecular weight size markers are indicated on the left hand side of the 
autoradiogram. 
Panel B) Immunoprecipitation was then performed using either protein A sepharose 
beads only or with rabbit anti NSP6 polyclonal antisera on uninfected or infected 
cells As described in the Materials and Methods. Track A) Uninfected cell whole 
lysate, track B) Immunoprecipitation of uninfected cells using protein A sepharose 
beads only, track C) Immunoprecipitation of uninfected cells using NSP6 antisera, 
track D) Infected cell whole lysate, track E) Immunoprecipitation of infected cells 
using protein A sepharose beads only and track F) Immunoprecipitation of infected 
cells using NSP6 antisera. The migration positions of the molecular weight size 
markers are indicated on the left hand side of the autoradiogram. 
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4.3.7. Kinetics of NSP6 expression during a rotavirus infection 
A confluent monolayer of cells was infected with the UKtc strain of rotavirus 
at an m.oj. of 3 to produce one step growth conditions. The cells were then pulse 
labelled with 3SS methionine for 1 hour at 2, 3, 4, 6 and 8 hours post infection. 
Immunoprecipitation of the resulting pulsed cells lysates was then performed using 
rabbit anti NSP6 sera to determine the level of NSP6 expression over the course of 
the virus replication cycle (Figure 4.10). There appeared to be little NSP6 expressed 
at the 2-3 hour time point but after this there was a steady but low rate of NSP6 
expression (Figure 4.10). There appeared to be slightly less NSP6 found in the 8 
hour time point but, this may have been due to a reduction in the number of cells as 
a result of virus induced cell lysis (Figure 4.10). 
4.3.8. Stability of the NSP6 protein within the rotavirus infected ceO 
To test the stability of NSP6 pulse chase analysis was used. Infected cells 
were pulsed with 3SS methionine for 5 hours and then chased with an excess of cold 
methionine for a further 2 hours before harvesting. The cells were lysed and 
irnmunoprecipitations performed using either the anti NSP5 or anti NSP6 sera. The 
relative abundance of the two proteins in the pulse and chase samples were then 
compared by SOS-PAGE. There were approximately equivalent amounts ofNSP5 in 
both the pulse and chase lanes showing NSP5 was stable over the chase period. By 
contrast virtually all of the NSP6 had disappeared from the chase lane (Figure 4.11). 
This showed that NSP6 is unstable in virus infected cells and is turned over at a 
much higher rate than any of the other viral proteins. 
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Figure 4.10 Immunoprecipitation of the NSP6 protein over the course of a 
rotavirus infection 
A confluent monolayer of BSel cells was infected with rotavirus at an m.oj. of 3 to 
produce one step growth conditions. These cells were then pulse labelled with 35S 
methionine for 1 hour over the course of the infection at Track A) 2, track B) 3, 
track C) 4, track D) 6 and track E) 8 hours post infection. lmmunoprecipitation was 
then performed with the rabbit anti NSP6 sera as described in the Materials and 
Methods to determine the level of NSP6 expression over the course of an infection. 
The migration positions of the molecular weight size markers are indicated on the 
left hand side of the autoradiogram. 
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Figu re 4.11 Analysis of NSP6 stabiJjty in virus infected cells 
Confluent monolayers of BSCI cells were infected with the UKtc strain of rotavirus 
at an m.o.i. of 3. The cells were overlaid with methionine free DMEM and incubated 
at 37°C for 3 hours to deplete the methionine pool. The medium was then removed 
and replaced with methionine free DMEM containing approximately 200j.lCi of 35S 
methionine and incubated for a further 5 hours. Half of the cells were harvested in 
500pl of RIPA lysis buffer. The remaining cel1s were overlaid with DMEM 
containing 50x the normal level of cold methionine and incubated for a further 2 
hours before harvesting. Immunoprecipitation was then performed using either the 
guinea pig anti NSP5 polyclonal sera or the rabbit anti NSP6 polyc1onal sera as 
described in the Materials and Methods. The precipitated proteins were then 
separated by 14% SDS-PAGE gel showing track A) Immunoprecipitation of NSP5 
from infected cells after 5 hour pulse, track B) Immunoprecipi tation of NSP6 after 5 
hour pulse, track C) lmmunoprecipitation of NSP5 after 2 hour chase and track D) 
Immunoprecipitation of NSP6 after 2 hour chase. The migration positions of the 
molecular weight size markers are indicated on the left hand side of the 
autoradiogram and the positions of NSP5 and NSP6 are indicated by arrows on the 
right hand side. 
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4.3.9. Localisation of tbe NSP6 protein witbin tbe infected cell 
The failure to detect fluorescence in virus infected cells using the NSP6 
antisera prompted the construction of a GFP tagged NSP6 fusion. The coding region 
of the NSP6 protein was inserted in-frame into the multi-cloning site of the phrGFP-
N 1 vector this vector was then transfected into BSC-I cells and incubated at 37°C 
for 48 hours. The intracellular distribution of the GFP-NSP6 fusion protein was 
studied using confocal microscopy. 
Only a small number of cells were clearly positive for fluorescence of the 
GFP-NSP6 suggesting that the turnover of this protein is high even in the absence of 
a rotavirus infection. In all the cells observed the GFP-NSP6 fusion protein appeared 
to be clustered around one side of the nucleus in an amorphous mass in the 
cytoplasm and not found diffusely distributed through out the cell (Figure 4.12). 
Having established the intracellular distribution of GFP-NSP6 in transfected 
cells, the effect of a rotavirus infection upon this distribution was investigated. Cells 
were transfected with GFP-NSP6 and 48 hours post transfection infected with the 
UKtc strain of rotavirus. Sera against NSP5 were used to localise viroplasms within 
the infected cell (Figure 4.l3). A control experiment was set up in which GFP alone 
was transfected into cells which were subsequently infected with UKtc, the results 
showed that GFP remained diffuse throughout the cell and did not redistribute to 
viroplasms (Figure 4.13). Figure 4.14 shows a number of cells infected with 
rotavirus, one of which that had also been transfected with the GFP-NSP6 
expressing plasmid the distribution of the GFP-NSP6 (green) and the NSP5 (red) can 
be clearly seen. The GFP-NSP6 fusion protein was found to redistribute into small 
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discrete spherical structures, which co-localised with the NSP5 protein within the 
viroplasms (Figure 4.14). Figure 4.15 shows that the GFP-NSP6 appeared to be 
centred in the middle of the viroplasrns rather than distributed around the edge like 
the NSP5 protein. The distribution was reminiscent of that reported recently for the 
NSP2 protein (Eichwald et at., 2004). 
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Figure 4.12 Distribution of GFP-NSP6 in transfected cells 
Confluent monolayers of BSC} cells were transfected with the GFP-NSP6 vector 
using lipofectamine 2000. The cells were incubated for 48 hours at 37°C and fixed 
using methanol at -20°C. Nuclei were stained with DAPI (blue) and fluorescence of 
the GFP-NSP6 (green) was detected using confocal microscopy as described in the 
Materials and Methods. Size of scale bar is indicated on image. 
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Figure 4.13 Distribution of GFP control in rotavirus infected cells 
Confluent monolayers of BSCI cells were transfected with phrGFP-Nl vector using 
lipofectamine 2000. The cells were incubated for 48 hours at 37°C and infected with 
the Uktc strain of rotavirus at an m.o.i. of 3. The cells were incubated at 37°C for a 
further 8 hours and then fixed using methanol at -20°e. The fixed cells were stained 
using a 1 :200 dilution of guinea pig anti NSP5 sera, followed by staining with the 
secondary antibody goat anti guinea pig Alexa fluor 594 (red). Nuclei were stained 
with DAPI (blue) and fluorescence of the GFP (green) was detected using confocal 
microscopy as described in the Materials and Methods .. Size of scale bar is indicated 
on unage. 
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Figure 4.14 Distribution of GFP-NSP6 fusion protein in rotavirus infected celJs 
Confluent monolayers of BSCI cells were transfected with the GFP-NSP6 using 
lipofectamine 2000. The cells were incubated for 48 hours at 37°C and then infected 
with the Uktc strain of rotavirus at an m.o.i. of 3. The cells were incubated for a 
further 8 hours at 37°C and then fixed using methanol at -20°C. The fixed cells were 
stained using a 1 :200 dilution of guinea pig anti NSP5 sera, followed by staining 
with the secondary antibody goat anti guinea pig Alexa fluor 594. Nuclei were 
stained with DAPI and fluorescence of the GFP-NSP6 was detected using confocal 
microscopy as described in the Materials and Methods. The four panels above 
represent the three channels detected using the confocal microscope panel A) nuclei 
stained with OAPI (blue), panel B) GFP-NSP6 (green), panel C) NSP5 protein 
stained with Alexa fluor 594 (red) and panel 0) merge of all 3 channels. Size of 
scale bar is indicated on images. 
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Figure 4.15 Confocal image showing GFP-NSP6 localisation to the centre of the 
viroplasms 
Confocal microscopy image showing localisation of GFP-NSP6 to the viroplasm 
within cells transfected then infected with rotavirus. Cells were stained using a 1 :200 
dilution of guinea pig anti NSP5 sera, followed by staining with the secondary 
antibody goat anti guinea pig Alexa fluor 594 (red). Nuclei were stained with DAPJ 
(blue) and fluorescence of the GFP-NSP6 (green) was detected using confocal 
microscopy. Size of scale bar is indicated on image. 
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4.3.10. Viroplasm (ormation by NSP5 and NSP2 in tbe absence of otber 
rotavirus proteins 
An earlier study carried out by Fabbretti et at showed that the NSP2 and NSP5 
proteins can form viroplasm-like structures when co-transfected in the absence of 
other virus proteins (Fabbretti et at., 1999). These experiments were performed 
using constructs covering the whole coding region of gene 11 or regions still 
partially encoding the NSP6 protein. More recently an N-terminally tagged NSP5 
protein was shown to form these viroplasm-like structures in the absence of NSP2 
(Mohan et al., 2004). The NSP5 ORF when expressed with a GFP or HA N-terminal 
tag formed large punctate structures whereas the NSP5 ORF expressed without such 
a tag showed a diffuse intracellular distribution (Mohan et ai., 2004). To investigate 
the possibility that the NSP6 protein may be involved in some way in the formation 
of these viroplasrns-like structures, a gene II construct was generated which could 
not encode the second open reading frame. Site directed mutagenesis was used to 
change the ATG start codon of ORF2 to ACG, thereby preventing the expression of 
NSP6 without changing the amino acid sequence of NSP5 (Figure 4.16). The 
experiments using N-terminally tagged NSP5 and untagged NSP5 were replicated 
with the gene 11 that could not express NSP6. GFP-NSP5 and a GFP-NSP5 ORF2 
ATG-ACG (minus-NSP6) fusion constructs were generated and transfected into 
cells. The GFP-NSP5 formed viroplasm-like structures confirming the results of the 
previous study by Mohan et at (Figure 4.17a) (Mohan et al., 2004). The GFP-NSP5 
ORF2 ATG-ACG also formed viroplasm-like structures indicating that NSP6 is 
unnecessary for viroplasm-like structure formation. 
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Site directed 
mutagenesis 
ORF2 start codon 
ITyr I Lys I Asn I Glu I 
TCTTCTAGTATTTATAAAAACGAATCATCTTCAACAGCGTCAACTC 
ORF2 start codon deleted from sequence 
_ - ORFI amino acid sequence 
= ORF2 amino acids sequence 
Figure 4.16 Construction of the gene 11 ORF2 ATG-ACG mutant (minus 
NSP6) 
Site directed mutagenesis was used to change an adenine to a cytosine at nucleotide 
position 81 in the gene 11 sequence. This changes the A TG start codon of NSP6 to a 
non-functional ACG (ORF2 ATG-ACG). This change maintains the correct amino 
acid sequence of the NSP5 protein. The amino acid sequence of ORFI expressing 
NSP5 can be seen in green and the amino acid sequence of ORF2 expressing NSP6 
can be seen in blue. The change from ATG to ACG removes the possibility ofNSP6 
being expressed with the single base changed being shown in red. 
not required for the formation of viroplasm-like structures by the GFP-NSP5 fusion 
protein (Figure 4.17b). 
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The same experiment was carried out using untagged full-length gene I I or gene II 
minus, the start codon for NSP6 in combination with gene 9 (expressing the NSP2 
protein of the UKtc rotavirus strain). Gene 9, gene II and gene II ORF2 
ATG-ACG were cloned into the PCIneo mammalian expression vector. Cells 
transfected with these vectors were stained, using the guinea pig anti NSP5 sera to 
detect the distribution of the NSP5 and the potential formation of viroplasms. The 
results showed a diffuse intracellular distribution of NSP5 expressed from gene I 1-
PCIneo and genell-PCIneo ORF2 ATG-ACG when transfected alone (Figure 
4.18a and 4.18b). When genell-PCIneo was co-transformed with gene9-PClneo 
(expressing NSP2) viroplasm-like structures were formed (Figure 4.18c) in 
agreement with the earlier studies (Fabbretti et a/1999). When the genell-PCIneo 
ORF2 ATG-ACG was transfected with gene9-PClneo, the viroplasm-like 
structures were also formed (Figure 4.18d), taken together these results indicate that 
NSP6 is not required for NSP5 to distribute to the viroplasm-like structures in 
transfected cells. 
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Figure 4.17 GFP-NSP5 viroplasm formation in the absence of other rotavirus 
proteins 
Confluent monolayers of BSCI cells were transfected with either GFP-NSP5 or 
GFP-NSP5 ATG-tACG vectors using lipofectamine 2000. The cells were then 
incubated for 48 hours at 37°C, after this time the cells were fixed with methanol at -
20°C and nuclei stained with DAPI (blue). Expression of the GFP was detected 
using confocal microscopy. Panel A) GFP-NSP5 (green) viroplasm-Iike structure 
formation and panel B) GFP-NSP5 ORF2 ATG-tACG (green) viroplasm-like 
structure formation. Size of scale bar is indicated on images. 
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Figure 4.18 Viroplasm formation in the absence of other rotavirus proteins 
Confluent monolayers of BSCl cells were transfected with gene9-PCIneo and either 
genell-PCIneo or gene II-PClneo ORF2 A TG~ACG vectors using lipofectamine 
2000. The cells were then incubated for 48 hours at 37°e. After this time the cells 
were fixed with methanol at -20°e. The fixed cells were then stained using a 1:200 
dilution of guinea pig anti NSP5 sera, followed by staining with the secondary 
antibody goat anti guinea pig Alexa fluor 594. Nuclei were stained with DAPI (blue) 
and fluorescence was detected using confocal microscopy (Mohan et aI., 2004). 
Panel A) genell-PClneo, panel B) genell-PCIneo ORF2 ATG~ACG, panel C) 
PCIneo-gene9 and gene ll-PClneo and panel D) gene9-PClneo and gene II-PCIneo 
ORF2 ATG~ACG. Size of scale bar is indicated on images. 
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4.4. Discussion 
The work presented in this chapter investigates the kinetics of synthesis and 
sub-cellular distribution of both NSP5 and NSP6. NSP5 and NSP6 were both 
expressed from gene 11 in an in vitro transcription/translation system. The NSP5 
expressed from the in vitro transcription/translation system appeared to become 
hyperphosphorylated when incubated in the rabbit reticulate lysate at 200 e for 
extended periods of time. This hyperphosphorylation was not seen if the extended 
incubation was at 4°e, suggesting that NSP5 can be hyperphosphorylated either by 
cellular kinases or by slow autophosphorylation. NSP2 has been previously shown to 
enhance hyperphosphorylation (Afrikanova et ai., 1998) but this data suggests that 
hyperphosphorylation is not dependent on the presence of NSP2. Recent work has 
proposed that the binding of NSP2 may cause a conformational shift in the NSP5 
protein that allows it to be phosphorylated at a specific serine residue at position 67. 
This in turn is proposed to act as the catalyst for subsequent phosphorylation events 
leading to the formation of hyperphosphorylated NSP5 (Eichwald et ai., 2004). The 
cellular kinases casein kinase I and casein kinase II have both been suggested to be 
involved in this process (Eichwald et al., 2002; Eichwald et al., 2004). Evidence 
reported here suggests that cellular kinases may well be able to cause 
hyperphosphorylation without the presence of NSP2 but at a much slower rate. 
Previous work has shown the distribution ofNSP5 within the viroplasm to be 
a ring structure formed around the centre of the viroplasm in which the NSP2 protein 
can be localised (Eichwald et al., 2004). The viroplasms were also found to decrease 
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in number but, increase in size over the course of an infection, possibly due to 
coalescence and fusion of separate viroplasms (Eichwald et al., 2004). 
Work presented in this chapter indicates that the number of viroplasms 
appeared to increase from 2 - 6 hours post infection and then decreases thereafter as 
their size increases. The increase in the size of the viroplasms along with the 
decrease in number is consistent with the theory of viroplasm fusion, however no 
such fusion was directly observed by fluorescence. When viewing a confocal series, 
the distribution of NSP5 in viroplasms appeared to be cup shaped with the protein 
forming a ring around the centre of the viroplasm and narrowing into a base at the 
bottom. 
In agreement with previous reports for the YM and SAIl strains of rotavirus, 
work presented here shows the UKtc strain expresses an identifiable NSP6 protein 
(Mattion et al., 1991; Torres-Vega et al., 2000). Immunoprecipitation was used to 
show that in the infected cell NSP6 is expressed at a low level. 
Analysis of NSP6 kinetics of synthesis showed that the UKtc rotavirus NSP6 
is expressed throughout an infection. The amount expressed at 2 hours post infection 
was small, however the level of protein increased at 3 hours and was produced at a 
steady but low rate until 8 hours when its expression reduces slightly. Pulse chase 
analysis showed that NSP6 had a high rate of turnover, with pulse labelled protein 
being virtually undetectable at the end of a 2 hour chase period. 
NSP6 could not be detected by immunofluorescence using any of the antisera 
generated to the purified protein. However, GFP-NSP6 fusion protein when 
expressed in tranfected cells that were subsequently infected with rotavirus, 
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redistributed from a large amorphous mass within the cytoplasm of transfected cells, 
to viroplasm structures in the infected cell. The localisation ofthe GFP-NSP6 fusion 
protein appeared to be within the centre of the viroplasm, similar to the distribution 
that has been recently reported for the NSP2 protein (Eichwald et ai., 2004). The 
ability for OFP tagged NSP2 and NSP5 to redistribute to the viroplasm when cells 
are transfected and then subsequently infected has also been previously 
demonstrated (Eichwald et ai., 2002; Eichwald et aI., 2004). 
It has been previously shown that NSP2 and NSP5 can form viroplasm-like 
structures in the absence of a rotavirus (Fabbretti et ai., 1999). In these experiments 
deletion mutants were used to map this interaction however these mutants contained 
either the whole NSP6 coding region or encoded part of the NSP6 protein. The only 
deletion mutant still able to form viroplasm-like structure was a deletion mutant 
lacking the 81 to 130 amino acids from the middle of the NSP5 protein this mutant 
encodes an NSP6 protein that has a 37 amino acid C-terminal deletion. 
A study by Mohan et ai demonstrated that the NSP5 protein was able to form 
viroplasm-like structures in the absence of NSP2, provided that the N-tenninus was 
blocked by any non-rotavirus polypeptide and the C-terminus left unmodified 
(Mohan et aI., 2004) and it was postulated that the non-rotavirus polypeptide fusion 
to NSP5 mimics the binding by NSP2 allowing the formation of viroplasm-like 
structures. Deletion mutants were again used to map the critical part of NSP5 that 
contribute to the formation of viroplasm-like structures and again NSP6 or regions 
of NSP6 were encoded by these mutants. A mutant that lacked the first 65 amino 
acids still produced viroplasm-like structures but also contained the 59 C-terminal 
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amino acids ofNSP6, which potentially could be initiated from a methionine residue 
found within the NSP6 sequence. 
Work presented here using a mutated gene 11 which cannot express the 
NSP6 protein demonstrated that NSP6 is not required for the formation of 
viroplasm-like structures. The effect of silencing NSP6 expression on the formation 
of viroplasm-like structures was investigated by using mutants unable to code for 
NSP6 in both studies using transfection of NSP2 and NSP5 coding regions and by 
using an N-terminally fused GFP-NSP5 protein. 
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Results 
Chapter 5 
Investigation into the RNA Binding Ability 
of NSP6 
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5.1. Aims 
The aim of the work described in this chapter was to determine the RNA 
binding ability and specificity of the NSP6 protein of the UKtc strain of rotavirus. 
5.2. Introduction 
The NSP6 protein of rotavirus has previously been localised to viroplasms in 
the cytoplasm of infected cells (Mattion et ai, 1991). A number of other viral 
proteins have also been localised to these cytoplasmic occlusion bodies these are 
VPI, VP2, VP3, VP6, NSP2 and NSP5. (Petrie et al., 1982; Petrie et al., 1984; 
Welch et al., 1989; Gonzalez et aI., 2000). Viroplasms are the site of synthesis and 
replication of dsRNA, packaging of viral dsRNA into newly synthesised cores and 
the stages of viral morphogenesis that produce double-shelled pre-virions (Altenburg 
et al., 1980; Espaza et al., 1980; Patton & Gallegos, 1990; Wentz et al., 1996; Patton 
et al., 1997). Within the viroplasms three distinct species of replication intermediate 
(RI) have been detected, these are tenned the pre-core RI, core RI and double-
layered RI (Gallegos & Patton, 1989), the pre-core RI is composed ofVPl and VP3 
as well as the non-structural proteins NSP 1 and NSP3. The core RI contains all of 
the structural proteins found within the rotavirus single shelled core particle VP I, 
VP2 and VP3; it also contains the non-structural proteins NSP2 and NSP5. The 
double-layered RI is identical to the core RI except for the presence of the VP6 
protein. All of the viral proteins localised to the viroplasms have been shown to have 
RNA binding ability, with the exception of the inner shell protein VP6. Some such 
as VPI, VP3 and NSn have only ssRNA binding ability, where as others such as 
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VP2 and NSP5 have both ssRNA and dsRNA binding ability (Boyle et al., 1986; 
Kattoura et al., 1992; Patton, 1996; Patton & Chen, 1999; Vende et al., 2002). The 
defined role of these proteins varies; VP 1 is thought to be the viral RNA dependent 
RNA polymerase. VP2 is an essential part of the replicase complex needed for VPl 
function as well as being the major component of the viral core shell, the inner most 
part of the rotavirus virion. VP3 is the guanylyltransferase capping and methylating 
protein. There is evidence to suggest that NSP2 and NSP5 are part of the RNA 
synthesis and packaging machinery of the viroplasm (Bican et al., 1982; Pizarro et 
al., 1991; Lui et al., 1992; Zeng et aI., 1996; Taraporewala & Patton, 2004), and are 
both essential parts of the viroplasm and needed for replication to occur (Silvestri et 
al., 2004; Vascotto et al., 2004; Campagna et al., 2005; Lopez et al., 2005). NSP2 
has been shown to be a functional octamer and to possess both NTPase and helicase 
activity, leading to the suggestion that it is the molecular motor that drives the 
encapsidation of the viral RNA (Taraporewala et aI., 1999; Taraporewala & Patton, 
2001; Jayaram et al., 2002; Taraporewala et al., 2002). NSP2 also regulates the 
hyperphosphorylation of NSP5 (Afrikanova et al., 1998). 
Despite the data gathered to date it is still the case that the exact role of the 
non-structural proteins found within the viroplasm remains unclear. The previously 
described interaction between NSP5 and NSP6, together with the proposed 
localisation of NSP6 to the viroplasm appears to demonstrate a strong possibility 
that NSP6 may have a role as an RNA binding protein (Mattion et al., 1991; 
Gonzalez et al., 1998; Torres-Vega et al., 2000). 
185 
5.3. Results 
5.3.1. Viral ssRNA binding of the His-NSP6 protein 
In order to test the RNA binding capacity of the His-NSP6 protein a filter 
binding assay, described in the Materials and Methods, was employed. In brief, 
purified protein was incubated with radio-labelled RNA and passed through a 
nitrocellulose filter to which only protein adheres. If the protein possesses the ability 
to bind RNA then radio-labelled RNA will be quantitatively retained on the filter. 
NSP5 has been shown to have an equal affinity for ssRNA and dsRNA, 
consequently the His-NSP5 protein expressed and purified in this study was used in 
these RNA binding studies as both a comparison to, and positive control for, the 
NSP6 protein (Vende et al., 2(02). BSA was employed as a negative control due to 
its lack of RNA binding activity. 
Firstly the ability of NSP6 to bind viral ssRNA message was investigated. 
RNA was transcribed in vitro from a cDNA clone of rotavirus gene segment 7 
(1.059 kb) in the presence of radio-labelled p32 UTP and used to assess the affinity 
of NSP6 for ssRNA. Increasing amounts of BSA, NSP5 or NSP6 (0, 200, 400, 600, 
800, 1000ng) were incubated with 500nM of radio-labelled viral RNA and applied 
to the filter. The amount of radio-labelled RNA retained on the filter was measured 
by scintillation counting. As expected, the BSA bound little or no RNA compared to 
background, whereas NSP5 bound increasing amounts of RNA in direct correlation 
to the amount of protein employed in the assay. NSP6 was also revealed to be a 
strong RNA binding protein giving a linear increase in ssRNA retained with 
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increasing protein concentration (Figure 5.1). This assay was repeated using radio-
labelled transcripts generated from gene segment 4 (2.362 kb) of the UKtc strain and 
gave the same result showing that NSP6 has the ability to bind viral ssRNA with 
high affinity (Figure 5.2). The data shown in figure 5.1 was used to calculate 
dissociation constants (Kd) of the affinity of NSP5 and NSP6 for ssRNA. The values 
obtained were of 9.62 xlO- 1O M and 1.28 xlO- IO M for NSP5 and NSP6 respectively 
indicating that NSP5 has an approximately 8 fold higher affinity for ssRNA than 
NSP6. 
To gain insight into the nature of the interaction between these two viral 
proteins and ssRNA, the effect of NaCl concentration on RNA binding was 
examined. The binding of RNA by NSP6 showed an inverse correlation to NaCI 
concentration used in the assay (Figure 5.3). This was also true ofNSP5, confirming 
the previously reported results (Vende et ai, 2002). These data indicate that the basis 
of the RNA-protein interaction is ionic and that under normal intracellular 
concentrations of salt (-1 OOmM) both proteins still exhibit strong viral ssRNA 
binding ability. 
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Figure 5.1 Filter binding assay ofthe relative binding abilities of BSA, NSP5 
and NSP6 for radio-labelled rotavirus gene 7 ssRNA 
Reaction mixtures containing 500nM of 32P_labelled rotavirus gene segment 7 
ssRNA and varying amounts of NSP5, NSP6 or BSA (0, 200, 400, 600, 800 and 
1000ng) were incubated at 30°C for 30 minutes. 32P-Iabelled rotavirus gene segment 
7 ssRNA protein complexes were recovered by filtration through nitrocellulose and 
the amount of RNA bound measured by a scintillation counter. The highest value of 
counts per minute bound by NSP6 was given a value of 100% and the normalised 
values plotted as a function of the concentration of the proteins in the reaction 
mixtures. 
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Figure 5.2 Filter binding assay of the relative binding abilities of NSPS and 
NSP6 for radio-labelled rotavirus gene 4 ssRNA 
Reaction mixtures containing 500nM of 32P-labelled rotavirus gene segment 7 
ssRNA and varying amounts of NSP5 or NSP6 (0, 200, 400, 600, 800 and 1000ng) 
were incubated at 30°C for 30 minutes. 32P-Iabelled rotavirus gene segment 4 
ssRNA protein complexes were recovered by filtration through nitrocellulose and 
the amount of RNA bound measured by a scintillation counter. The highest value of 
counts per minute bound by NSP6 was given a value of 100% and the norrnaJised 
values plotted as a function of the concentration of the proteins in the reaction 
mixtures. 
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Figure 5.3 Filter binding assay of the effect of NaCI concentration on the 
relative binding abilities of NSP5 and NSP6 for radio-labelled rotavirus gene 7 
ssRNA 
Reaction mixtures containing 500nM of 32P_labelled rotavirus gene segment 7 
ssRNA and a set concentration of 1000ng of NSP5 or NSP6 were incubated in 
binding buffer containing increasing of NaCI (0, 50, 100, 200, 300, and 500mM), at 
300 e for 30 minutes. 32P-labelled rotavirus gene segment 7 ssRNA protein 
complexes were recovered by filtration through nitrocellulose and the amount of 
RNA bound measured by a scintillation counter. The values were normalised using 
the value of the 32P-labelled-NSP6 in OmM NaCl as 100%. The normalised values 
were then plotted as a function ofthe concentration ofNaCI in the reaction mixtures. 
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In order to verify these findings a gel mobility shift assay was employed to 
study the ssRNA binding ability of NSP6. These assays depend on the fact that when 
analysed on agarose or polyacrylamide gels complexes of RNA and proteins have 
retarded mobility compared to that of free RNA. Assays were perfonned using 
radio-labelled ssRNA covering the 5'-tenninal 100 nucleotides of the rotavirus gene 
segment 5 as a probe. The radio-labelled probe and purified NSP6 were mixed, 
incubated and fractionated on a 1 % agarose gel. The results (Figure 5.4) show that as 
the concentration of NSP6 used in the assay was increased, so were the amounts of 
RNA retardation evident on the gel, confirming that NSP6 has viral ssRNA binding 
ability. 
Additionally a gel mobility shift assay was used to confirm the previous 
results demonstrating the effect of NaCI concentration on RNA binding of NSP6. 
The assay was performed, as before, with the exception that the binding buffers used 
in this assay varied in the concentration of NaCI. The results (Figure 5.5) showed an 
inverse correlation between NaCI concentration and the amount of RNA bound to 
NSP6 and retained on the filter, confinning an ionic interaction. 
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Figure 5.4 Gel mobility shift assay of radio-labelled RNA mobility on an 
agarose gel with increasing concentrations of NSP6 protein 
Radio-labelled ssR A fragments of the 5' terminal 100 nucleotides of the rotavirus 
gene segment 4 were u ed to in this assay. 500nM of radio-labelled probe and 
increasing amounts of the purified NSP6 (0, 200, 600 and 1000ng) were mixed, 
incubated for 300 e for 30 minutes and loaded onto a 1% agarose gel. The gel was 
electrophoresed at 10 milliamps for I hour, dried and exposed to X-ray film. 
Autoradiography was then performed at -70oe GIN and the film developed in an 
automatic X-ray developer. Track A) Control track with no added NSP6, track 8) 
200ng ofNSP6 added to the assay, track C) 600ng ofN P6 added to the assay, track 
D) I /lg of SP6 added to the assay. 
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A B c D 
Figure 5.5 Gel mobility shift assay showing the effect of increasing NaCl 
concentration on radio-labelled RNA mobility 
500nM of radio-labelled probe and 500ng of the purified NSP6 were mixed and 
incubated in buffer containing increasing concentrations ofNaCI (100, 200, 500, and 
1000mM) for 30°C for 30 minutes and loaded onto a 1% agarose gel. The gel was 
electrophoresed at 10 mi lliamp for I hour, dried and exposed to X-ray film. 
Autoradiography was then performed at -70°C OIN and the film developed in an 
automatic X-ray developer. Track A) Assay calTied out at 100mM NaCI , track B) 
Assay carried out at 200mM NaCI, track C) Assay carried out at 300mM NaCI, track 
D) Assay carried out at 500mM NaCI. 
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5.3.2. Cellular ssRNA binding of His-NSP6 
To investigate the ability of NSP6 to bind to non-viral ssRNA, two cellular 
genes were transcribed in the presence of 32p VTP and used in filter binding assays. 
The actin (1.128kb) and luciferase (1.652kb) genes were used in these assays and 
again both NSP5 and NSP6 showed strong affinity for the ssRNA transcripts derived 
from both genes (Figures 5.6a and 5.6b). Each of these ssRNA binding assays 
appeared to have a linear correlation between the amount of protein present in the 
assay and the amount of radio-labelled RNA retained on the filter. The amount of 
ssRNA binding appeared to be equivalent to that demonstrated in the filter binding 
assays using ssRNA of a viral origin. 
5.3.3. Specificity of ssRNA binding by His-NSP6 
A competition assay was used to determine the specificity of ssRNA binding 
by His-NSP6. This was performed to establish if the protein had any affinity for 
viral ssRNA over cellular ssRNA. A standard filter binding assay was carried out 
using radio-labelled gene segment 7 ssRNA, with the addition of an increasing 
concentration of cold competitor RNA of, either rotavirus gene segment 7 ssRNA or 
luciferase ssRNA. Cold competitor ssRNA was added at 0%, 25%, 50%, 100%, 
200% and 500% of the quantity of radio-labelled gene segment 7 present. Both of 
the cold competitor ssRNA's reduced the amount of radio-labelled RNA retained on 
the filter with equal efficiency indicating that NSP6 has a sequence independent 
affinity for ssRNA (Figure 5.7). 
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Figure 5.6 Filter binding assay measuring the relative binding abilities of NSP5 
and NSP6 for non-viral ssRNA 
Panel A) Reaction mixtures containing 500nM of 32P-Iabelled Actin ssRNA and 
varying amounts of NSP5 or NSP6 (0, 200, 400, 600, 800 and 1000ng) were 
incubated at 30°C for 30 minutes. p32 -labelled ssRNA protein complexes were 
recovered by filtration through nitrocellulose and the amount of RNA bound 
measured by a scintillation counter. 
Panel B) Reaction mixtures containing 500nM of 32P-Iabelled Luciferase ssRNA and 
varying amounts of NSP5 or NSP6 (0, 200, 400, 600, 800 and lOOOng) were 
incubated at 30°C for 30 minutes. p32-labelled ssRNA protein complexes were 
recovered by filtration through nitrocellulose and the amount of RNA bound 
measured by a scintillation counter. 
The highest value of counts per second bound by NSP6 was given a value of 100% 
and the normalised values plotted as a function of the concentration of the proteins 
in the reaction mixtures. 
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Figure 5.7 Competition filter binding assay of unlabelled rotavirus gene 
segment 7 ssRNA or Luciferase ssRNA competing with 3zP_labeUed rotavirus 
gene segment 7 ssRNA for binding by the NSP6 purified protein 
Reaction mixtures containing 500nM of p32 -labelled rotavirus gene segment 7 
ssRNA and 1000ng of NSP6 were incubated with increasing amounts of unlabelled 
rotavirus gene segment 7 ssRNA or Luciferase ssRNA (0, 20, 50, 100, 200 and 
500% of the amount of radio-labelled gene segment 7 present in the assay). These 
reaction mixtures were incubated at 30°C for 30 minutes. p32 -labelled rotavirus gene 
segment 7 ssRNA protein complexes were recovered by filtration through 
nitrocellulose and the amount of RNA bound measured by a scintillation counter. 
The 0% competitor ssRNA value was designated 100% and normalised values 
plotted as a function of the percentage of the unlabelled competitor ssRNA in the 
reaction mixtures. 
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5.3.4. Affinity of the purified His-NSP6 protein for dsRNA and dsDNA 
In order to test the binding capability of His-NSP6 for other nucleic acid 
molecules a filter binding competition assay was again used. Rotavirus gene 
segment 7 ssRNA, purified whole virus dsRNA and rotavirus gene segment 7 in the 
PCIneo vector dsDNA and linearised using the Xbal restriction enzyme were used as 
competitors for the radio-labelled gene segment 7 transcripts. The results (Figure 
5.8) showed that the dsRNA and dsDNA interfered with the radio-labelled RNA 
binding to NSP6 with similar efficiency to that of the ssRNA, indicating that NSP6 
appears to have an almost equal affinity for each type of nucleic acid molecule. 
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Figure 5.8 Comr,etition filter binding assay of unlabelled ssRNA, dsRNA or 
dsDNA against lP-labelJed rotavirus gene segment 7 ssRNA for binding by 
NSP6 
Reaction mixtures containing 500nM of p32-labelled rotavirus gene segment 7 
ssRNA and 1000ng of NSP6 were incubated with increasing amounts of unlabelled 
rotavirus gene segment 7 ssRNA, whole virion dsRNA or rotavirus gene segment 7 
in the PClneo vector dsDNA, linearised using the Xbal restriction enzyme (0, 20, 50, 
100, 200 and 500% of the amount of radio-labelled gene segment 7 present in the 
assay). These reaction mixtures were incubated at 30°C for 30 minutes. p32-labelled 
rotavirus gene segment 7 ssRNA protein complexes were recovered by filtration 
through nitrocellulose and the amount of RNA bound measured by a scintillation 
counter. The 0% competitor dsDNA value was designated 100% as it had the highest 
percentage of probe bound and normalised values plotted as a function of the 
percentage of the unlabelled competitor in the reaction mixtures. 
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5.4. Discussion 
The results presented in this chapter define the RNA binding ability of the 
His-NSP6 protein. They demonstrate that both His-NSP5 and His-NSP6, the 
expression and purification of which are described in earlier chapters, are 
functionally active. In the case of His-NSP5 the results obtained concur with 
previous findings regarding the RNA binding ability of the protein (Vende et al., 
2002). 
The RNA binding capacity of NSP6 had not been previously characterised. 
Work in this chapter demonstrates that NSP6 has affinity for ssRNA in a sequence 
independent manner and additionally has close to equal affinity for ssRNA, dsRNA 
and dsDNA. It can be concluded from these data that NSP6 is a sequence 
independent nucleic acid binding protein. The NSP6 KDiss for ssRNA was found to 
be eight fold lower than that for NSP5. 
The finding that NSP6 localises to the viroplasm occlusion bodies within the 
infected cell and its interaction with NSP5 were both clear indicators of a possible 
RNA binding capability for the protein and an indication that NSP6 might be 
implicated in the complex events of RNA synthesis and replication within the 
viroplasm (Gonzalez et al., 1998; Mattion et al., 1991; Torres-Vega et al., 2000). 
The evidence presented here for the RNA binding of both ssRNA and dsRNA by 
NSP6 strongly support this hypothesis. The RNA binding capability of NSP6 also 
matches that ofNSP5, both proteins are strong binders of ssRNA and dsRNA, unlike 
the other non-structural protein (NSP2) found within the viroplasm, which only has 
affinity for ssRNA. The sequence independent nature of the binding demonstrated 
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by NSP6 has also been observed previously for NSP5 and NSP2 (Kattoura et aI., 
1992; Vende et al., 2004). 
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Results 
Chapter 6 
Investigation into the Mechanism of 
Expression of NSP6 from the Second ORF 
of Rotavirus Gene Segment 11 
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6.1. Aims 
The aims of the work presented in this chapter are to investigate the factors 
involved in the translation of the second open reading frame of rotavirus gene 11, 
which encode the NSP6 protein. 
6.2. Introduction 
6.2.1. The effect of Rotaviruses on cellular translation 
The rotavirus gene segments are all monocistronic with the exception of gene 
11 which has been found to encode for two proteins (Estes & Cohan, 1989; Mattion 
et al., 1991). The rnRNA of members of the Reoviridae family selVes two distinct 
functions within the infected cell; it is used in translation to generate viral proteins 
and it acts as a template for the synthesis of minus strands in the production of 
progeny genomic dsRNA (Nonoyama et al., 1974). The viral mRNAs lack a poly(A) 
tail but do have as' -terminal cap structure m 7 GpppO(m)Gpy (lmai et al., 1983; 
McCrae & McCorquodale, 1983). The rotavirus mRNA sequences contain 
untranslated regions (UTR's) flanking the open reading frames, both of these regions 
vary widely between individual genes with the exception of short 5' and 3' 
consensus sequences. These short consensus sequences at the 5' and 3' termini are 
5' -OOC-poly(AIU)-3' and 5' -AUOUOACC-3' respectively (Desselberger & 
McCrae, 1994). The levels of the different mRNA species and their corresponding 
proteins have been measured and this revealed that there was both transcriptional 
and translational control of viral gene expression (Johnson & McCrae, 1989). 
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Rotaviruses block translation of cellular mRNA in mammalian cells leading 
to preferential translation of viral mRNA. In mammalian cells a range of protein-
protein and protein-RNA interactions cause recognition and initiation of translation 
by the ribosome. The 5' cap structure and 3' poly(A) tail are recognised by 
translational initiation factor eIF4E and poly(A)-binding protein (PABP) 
respectively (Sachs et ai., 1997; Sachs et ai., 2000). This leads to the recruitment of 
other proteins, eIF4G binds to both eIF4E and P ABP leading to mRNA 
circularisation (Wells et ai., 1998). Then elF3 joins this complex and is followed by 
the 40S small ribosomal subunit (Pestova & Hellen, 1999; Preiss & Hentze. 1999), 
which has a Met-tRNAi-eIF2-GTP complex attached to it (Maitra et al., 1982). 
After the 40S ribosomal subunit has bound to the 5' cap structure it scans 
along the mRNA in a 5' to 3' direction until it reaches an AUG initiation codon 
(Kozak, 1980). In eukaryotic cellular mRNAs this is generally the most 5' proximal 
AUG, a feature known as the position effect (reviewed in Kozak, 2002). Initiation at 
this AUG is also regulated by the surrounding sequence or "context" of the AUG. 
The Kozak consensus sequence GCCRCCaugG, where R is a purine, has been found 
to be optimal for the recognition by the 40S subunit of an AUG start codon. The 
most important features of this consensus sequence are the purine at position -3 and 
the guanidine at position +4 (Kozak, 1989). These two nucleotides positions have 
been shown to be the key nucleotides in the consensus sequence and deletion or 
substitution mutation of these has been shown to be detrimental to the initiation of 
translation at an AUG start codon (Kozak, 1986). Following recognition of the AUG 
start codon by the 40S subunit hydrolysis of eIF2-GTP to eIF2-GDP occurs, in a 
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process mediated by eIF5. This hydrolysis allows recruitment of the 60S subunit, 
leading in tum to the formation of the 80S ribosome complex and the start of the 
elongation process (Chakrabarti & Maitra, 1991). 
Rotaviruses circumvent these normal cellular processes through the action of 
the non-structural protein NSP3 which is a functional homologue of P ABP and has 
been shown to bind eIF4G with a higher affinity than P ABP (Both et at., 1984; 
Imataka et at., 1998; Piron et al., 1998 and Groft & Burley, 2002). The NSP3 
protein specifically binds to the 3' tenninus of viral mRNAs through recognition of 
the consensus sequence UGACC and because it competes effectively with P ABP for 
binding of the translation initiation complex viral mRNA is preferentially translated. 
This leads to the shut off of host cell protein synthesis and results in the inability of 
capped and polyadenylated cellular mRNA to be translated (Poncet et al., 1994). 
Gene 11 is the only polycistronic rotavirus gene segment, expressing both 
NSP5 and NSP6 (Matti on et al., 1991). The 92aa NSP6 protein is expressed in a plus 
one frame with respect to the larger NSP5 and its coding sequence is found entirely 
within the NSP5 ORF. The mechanism by which the translation from this second 
ORF occurs has not been previously examined. However, in other studies a variety 
of mechanisms have been observed for achieving translation from a non 5' proximal 
AUG. These are reviewed below: 
6.2.2. Internal ribosome entry sites (IRES) 
This method of translation initiation has been found in several virus families 
but was first defined in the Picornaviridae. The members of this virus family have a 
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positive sense RNA genome, with a genome linked protein (VPg) found at the 5' 
end of their mRNA in place of the usual cap structure. They also have long 5' non-
coding regions of between 610-1200 nucleotides. These regions are highly 
structured and have been implicated as the IRES allowing the 40S ribosomal subunit 
to bind to the mRNA molecule and promote initiation of translation from a non 5' 
proximal AUG. The region involved in this IRES function has been shown to form 
stable secondary and tertiary structures which are thought to facilitate the 40S 
ribosomal subunit binding (lang et al., 1990; Pelletier & Son enberg, 1988). Work 
performed on the Foot and Mouth disease virus (FMDV) IRES has identified five 
structural domains containing conserved sequence within the IRES element 
(Martinez-Salas et al., 2002). These domains have been shown to be the binding 
sites for several key proteins of the initiation complex: eIF4G interacts with domain 
4, elF4B with domain 5, elF3 with domain 3 and the polypyrlmidine tract binding 
protein (PTB) binds at the 5' and 3' termini of the IRES (Martinez-Salas et al., 
2002). These structural features of the FMDV IRES were also observed within the 
IRES elements of both hepatitis C virus and encephalomyocarditis virus (Luz & 
Beck, 1991; Kolupaeva et al., 1996; Lopez de Quinto & Martinez-Salas, 2000; 
Lopez de Quinto et al., 2001). 
6.2.3. Leaky scanning 
Leaky scanning involves the bypassing of the 5' proximal AUG initiation 
codon by some fraction of the 40S ribosomal subunits scanning a mRNA. These 
subunits then continue until encountering another suitable AUG initiation codon, 
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this occurs as a result of the 5' proximal AUG being in a suboptimal Kozak 
consensus sequence (Kozak, 1989). As previously stated the Kozak consensus 
sequence (GCCNGCCAuGG) is crucial in dictating the efficiency with which an 
AUG is recognised as an initiation codon (Kozak, 1987). Initiation codons in poor 
consensus sequences may not signal the initiation of translation to all 40S ribosomal 
subunits. The 40S ribosomal subunits which fail to initiate translation will continue 
to scan along the mRNA until the next AUG with a suitable Kozak consensus 
sequence. The features that define suboptimal Kozak consensus sequence vary, but 
usually involve the absence of the purine preferentially adenine, at the -3 position 
and/or the guanine at position +4 (Kozak, 1986). Leaky scanning has been found to 
be a common mechanism employed by viruses for the translation of two or more 
proteins from a single piece of mRNA (Bustamante & Hull, 1998; Kozak, 2002; 
Schneider & Mohr, 2004). 
6.2.4. Frameshifting 
This mechanism of translation has been found in several retroviruses 
including, human immunodeficiency virus (HIV) (Jacks et al., 1988). In this case 
expression of proteins from an overlapping open reading frame is achieved by a 
ribosome shifting position by one nucleotide to allow translation of the non 5' 
proximal ORF. This can be a -I nucleotide frameshift. as occurs in the gag-pol 
region of HIV or a + 1 nucleotide frameshift, as seen in the yeast retrotransposon Ty 
(Jacks et al., 1988; Belcourt & Farabaugh, 1990). The position at which 
frameshifting occurs is dictated by a heptanucleotide sequence referred to as a 
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slippery sequence. The slippery sequence has been defined as XXXYVYZ with X 
being any nucleotide, Y being either A or U and Z may again be any nucleotide 
(Dinman et al., 1991; lacks et al., 1988). The slippery sequence varies between 
different viruses from AAAAAAC in mouse mammary tumour virus, to 
AAAUUUA in Rous sarcoma virus and UUUUUUA in HIV (Hatfield et al,. 1989). 
A further feature of these regions is that 5-9 nt downstream of the slippery sequence 
is a RNA pseudoknot (Jacks et al., 1988; Brierley et al., 1989). The ribosome pauses 
when it reaches the pseudoknot and the slippery sequence causes the tRNA in the A 
and P sites of the ribosome to shift frame either -lor + I and re-establish binding 
before continuing translation in the new ORF (Farabaugh, 1996). 
6.2.5. Ribosomal shunt 
Ribosomal shunting as a mechanism for the expression of an alternate ORF 
has been described for several viruses, Cauliflower mosaic virus (CaMV) (Futterer 
et aI., 1993) adenoviruses (Yueh & Schneider, 1996), Sendai virus (Curran & 
Kolakofsky, 1988; Latorre et al., 1998) and most recently in duck hepatitis B virus 
(OHBV) (Sen et al., 2004). It occurs when the 40S ribosomal subunit binds to the 5' 
end of mRNA, begins to scan and then, due to the presence of secondary structural 
elements within the 5' UTR, is "shunted" to a different position downstream, 
skipping large regions of the mRNA (Futterer et al., 1993). This mechanism is most 
dramatically shown in Sendai virus, where the start of the PIC mRNA contains 
initiation sites for several proteins P, C', C, YI and Y2, with C' ORF having the first 
initiation codon (ACO) at position 81. Although it has a non-AUG start codon the C' 
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ORF is then expressed using the conventional 5' scanning initiation. The P and C 
proteins (which initiate at positions 104 and 114 respectively) are expressed via 
leaky scanning and when site directed mutagenesis was used to improve the Kozak 
consensus sequence around the initiation codon of the C' ORF, expression of the P 
and C proteins were lost. The expression of the Yl and Y2 proteins which initiate at 
positions 183 and 201 respectively, downstream of the P and C start codons were not 
lost following site directed mutagenesis (Curran & Kolakofsky, 1989). The 
translation initiation of these proteins was found to be via ribosomal shunting, with 
the first 50 nucleotides of the PIC gene being required for this to occur and 
ribosomes shunted from this 5' terminal region directly to the initiation codons of 
the YI and Y2 ORF's (Latorre et aI., 1998). 
6.3. Results 
6.3.1. Mechanism of expression of the second open reading frame of gene 11 
The second ORF of the rotavirus gene 11 is in a + 1 frameshift relative to that 
of the first ORF and initiates 56 bases from the ATG start codon of ORFI. As 
previously indicated a number of possible mechanisms exist for achieving the 
expression of NSP6 from ORF2. 
6.3.2. Experimental approach 
Three approaches were used in order to assess each of the possible 
mechanisms for achieving the expression of NSP6, RNA secondary structure 
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prediction, a coupled in vitro transcription/translation system and a reporter gene 
expression system. 
RNA secondary structure prediction was used to investigate the possible 
existence of stable secondary structures fonned by the RNA molecule. Several 
different types of these structures have been found to be required for the function of 
IRES elements, ribosomal shunting and frameshifting. 
The coupled in vitro transcription/translation system allows rapid analysis of 
protein expression from the cDNA clone of a gene of interest. Deletion mutants and 
site directed mutagenesis were used in order to determine the features of gene 11 
that influence protein expression in such a system. Additionally this system was 
utilised to detect the presence of any cap-independent initiation mechanisms (such as 
an IRES element) within gene 11 by employing constructs of gene 11 containing 
upstream sequences that block the scanning of ribosomes to the nonnal initiation 
codons. The rationale of this approach was that if ribosomal scanning was blocked 
but NSP5 and/or NSP6 expression could still be detected, then it would be a strong 
indication of the presence of an IRES element. 
The coupled in vitro transcription/translation system was also used to detect 
the possible presence of leaky scanning within the gene 11 sequence. Mutational 
analysis was employed to examine the effect of removal of the initiation codon of 
ORFI on the expression from ORF2. Increased expression levels from ORF2 would 
suggest a leaky scanning mechanism of expression. 
As an alternative approach to investigating the possible presence of a leaky 
scanning mechanism a reporter gene expression system was employed. Fusions 
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between cDNA of gene 11 and the CAT reporter gene were constructed replacing 
the NSP6 coding region with the CAT gene. Site directed mutagenesis was again 
used to generate a mutant that lacked the ORFI initiation codon to determine what 
effect this had on expression of CAT from the second ORF. Mutants were also 
created in which the ORFI initiation codon was placed into a better Kozak 
consensus sequence with the purpose of determining if this had a detrimental effect 
of ORF2 expression. If expression from the second ORF was found to be dependent 
on the context surrounding the first ORF initiation codon, then this would point 
towards a leaky scanning mechanism of expression. By contrast IRES elements and 
ribosomal shunting are not dependent on the context of the first ORF initiation 
codon as both bypass upstream initiation codons using RNA secondary structural 
elements. 
6.3.3. RNA secondary structure prediction of gene 11 
Several of the possible expression mechanisms for NSP6 require the 
presence of specific RNA secondary structures. The standard RNA secondary 
structure prediction algorithm of Zucker was used to investigate the RNA folding 
pattern of the gene 11 RNA sequence. The resulting prediction (Figure 6.1 a and 
6.1 b) showed that there was some potential for the formation of secondary structures 
in the 5' portion of gene II, but these were primarily in the region of the gene 
following the initiation codon of the second ORF and were low in GC pairing, 
suggesting that they would not have a high level of stability. 
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IRES elements are characterised by their ability to form stable secondary 
structures to allow binding of ribosomes and initiation of translation. There was no 
evidence of highly stable folded hairpins at the 5' terminus of gene 11 strongly 
suggesting that no IRES element was present. 
Frarneshifting requires the presence of a stable pseudoknot downstream of a 
heptanucleotide sequence with the structure XXXYYVZ at which the frameshift 
occurs. Examination of the primary sequence of gene 11 showed that the required 
heptanucleotide sequence was not present in the RNA and secondary structure 
analysis (Figure 6.1 a) does not predict the formation of a pseudo knot after the ORF2 
initiation codon. 
Ribosomal shunting uses secondary structures to reposition ribosomes from 
the 5' proximal ofa RNA molecule to an internal position before an initiation codon. 
This has been documented to be associated with several hairpins such as those found 
in adenovirus RNA (Yueh & Schneider, 1996). Although gene 11 does appear to 
possess some hairpins in the 5' proximal region (Figure 6.lb) these are small and do 
not contain a high amount of GC base pairing in contrast to those RNA determined 
to exhibit ribosomal shunting. 
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Figure 6.1 Secondary structure prediction of the rota virus gene 11 
Panel A) Secondary structure prediction of rotavirus gene 11 perfonned using the 
standard Zuker method. 50 nucleotide blocks are indicated on the plot and at the 
bottom of the plot there is the value of the structures dO (free energy at 37°C). The 
area enlarged in panel B is outlined in green. 
Panel B) Enlargement from Zuker plot in panel A showing the area containing 
ORFI and ORF2 start codons, which are highlighted by the blue and red boxes 
respectively. 
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6.3.4. Effect of gene 11 untranslated regions on the expression of NSPS and 
NSP6 
A cDNA, lacking the 5' and 3' UTR's of gene 11, was generated using PCR 
and cloned into the PCIneo vector. Expression of NSP5 and NSP6 from this vector 
was compared to that from PCIneo containing the full length gene 11 sequence using 
the coupled in vitro transcription/translation system (Figure 6.2). There were no 
apparent differences in the amount of NSP5 and NSP6 expressed from the two 
clones. This suggests that the 5' and 3' UTR's do not affect the levels of expression 
of the two proteins when expressed in the coupled in vitro system used in this study. 
Ribosomal shunting and IRES elements are dependent on the formation of 
secondary structures usually found within the 5' sequence of a gene. The 
observation that the loss of these regions does not effect expression of NSP5 and 
NSP6 suggests that the RNA secondary structures required for these mechanisms of 
expression are not present within gene 11, as predicted by the RNA secondary 
structure model. 
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Figure 6.2 Effect of the gene 11 untranslated regions on expression of the NSPS 
and NSP6 proteins 
Panel A) Schematic representation of gene 11 with and without the 5' and 3' 
untranslated regions (VTR's). The 5' VTR is 21 nucleotides in length and the 3' 
UTR is 49 nucleotides in length. 
Panel B) In order to assess the effect of the 5' and 3' VTR's on the expression of 
NSP5 and NSP6 the NSP5 coding region was cloned into the PCIneo expression 
vector and its expression in the coupled in vitro transcription/translation system 
compared to that of the genell-PCIneo construct. In vitro transcription/translation 
using these cDNA constructs was carried out as described in the Materials and 
Methods. The protein products were analysed by PAGE as described in the 
Materials and Methods. After drying the gel was autoradiographed as described in 
the Materials and Methods. Track A shows protein expression from the gene 11-
PCIneo construct and track B shows protein expression from the NSP5-PClneo 
(without the 5' and 3' termini) construct. The migration positions of the molecular 
weight size markers are indicated on the left hand side of the autoradiogram and the 
positions of NSP5 and NSP6 are indicated by arrows on the right hand side. 
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6.3.5. Investigation into the presence of an IRES element within the gene 11 
sequence 
IRES elements allow ribosomal binding in a cap-independent manner, to 
directly investigate whether or not an IRES was present within gene II, the coding 
region for the cellular gene actin was inserted at the 5' end of gene 11, preventing 
any expression of the NSP5 and NSP6 proteins by cap-dependent ribosome 
scanning. Placing the actin ORF in front of the gene 11 sequence would stop 
ribosomes reaching ORFI and ORF2 via scanning as the ribosomes terminate and 
detach from the RNA after the actin stop codon, thus any expression of NSP5 and 
NSP6 must be mediated by a cap-independent mechanism. Plasmids carrying the 
Actin gene (Actin-PCIneo), the actin-gene 11 fusion (Actin-genell-PCIneo) and an 
actin-gene 11 fusion in which the A TO start codon of NSP5 had been made non-
functional by site directed mutagenesis (Actin-genell t23c-PClneo) (Figure 6.3), 
were all tested in the coupled in vitro transcription/translation system. The results 
(Figure 6.4) showed that only the actin protein was expressed and neither NSP5 nor 
NSP6 expression could be detected from any of the three constructs. Taken together 
these results and the apparent efficient expression from ORF2 from cDNA with a 5' 
UTR deletion strongly suggest that expression of NSP6 does not involve a cap-
independent IRES based mechanism. 
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Figure 6.3 Construction of actin-gene 11 fusions plasmids to investigate the 
possible presence of an IRES element is the gene 11 sequence 
The coding region of the actin gene was positioned before the gene II sequence. 
The Actin-PClneo plasmid was provided by Dr A.C. Marriott, University of 
Warwick. Using PCR the actin gene was amplified with a Nhel restriction enzyme 
site at the 5' tenninus and an Xhol restriction enzyme site at the 3' tenninus. Using 
these restriction enzyme sites the actin gene was then cloned into the gene ll-PCIneo 
and Genel! t23c-PClneo vectors (which cannot express the NSP5 protein) as 
described in the Materials ad Methods .. 
Panel A) Schematic representation of the actin gene, Actin-gene I1-PClneo construct 
and Actin-genel! t23c-PCIneo construct (which cannot express the NSP5 protein). 
Panel B) DNA sequence chromatogram of Actin-genell-PCIneo construct showing 
the junction between the actin ORF and the genet 1 sequence separated by the XhoI 
restriction site. The stop codon of the actin ORF and the start codon of the NSP5 
ORF are identified at the top of the chromatogram. 
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73kDa • 
54kDa • 
48kDa • 
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16kDa--... 
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Figure 6.4 Ana lysi of Actin-Gene 11 fu ion constructs to probe for the 
presence of an IRES element in rotavirus gene 11 
Pia mid cD A constructs of track A) Actin-PClneo, track 8) Actin-gene II-PClneo 
and track C) Actin-gene II t23c-PClneo were used in the coupled in vitro 
transcription/translation system. The in vitro transcription/tran lation was carried out 
a de cribed in the Material and Methods. The protein product were analysed by 
PAGE a described in the Materials and Method. After drying the gel wa 
autoradiographed as de cribed in the Material and Method. The migration 
po itions of the molecular weight size marker are indicated on the left hand ide of 
the autoradiogram and the position of the expressed actin protein is shown on the 
right hand side. 
222 
6.3.6. Investigation of a possible context-dependent leaky scanning mechanism 
of NSP6 expression from ORF2 
An alternative method of expression of NSP6 is leaky scanning, in which a 
number of ribosomes fail to initiate at the start codon of ORFI and continue to scan 
along the RNA molecule until the 40S ribosomal subunit encounters the ORF2 start 
codon. To test this possibility site directed mutagenesis was applied to a cDNA 
clone of gene 11 to replace the ATG start codon of ORFI with ACG (gene 11 t23c-
PCIneo). The cDNA is therefore unable to express NSP5 and ribosomes should 
continue scanning past the non functional ORFI start codon until they reach the 
ORF2 start codon leading to an increase in the levels of NSP6 being synthesised. 
The results of examining the expression from the gene11 t23c-PClneo construct in 
the coupled in vitro transcription/translation system are shown in figure 6.5. The 
relative intensities of the NSP6 protein expressed from the three clones were 
quantified using image quant software (Molecular dynamics). This showed an 
almost two fold increase between the amount of NSP6 expressed from gene 11 t23c 
-PClneo, compared to amounts expressed from the gene II and NSP5 coding region 
constructs (Figure 6.6). 
There appeared to be a small amount of protein at the NSP5 molecular 
weight, this could be due to alternate codon usage for initiation at the mutated ACG 
ORFI start codon or may possibly be background from the coupled in vitro 
transcription/translation system (see Chapter 4, Figure 4.2b). 
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Figure 6.5 Analysis of the effect of removing the NSPS ATG on ribosome read-
through and effect on expression of NSP6 from ORF2 of rotavirus gene 11 
In order to assess the possible leaky scanning mechanism of expression from ORF2 
of gene 11 constructs were used in the coupled in vitro transcription/translation 
system. The In vitro transcription/translation reaction was carried out as described in 
the Materials and Methods. The protein products were analysed by PAGE as 
described in the Materials and Methods. After drying the gel was autoradiographed 
as described in the Materials and Methods. Track A) shows expression from the 
gene I I-PClneo construct, track 8) shows expression from the NSPS-PClneo 
construct and track C) shows expression from the gene II-PClneo t23c construct 
(which has a non-functional ORF I start codon). The migration positions of the 
molecular weight size markers are indicated on the left hand side of the 
autoradiogram and the positions of NSPS and NSP6 are indicated by arrows on the 
right hand side. 
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Figure 6,6 Quantification of autoradiograph show n in figure 6,5 
The relative intensities of the SP6 protein in the three tracks from figure 6.5 were 
quantified using image quant software (Molecular dynamics). 
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6.3.7. Investigation into leaky scanning expression with the CAT reporter 
system 
To facilitate simpler measurement of the levels of expression from the 
second ORF of gene 11 a cDNA was constructed in which the NSP6 coding region 
was replaced with that of the reporter gene CAT, the product of which can be easily 
assayed. Figure 6.7 shows a strategy employing sequential PCR with 4 overlapping 
primers which was used to place the 5' 80 nucleotides of the gene 11 sequence (up 
to the ATG ofORF2) upstream of the 5' of the CAT gene, such that any expression 
from ORF2 would result in the expression of CAT reporter protein (Figure 6.7). The 
gene II-CAT fusion was ligated into the PCIneo expression vector using the XhoI 
andXbaI restriction sites to create genell-CAT-PCIneo. 
In order to analyse the effect of the 5' UTR of gene lIon the expression of 
the second ORF another, construct was made which lacked the 5' UTR sequence of 
gene II and began with the ATG start codon ofORFI (ORFI-CAT). 
6.3.8. Detection of CAT expression from the genell-CAT fusion construct 
The expression of CAT from the full length gene II-CAT fusion was 
examined. Cells were transfected with a CAT PCIneo positive control plasmid, a 
PCIneo negative control plasmid or a gene II-CAT PCIneo plasmid. At 48 hours 
post transfection cells were lysed and CAT expression levels assayed. The results 
(Figure 6.8) showed that significant CAT expression from the second open reading 
frame of the gene I I-CAT construct could be detected. 
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Figu re 6.7 Construction of the genel1-CA T -PClneo construct 
Panel A) The 5' -terminal 80 nucleotides of rotavirus gene 11 (seen in red) was 
placed onto the 5' terminus of the CAT gene by sequential PCR using 4 
oligonucleotide primers. The CAT reporter ORF (seen in blue) was positioned such 
that it now lay after the ORF2 start codon. 
Panel B) DNA sequence chromatogram of gene II-CA T -PCIneo construct showing 
the junction between the 80 5' nucleotides of gene II and the CAT ORF. The ORF I 
start codon of gene II and the ORF2 start codon which indicates the start of the 
CA T gene are identified at the top of the chromatogram. 
Panel C) Sequential PCR was used to place the 5' 80 nucleotides of gene II onto the 
5' termini of the CAT ORF. PCR product and the PCIneo vector were both cut with 
Xhol and Xbal restriction enzymes and gel purified. A ligation was performed and 
the resulting vector (genell-CAT-PClneo) was transformed into E. coli as described 
in the Materials and Methods. 
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Figure 6.8 CAT assay for the detection of CAT expressed from the gene-tt-
CAT-PCIneo construct 
Panel A) Confluent mono layers of BSC-I cells were transfected with appropriate 
plasmids and after 48 hours incubation at 37°C harvested in lysis buffer. CAT assays 
were perfonned on the celllysates using the CAT detection kit (Roche) as described 
in the Materials and Methods. A = CAT +ve control, B = PClneo -ve control, C = 
genell-CAT-PClneo undiluted lysate, D = genell-CAT-PClneo 1110 diluted lysate 
and E = genell-CAT-PClneo 11100 diluted lysate. 
Panel B) Bar graph of the expression of CAT protein from the samples described in 
panel A. All values are nonnalised with the CAT +ve control ascribed a value of 
100%. 
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6.3.9. Generation of mutants to test for the presence of leaky scanning 
expression of ORF2 
Having established the validity of using this approach to measure expression 
levels from ORF2 of gene 11, several mutants of the gene 1 I-CAT fusion plasmid 
were constructed in order to investigate whether leaky scanning was the mechanism 
responsible for ORF2 expression. Leaky scanning has been shown to be dependent 
on the Kozak consensus sequence around the first ORF, the context surrounding the 
first initiation codon dictates the level of readthrough and any change to this context 
would have a dramatic effect on the expression of the second ORF. If this 
mechanism was responsible for expression from ORF2 then improving the Kozak 
consensus sequence around the first ORF would diminish expression of the second. 
In addition if the first ORF ATG start codon is made non-functional, expression 
from the second ORF would be greatly increased due to ribosomes now bypassing 
the first mutated ATG and initiating at ORF2. 
Mutations were made around the ATG start codon ofORFl to either improve 
its Kozak consensus sequence or to render the NSPS start codon non-functional 
(Figure 6.9). Thus the GAGATGT sequence around the ORFI start codon was 
mutated to generate either a partial Kozak consensus sequence in which the 
thymidine in position +4 was changed to a guanidine creating GAGA TGG (gene 11-
CAT-PCIneo t2Sg) or a full Kozak consensus sequence ACCATGG in which four 
nucleotides were mutated (genell-CAT-PClneo g19a, a20c, g21c, t2Sg) (Figure 
6.9). To generate a cDNA carrying a non-functional NSP5 start codon the adenine of 
the ATG was mutated to a guanine (genell-CAT-PClneo a22g) (Figure 6.9). 
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Kozak consensus sequence:1 ACCAUGG I 
Sequence surrounding the Gene 11 ORF 1 start codon: 
I UACAGUGAUGUCU I 
gene 11 t2Sg ORF 1 start codon sequence: 
IUACAGUGAUGGCU I 
gene 11 g20a/t21c/g22c/t2Sg ORFI start codon sequence: 
IUACAACCAUGGCU I 
gene 11 a22g ORF 1 start codon sequence: 
I UACAGUGGUGGCU I 
Figure 6.9 Genell-CAT mutants 
ite directed mutagenesi wa u ed to mutate the AUG tart codon of the fir t ORF 
to either a nonfunctional GUG or to place it in a better Kozak consensu eq uence in 
the gene ll-C T-PClneo con truct. The AUG ORF tart codon i underlined and the 
changes made by site di rected mutagenesi can be seen in red. 
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6.3.10. Effect ofthe gene 11 UTR on CAT expression from ORF2 
The data collected from the assay (Figure 6.10) for CAT expression from 
these mutants showed that the eDNA of the gene II-CAT construct which contained 
the 5 'UTR of gene 11, had a small increase in the amount of CAT produced 
compared to that of the ORFI-CAT construct, which lacked the 5' UTR (Figure 
6.10). This is contrary to what had been obsereved in the coupled in vitro 
transcription/translation system, in which no visible difference was discerned 
between the amount of NSP6 expressed from a construct containing the UTR and a 
construct without this sequence as detected by autoradiography. 
6.3.11. Effect of improving the context of the ORFI Kozak consensus sequence 
on CAT expression from ORF2 
The t25g mutant, which had a partial Kozak consensus sequence showed a 
large reduction in CAT expression compared to that of the gene II-CAT construct 
(Figure 6.10). The mutant in which a full Kozak consensus sequence (ACCAUGG) 
was generated around ORFI showed levels of CAT expression that were only 
slightly above background (Figure 6.10). This strongly indicates that in this case the 
vast majority of ribosomes were initiating at the first ATG start codon of the cDNA 
and hence cannot bypass it to initiate translation at the second A TG start codon and 
allow CAT expression. 
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6.2.12. Effect of removing the ORFl initiation codon on the expression of CAT 
fromORF2 
Consistent with the above findings, when the first A TG initiation codon was 
mutated to a non-functional GTG codon, the expression of CAT increased to a level 
comparable to that of the CAT positive control (Figure 6.10). This suggests that 
when the first ATO initiation codon was removed, the ribosomes preferentially 
scanned to the second A TO start codon and then began translation. These data are all 
consistent with a cap-dependent leaky scanning mechanism being responsible for the 
translation ofNSP6 from the second ORF in rotavirus gene 11. 
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Figure 6.10 CAT assays to determine the effect of nucleotide changes around 
the ATG start codon on the expression of CAT from ORFl of the rotavirus 
gene 11 
Panel A) Confluent monolayers of BSC-l cells were transfected with the appropriate 
plasmids and after 48 hours incubation at 37°C harvested in lysis buffer. CAT assays 
were performed on the cell lysates using the CAT detection kit (Roche) as described 
in the Materials and Methods. Al & A2 = PCIneo -ve control, Bl & B2 = CAT +ve 
control, Cl & C2 = ORFI-CAT, 01 & 02 = gene 1 I-CAT, El & E2 = gene 1 I-CAT 
t23c, Fl & F2 = genell-CAT t25g, Gl & G2 = gene 1 I-CAT gl9a, a20c, g21c, t25g, 
A3 & A4 = Opg CAT standard, B3 & B4 = SOpg CAT standard, C3 & C4 = l00pg 
CAT standard, 03 & D4 = 150pg CAT standard, E3 & E4 = 200pg CAT standard, 
F3 & F4 = 300pg CAT standard and 03 & 04 = 400pg CAT standard. 
Panel B) Bar graph of the expression of CAT protein from the samples described in 
panel A. All values are normalised with the CAT +ve control ascribed a value of 
100%. 
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6.4. Discussion 
Work presented In this chapter had as its aim the investigation of the 
mechanism of expression of NSP6 from the second ORF of gene II. A number of 
possible mechanisms use secondary structures formed by the 5' termini of mRNA to 
aid initiation of translation. RNA secondary structure prediction showed little 
secondary structure at the 5' termini of gene 11 mRNA consistent with those known 
to influence translation in other systems. In addition deletion of the 5' VTR from 
this mRNA did not appear detrimental to the expression of the NSP5 and NSP6 
proteins in a coupled in vitro transcription/translation system. The lack of 
appropriate predicted RNA secondary structure and the deletion of the 5' VTR not 
affecting efficient protein expression in vitro would indicate that translational 
mechanisms such as IRES elements and ribosomal shunting are not involved. 
In order to exclude the possible existence of an IRES element within gene 
11, dicistronic gene fusions were constructed in which the actin gene was inserted in 
front of gene 11. These cDNA constructs only expressed actin and demonstrated that 
there was no expression of gene 11 proteins downstream of the actin ORF, 
indicating the absence of any cap-independent expression mechanisms in gene 11. 
To assess the possible expression of NSP6 via a leaky scanning mechanism 
the 5' 80 nucleotides of gene 11 were placed before the CAT reporter gene 
sequence. This was done in such a way that the CAT gene initiated from the ORF2 
position. The expression of CAT from the second ORF of the gene 11 fusion was 
tested with the ORFI AVG start codon in a variety of Kozak consensus sequences, 
this showed that the expression of CAT from the second ORF was diminished when 
237 
ORFI AUG start codon was placed into a better consensus sequence and greatly 
improved when the ORFI AUG was removed. This suggests that the expression of 
ORF2 was dependent on the proportion of ribosomes initiating translation at the 
ORFI AUG. This context-dependent manner of ORF2 expression can only be 
attributed to leaky scanning. A small decrease in efficiency of expression was seen 
when the 5' gene 11 UTR was removed in this system, which was not seen in a 
similar experiment using the coupled in vitro transcription/translation system. 
Other mechanisms such as ribosomal shunting are not affected by the context 
in which the first AUG initiation codon is found and also predominantly require the 
presence of secondary structural elements at the 5' terminus, which are not present 
in the gene 11 RNA. Rotavirus RNA is very A!U rich and secondary structure 
prediction of gene 11 shows only limited secondary structure at the 5' terminus and 
little stable G/C bonding. Ribosomal shunting is also not affected by the context 
around the initiation codon of the first ORF. 
Frameshifting is also unlikely as this would produce a fusion of the 5' of 
NSP5 and then slippage to engage the ORF of NSP6, which has not been detected in 
NSP6 protein recovered in vivo. Furthermore the gene 11 sequence does not contain 
the required slippery sequence or pseudoknot required for this mechanism of 
translation to occur. 
The work presented in this chapter indicates that the most likely mechanism 
of expression of rotavirus gene 11 second ORF is leaky scanning. The efficiency of 
expression from ORF2 appears to be directly related to the context of the Kozak 
consensus sequence surrounding the initiation codon of ORFI. Thus the expression 
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of NSP6 appears to be controlled at the translational level by the amount of 
ribosomal read through at the first ATG start codon. However, it is difficult to 
determine if the low level of NSP6 expression detected in the cells during virus 
infection is due to low level leaky scanning or to the high protein turnover noted in 
other experiment performed as part of this study. 
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Chapter 7 
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Rotaviruses are the major etiological agent for gastroenteritis in children and 
young animals (Kapikain et al., 2001). They possess a dsRNA genome composed of 
11 segments which encode six structural and six non-structural proteins. The gene 
segments are monocistronic with the exception of the smallest gene segment 11 
which encodes two proteins. The complex interactions involved in virus replication 
and the role that the non-structural proteins play in these events is not yet fully 
understood (Estes, 2001). However, those non-structural proteins that have been 
associated with the formation of the large occlusion bodies termed viroplasms have 
been shown using siRNA and intracellular antibodies, to be essential for virus 
replication (Vascotto et al., 2004; Silvestri et aI., 2005; Lopez et ai., 2005). The 
viroplasms are the site of synthesis and replication of dsRNA, packaging of viral 
dsRNA into newly synthesised cores and the steps of viral morphogenesis that result 
in the formation of double-shelled pre-virions (Altenburg et al., 1980; Espaza et ai., 
1980; Patton & Gallegos, 1990; Wentz et aJ., 1996; Patton et ai., 1997). 
Two proteins NSP5 and NSP6 have been shown to be encoded by gene 
segment 11 in overlapping reading frames (Oyall-Smith et aI., 1981; Mattion et ai., 
1991). The NSP5 protein has been identified as a major component of viroplasms 
(Petrie et ai., 1984; Fabbretti et ai., 1999; Eichwald et al., 2004), whereas only 
tentative observations have linked NSP6 localisation to be within these structures 
(Mattion et ai., 1991). 
An in vitro transcription/translation system was used to study the expression 
of proteins from gene segment 11. NSP5 and NSP6 were both clearly expressed in 
this system, which was also employed to investigate the phosphorylation of NSP5. 
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When isolated from infected cells NSPS exists in three isofonns which vary on their 
level of phosphorylation and can be identified because of the retardation caused by 
phosphorylation when the proteins are fractionated by SDS-PAGE. The three 
isofonns of NSPS migrate at 26, 28 and 30-34 kDa (Welch et al., 1989; Afrikanova 
et al., 1996; Poncet et al,. 1997; Blackhall et al., 1997). It has been suggested that 
NSP5 has putative autocatalytic kinase activity potentially leading to 
autophosporylation of the protein (Welch et al., 1989; Poncet et al., 1997; Torres-
Vegas, 2000). In addition the generation of the hyperphosphorylsated form of the 
protein (30-34 kDa) has been shown to be up-regulated by the presence of NSP2 
(Afrikanova et al., 1998). In the results reported here, NSP5 expressed from the 
coupled in vitro transcription/translation system appeared to become 
hyperphosphorylated when incubated in the rabbit reticulate lysate at 20°C for 
extended periods of time. This hyperphosphorylation was not seen if the extended 
incubation was at 4OC. Work presented here suggests that NSP5 can be 
hyperphosphorylated in the coupled in vitro transcription/translation system in the 
absence of NSP2 either by cellular kinases within in the rabbit reticulate lysate or by 
slow autophosphorylation. There is recent evidence to suggest that NSP2 may cause 
a conformational shift in the NSPS protein that allows it to be phosphorylated at a 
specific serine residue at position 67 (Eichwald et al., 2004). The phosphorylation at 
this residue is thought to lead to subsequent phosphorylation events which in tum 
lead to the generation of the hyperphosphorylated form of the protein (Eichwald et 
al., 2004). Two cellular kinases casein kinase I and casein kinase II have been 
suggested to be involved in NSP5 phosphorylation (Eichwald et al., 2002; Eichwald 
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et al., 2004). Evidence reported here suggests that cellular kinases may well be able 
to cause hyperphosphorylation without the presence of NSP2 but at a much slower 
rate. 
To further investigate the function of NSP5 and NSP6 cDNA's of both ORF 
were cloned into the pET expression vector system to facilitate the production and 
purification of the two proteins. GST tagged fusions were originally used for 
purification but these proved to be unstable during the purification process and 
consequently large amounts of protein could not be obtained. Subsequent 
purification attempts using a modified pET vector constructed in the rotavirus lab 
(Chung, 2004) again proved unable to provide suitable purified protein. However, 
purified protein was obtained via construction of cDNA fusion constructs containing 
a 6xHis tag at the 5' terminus of the NSP5 or NSP6 ORF's. The His tagged ORF 
constructs were separately cloned into a modified pET42b vector which lacked the 
GST tagging region usually found in this vector. The His-NSP5 protein was shown 
by mass spectroscopy to exist in two forms at 26 and 28 kDa this being the correct 
size to be the two lower phosphorylated forms found within the infected cells. This 
might be an indication of autophosphorylation occurring during prokaryote protein 
expression. Purified NSP5 and NSP6 were then used to generate monospecific 
polyclonal antisera for each protein. 
NSP5 has previously been shown to localise to the viroplasms within 
infected cells (Petrie et af., 1984). It has also been observed that the number and size 
of these viroplasms changes over the course of an infection with the number of 
viroplasms decreasing as their size increases (Eichwald et 01.,2004). 
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Work presented here using immunofluorescence to detect the distribution of 
the NSP5 protein over the course of a rotavirus infection indicated that the number 
of viroplasms appeared to increase from 2 - 6 hours post infection and then 
decreases thereafter as their size increased. One suggestion put forward for the 
decrease in viroplasm number and increase in size is coalescence and fusion of 
separate viroplasms (Eichwald et al., 2004) however, there was no direct observation 
of fusion using fluorescence microscopy. There appeared to be an increase in the 
number of viroplasms at the last time point, this may be an indication of newly 
formed double layered particles causing secondary rounds of replication leading to 
the formation of new viroplasms. 
The distribution of NSP5 within the viroplasm was seen by Eichwald et al 
(2004) to be a ring shape, surrounding the NSP2 which appeared to fonn the core of 
the viroplasm. From observations made while viewing confocal images the 
distribution of NSP5 within the viroplasm appeared to be cup shaped with the 
protein fonning a ring around the centre of the viroplasm and narrowing into a base 
at the end of the confocal series. How this distribution may contribute to the function 
ofNSP5 in unknown. 
NSP6 was not detectable by immunofluorescence or Western blotting using 
either rabbit anti-NSP6 or rat anti-NSP6 sera but could be immunoprecipitated from 
cells infected with the UKtc strain of rotavirus. Immunoprecipitation showed that 
NSP6 was expressed at a low level throughout the course of an infection. The 
amount expressed at 2 hours post infection was smaller than that evident at 3 hours 
and it continued to be produced at a steady but low rate until 8 hours when its 
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expression reduced slightly. Previous work has shown that NSP6 could be 
immunoprecipitated at 8 hours post infection (Torres-vega et al., 2000). Pulse chase 
analysis performed in this study showed for the first time that NSP6 had a high rate 
of turnover with NSP6 pulse labelled protein virtually undetectable at the end of a 2 
hour chase period. This is unusual among the rotavirus proteins which do not show 
such high tum over (McCrae & Faulkner-Valle, 1981). 
To determine the distribution of NSP6 within a rotavirus infected cell a 
GFP-NSP6 fusion was constructed. When this fusion protein was expressed in 
tranfected cells it appeared to form a large amorphous mass within the cytoplasm. 
When cells transfected with the fusion construct were subsequently infected with 
rotavirus, the expressed fusion protein was redistributed to viroplasm structures in 
the infected cell. The localisation of the GFP-NSP6 fusion protein appeared to be 
within the centre of the viroplasm, similar to the distribution reported recently for 
the NSP2 protein (Eichwald et al., 2004). It was only possible to find a limited 
number of cells with detectable levels of GFP-NSP6, a possible indicator that NSP6 
still has a high rate of turnover when expressed in the absence of other viral proteins. 
From work done in previous studies (Matti on et al., 1991) it has become 
widely accepted that NSP6 localises to the viroplasms however these claims are not 
fully supported by the evidence presented. In the experiments performed by Mattion 
et af immunofluorescence images were generated using hyperimmune sera from 
animals inoculated with recombinant baculovirus lysate, containing either the NSP6 
ORF or a complete gene 11 sequence. Immunofluorescence using the NSP6 specific 
sera does show what are termed discrete foci within rotavirus infected cells. 
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However, the immunofluorescence image that corresponds to NSP5 localising to the 
same structures was performed using the sera generated against the recombinant 
baculovirus lysate containing the whole gene 11 and thus contained antibodies to 
both NSP5 and NSP6, a fact that had been previously demonstrated in the same 
publication (Matti on et al., 1991). This means that both NSP5 and NSP6 would be 
stained by the same sera and if the foci that NSP6 was localised to were not the 
viroplasms then no distinction could be made between the two. The image generated 
from this sera not only showed discrete foci but also a large amount of diffuse 
cytoplasmic staining making any detection of separate species of foci based on size 
or morphology impossible. Therefore the co-localisation ofNSP5 and NSP6 to the 
viroplasm of infected cells by these means should only be tentatively suggested. 
Work perfonned during the course of this investigation using the GFP-NSP6 
construct has definitively shown by double immunofluorescence confocal 
microscopy ofNSP5 and NSP6 co-localise to viroplasms within infected cells. 
With the localisation of NSP6 to the viroplasms confirmed the question of 
whether the NSP6 protein is essential for viroplasm formation was addressed. It has 
been previously shown that NSP2 and NSP5 can form viroplasm-like structures in 
the absence of a rotavirus infection (Fabbretti et at., 1999) and that NSP5 when 
expressed with fusions of other proteins or peptides at its N terminus can also form 
viroplasm-like structures in the absence of NSP2 (Mohan et al., 2003). However, 
these studies used a range ofNSP5 deletion mutants in order to assess which regions 
ofNSP5 were crucial to form the viroplasm-Iike structures. These mutants contained 
either the whole NSP6 coding region or encoded part of the NSP6 protein. In order 
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to assess the effect NSP6 has on the formation of viroplasm-like structures a gene 11 
cDNA which contains a mutated nonfunctional ORF2 start codon was constructed 
by site-directed mutagenesis. As the construct had a mutated ORF2 start codon there 
would be no expression of the NSP6 protein. The construct was then used in 
transfection experiments along with the NSP2 ORF in order to assess the formation 
of viroplasm-like structures. 
Experiments performed using the gene 11 unable to express NSP6 showed 
that NSP6 was not required for the formation of viroplasm-like structures. Cells 
transfected with an NSP2 construct and a gene 11 mutant which could not express 
NSP6 were still capable of forming viroplasm-like structures. To confirm these 
findings a N-terminally fused GFP-NSPS mutant which was unable to express NSP6 
was used, as stated above it was found that GFP-NSP5 fusions were able to form 
viroplasm-like structures in the absence of NSP2 (Mohan et al., 2003). Transfection 
of the GFP-NSP5 mutant which could not express NSP6 showed formation of 
viroplasm-like structures. This evidence shows that NSP6 is not required for the 
formation of viroplasm-like structures by NSP5 and NSP2 or by GFP-NSP5. This 
suggests that NSP6 does not a play a major structural role in formation of the 
viroplasms. 
The localisation of NSP6 to the viroplasm was a strong indication of it being 
a potential RNA binding protein. NSP2 and NSP5 have both been shown to have 
RNA binding ability (Kattoura et al., 1992; Vende et al., 2002), with NSP2 binding 
ssRNA in a sequence independent manner (Kattoura et al., 1992) and NSP5 binding 
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both ssRNA and dsRNA with equal affinity in a sequence independent manner 
(Vende et al., 2002). 
Using both filter binding and gel retardation assays the RNA binding ability 
of NSP6 was characterised. NSP6 was found to bind ssRNA in a sequence 
independent manner and a close to equal affinity for ssRNA, dsRNA and dsDNA. 
From this data it can be concluded that NSP6 is a sequence independent nucleic acid 
binding protein. The KDiss of NSP6 for ssRNA was found to be some eight fold 
lower than that of NSP5, showing NSPS has a far greater affinity for RNA than 
NSP6. The identification of an RNA binding ability for NSP6 suggests a possible 
role along side NSP2 and NSP5 in the RNA replication and packaging events which 
occur within the viroplasm however, the exact RNA-protein and protein-protein 
interactions involved still remain unclear. 
The mechanism of expression of ORF2 from rotavirus gene 11 was also 
investigated. The NSP6 ORF is encoded in a + I frame shift from that of the NSPS 
ORF and is contained entirely within the NSP5 ORF. Several possible mechanisms 
could be utilised for the expression of NSP6 and these were addressed in this study. 
Data presented here suggests a leaky scanning mechanism for NSP6 expression. The 
expression of NSP6 from the second ORF was found to be dependent upon the 
Kozak consensus sequence surrounding the first ORF (NSP5) start codon suggesting 
that expression involved a fraction of scanning ribosomes failing to initiate at the 
ORFI start codon but continuing to scan to the ORF2 start codon were they initiate 
protein synthesis. 
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The significance of the NSP6 protein in virus replication has come under 
scrutiny as some rotavirus gene 11' s that have been sequenced do not appear to 
encode this protein. Two human virus isolates Mc323 (Kojima et al., 1996) and 512-
C (Wu et al., 1998) do not posses the NSP6 start codon. In addition two viruses have 
been discovered that appear to have truncated NSP6 ORF's, the Alabama strain of 
lapine virus (Gorziglia et al., 1989) lacks the 5' terminus of the NSP6 ORF but an 
internal start codon may express a 79aa protein and the porcine OSU strain 
(Gonzalez & Burrone, 1989) which potentially encodes for a 51aa NSP6 protein due 
to a premature stop codon found in the NSP6 ORF. This is based entirely on 
sequence data and as yet no attempts have been made to identify the NSP6 protein 
expressed by these strains. The lack of sequence conservation and its seemingly low 
level of expression in virus infected cells, has led to the suggestion that NSP6 may 
playa non-essential regulatory role within a rotavirus infection (Lopez et al., 2005; 
Mattion et al., 1991; Torres-Vega et al., 2000). The interaction domain ofNSP5 that 
binds the NSP6 protein is found at its C-tenninus a region which is also crucial for 
NSP5 dimerisation and hyperphosphorylation perhaps suggesting a regulatory role 
for NSP6 in these events (Torres-Vega, et al., 2000). Recent work using siRNA and 
intracellular antibodies has demonstrated that NSP5 is essential for viroplasm 
formation and virus replication. These studies were performed using the Alabama 
and OSU strains in order to try and circumvent the issue of knockdown in the level 
of NSP6 contributing to the effect seen by knockdown of NSP5 (Vasscotto et al., 
2004; Lopez et al., 2005). Whether there is expression of NSP6 in a truncated fonn 
from these strains and if the regions expressed are functionally active for example 
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still able to bind RNA and what affect this may have on the observations seen in 
these experiments is a matter that requires further investigation. 
The NSP6 protein is the most uncharacterised of all the rotavirus proteins 
and this study has been aimed at increasing the understanding of this the smallest 
protein expressed by the virus and investigating its possible role in virus replication. 
Work presented here suggests that NSP6 may have a more central role in virus 
replication than previously thought. The high rate of NSP6 turnover may be an 
indication of a regulatory protein but how this is coupled to a possible role in the 
complex events within the viroplasm is unknown. Its RNA binding ability indicates 
a possible place for NSP6 in the events of RNA replication and packaging and there 
is the possibility that it may act as a mediator between NSP2 and NSP5. 
Despite the progress made in this and previous studies a great many 
questions remain unanswered about NSP5 and NSP6 and there is an extensive 
amount of future research on this area. The lack of a reverse genetics system to 
knock out specific genes has hampered research into rotaviruses however there are 
many other techniques available which offer great insight into protein function. The 
crystal structure of NSP5 and NSP6 would yield new insights into their functions, 
much has been learnt from the resolution of the NSP2 proteins crystal structure 
(Jayaram et al., 2002). One such area where this type of study would be useful 
would be the elucidation of the residues in NSP5 and NSP6 involved in RNA 
binding. 
An area of further investigation is the high rate of turnover of NSP6, the 
determination of the mechanism of this degradation may yield some insights into its 
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function. A first step would be to perform pulse chase analysis using a cDNA of the 
NSP6 ORF transfected into cells to determine the rate of turnover of NSP6 in the 
absence of a viral infection. Determining the signal for degradation may also be 
important as NSP6 may contain a novel degradation signal that has not been seen 
before. 
Another area of investigation might be to determine if there is any interaction 
between NSP2 and NSP6. Co-immunoprecipitation, yeast or mammalian two hybrid 
and GST pull down analysis could be used in order to experimentally confirm this 
interaction. If found to be true this would be an important step in further 
understanding the relationship between the non-structural proteins found within the 
viroplasm. To understand the complex interactions found in the viroplasm the 
interactions between these proteins and their functional abilities as multimers should 
be investigated and not just their individual attributes. One such area would be 
studying what effect if any NSP6 may have on NSP5 phosphorylation and how this 
relates to the ability of NSP2 to enhance NSP5 phosphorylation to form the 
hyperphosphorylated isofonn. 
The events that occur within the viroplasm which play a role in virus 
replication are still not fully understood and many challenges lie ahead. This 
investigation has shed new light on NSP6 the most uncharacterised of the rotavirus 
proteins and attempted to investigate how this protein may be involved in the virus 
replication cycle. 
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tyro ine over hangs for rapid I igation to P R product gen rated u ing Taq 
polymerase with. It contains the lacZ-alpha complementation fragment for blue-
white co lour screening, ampicillin and kanamycin re i tan e gene for election. 
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Gene egment II wa cloned directly into th p R2. 1 vector b TA loning t 
generate pCR2.I-gene II. 
07 
BspH 
Ahdl 
Bsa 
pUC origin 
" 4000 
pCR2.1-NSP5 1000- T7 Promoter 
4575 bps 
3000 
/' 
2000 
\ 
f1 origin 
Appendix 1.3 N P5 cloned into the p R2.1 expre sion vector 
Munl 
EcoRV 
Noli 
Aval 
Xhol 
~ __ -----j BfrBI 
Nsil 
Dralll 
Xbal 
Eco01091 
Apal 
PspOMI 
P5 ORF wa cloned directly into the p R2. 1 vector by TA clon ing to g neratc 
pCR2.1- P5. 
o 
Hindlll 
Aec651 
Kpnl 
BamHI 
Spel 
pUC origin 
EeoRV 
Noll 
Aval 
Xhol 
BfrBI ~----1 Nsil 
Ahd 
Bsal 
T7 Promoter 
4000 
pCR2.1-NSP6 1000-
3000 4226 bps 
2000 
\ 
f1 origin 
Xcml 
Bgil l 
Bell 
Appendix 1.4 NSP6 cloned into the peRl.} expre sion vector 
Oralll 
BstAPI 
Xbal 
Eco01091 
Apal 
PspOMI 
NSP6 ORF was cloned directly into the p R2.1 vector by T A cloning to generate 
pCR2.I-NSP6. 
09 
Bst11071 
Tth1111 
"-
5000 
4000 
Bigi 
Inl 
/ 
1000 
pET42b 
5929 bps 
2000 
..... 
3000 
I 
PpuMI 
Appendix I.S Expre ion vector pET42b 
Xhol 
Noll 
Eagl 
Hindlll 
Sail 
Ec113611 
Sacl 
Sbfl 
PsII 
Asci 
Stu I 
BsrGI 
EcoRI 
BamHI 
EcoRV 
Ncol 
PshAI 
Ndel 
Xbal 
SgrAI 
Sphl 
BstAPI 
The pET42b expre ion vector generate high level expre ion of fLl i n prolein 
with a G T, 6 hi tidine and tag. The ector contain a T7 promot I' region, 
mullicloning ite, Kanamycin re i tance gen and fa lor a protea cleavage ite 
for removal of the tag after protein purification. 
10 
Xhol 
Noll 
Eagl 
Hindll l 
,-------,-Pst1tAf- ---j Sail 
Nru 
EcoS7 
A1wNI 
BssSI 
Bsl11071 
Tth1111 
\ 
6000 
/ 
1000 
- 5000 pET 42b-NSP5 
6532 bps 2000_ 
4000 
/ 
Hpal 
Mscl 
Ndel 
Xbal 
SgrAI 
BstAPI 
Appendix 1.6 NSPS ORF cloned into the pET42b expression vector 
Ecl136 11 
Sacl 
PsII 
The P5 ORF wa cloned into PshAI and Ps/l re triction enzyme ite of the 
multicloning site of pET42b to generate pET42b- P5. 
3 11 
Eco571 
AIwNI 
Bsl11071 
Tlh1111 
BliJl 
Bini 
)(hol 
Noll 
Eagl 
Hindlll 
.----+Hfutt1r--- -----1Sall 
\ I 
6000 
,.-
1000 
pET 42b-NSP6 
6183 bps 
2000 
4000 
3000 
I 
...... 
PpuMI 
Ndel 
Xba l 
SgrAI 
Sphl 
BstAPI 
Ecl13611 
Sacl 
Pstl 
Appendix 1.7 N P6 ORF cloned into the pET42b exp"e sion vector 
The NSP6 ORF wa cloned into P hA l and P II re triction enzyme ite or the 
multicloning site of pET42b to generate pET42b- P6. 
12 
BssSI 
BspLU111 
Ora'" 
/ 
Sapl 
Bsl11071 
Tlh1111 
Bpu11021 
Bini 
f1 origin His-Tag 
5000 
pET4215 
5204 bps 
3000 
2000 
Agel 
Acc651 
Kpnl 
Xhol 
Ndel 
Ncol 
Xbal 
1000 
, 
Bgill 
SgrAI 
Sphl 
EcoNI 
PpuMI 
Appendix 1.8 Expre ion vector pET4215 
Mlul 
Bell 
BstEil 
Apal 
Bsp1201 
Xhol 
Not! 
Eco521 
Hindlll 
Sail 
Ee113611 
Sacl 
Sbfl 
Pst! 
Asci 
Slul 
BsrGI 
EcoRI 
BamHI 
EcoRV 
Ncol 
PshAI 
The p T4215 expre ion vector g n rate high lev pr ion of fu ion prot in 
with a 6 hi tidine tag. The vector contain a T7 promoter region. multicloning it . 
Kanamycin resi tance gene and factor Xa protea e cleavage itc ~ r rcmoval of lh 
tag after protein puri fication. 
Eco521 
Notl 
Hindlll 
Sail 
Sacl 
Ecl13611 Munl Pstl 
Sbfl r-----------~~~~~~ 
Asci -1D'l- --t:~!11_ .... ~ Stul :. 
BsrGI 
EcoRI 
BamHI 
EcoRV 
Ncol 
Sphl 
Actl 
BstAPI 
" 5000 
f1 origin 
;' 
1000 
pET4215-NSP5 
4000 
5801 bps 
3000 
I 
Acll 
2000 
BsaAl 
Tth1111 
Clal 
Nrul 
Eco5?1 
Appendix 1.9 P5 ORF cloned into the pET4215 expre ion vector 
The P5 ORF wa cloned into Psh AI and p ./ I re triction enz m 
multicloning site ofpET4215 to generate pET4215- P5. 
or the 
14 
Xhol 
Eco521 
Notl Taqll 
Hindlll Adl 
Sail Tall 
Hindi AlwNI 
Sad Eco57MI 
Ecl13611 Bpm l 
Bpu11021 
Bini 
Pstl l--------<=UJ-IU'r--i--ttt--. 
Sbfl ~1L-l-"-fliiQ_a.L Asci :J 
Stul 
Tall 
BsrGI 
EcoRI 
BamHI 
EcoRV 
Ncol 
Acll 
BstAPI 
Eco57MI 
Bpml 
Taqll 
Mlul 
Bcll 
Taqll 
BstEIl 
Bsp1201 
Apal 
Eco57MI 
Bpml 
Hpal 
Hincll 
\ 
5000 
.;-
1000 
pET4215-NSP6 
4000 5501 bps 
3000 
/ 
Acll 
2000 
" 
pBR322 origin 
Bpml 
Eco57MI 
Taqll 
Sgfl 
Pvul 
EcoNI 
Smal 
Xmal 
Clal 
Nrul 
BssSI 
Appendix 1.10 NSPS ORF cloned into the pET4215 exprc ion vector 
The SP6 ORF was cloned into P h AI and P t I r triction nzyme ite of the 
multicloning site of pET4215 to generate pET42 15- P6. 
3 15 
Nru 
BssSI 
Xhol 
Noll 
Eagl 
Hindlll 
'i-"-- ------------i Sail 
Kanamycin , 
5000 
;' 
1000 
pET -His-NSP5 
4000 5720 bps 
Bsl11071 
Tth1111 
3000 
J 
2000 
" 
PpuMI 
Sphl 
BstAPI 
Mlul 
Hpa l 
Ecl13611 
Sacl 
Pstl 
Appendix 1.11 P5 ORF cloned into the pET42b cxprc ion vector which ha 
had the G T tag region removed. 
P R wa used to place the un ique r triction ite de I and Pst I at the 5" and 
3're petive ly and a 6 Hi tag onto the 5' of th P5 ORF thi ,wa ub eq ucnt ly 
cut with Nde I and Pst I cloned into pET42b v tor that had be n al 0 leav d with 
de I and Pst I re triction enzyme and then the two cD ' were ligated to 
generate pET-Hi - P5. 
16 
Nru 
AIwNI 
BssSI 
Xhol 
Noll 
Eagl 
.~-------------t Hindlll 
Sail 
Ecl13611 
Sacl 
Pstl 
\ 
5000 
-1000 
_ 4000 pET -His-NSP6 
5371 bps 
3000 
I 
2000 
" 
PpuMI 
SgrAI 
Sphl 
Mlul 
BsIEl1 
Apal 
PspOMI 
Appendix 1.12 NSP6 ORF cloned into the pET42b expression vector which has 
had the GST tag region removed. 
peR was used to place the unique restriction sites Nde I and P I I at the 5' and 
3'respetively and a 6 Hi tag onto the 5' of the P6 ORF thi ,wa lib equ ntly 
cut with Nde I and PsI I cloned into pET42b vector that had been al 0 cleaved wi th 
Nde I and Pst I restriction enzymes and then the two cDNA' were ligated to 
generate pET-His- P6. 
17 
Appendix 2 - Result Chapter 4 
Amp resistance gene 
BamHI 
89111 
\ 
5000 
PClneo 
4000 5474 bps 
Synthetic poly(A) 
3000 
/ 
neo 
Appendix 2.1 PCIneo expression vector 
Sacl 
Bbsl 
8mt! 
Nhel 
Xhol 
EcoRI 
Aflill 
.~~ ____ ----j Mlul 
Xbal 
Accl 
Sail 
Smal 
Xmal 
Noll 
...-
1000 
2000 
" 
SV40 enhancer and early promoter 
The PClneo expression vector contain both the human cytomegalovirus ( MV) 
immediate early, T7 and T3 promoter region . The MV promot I' enable 
expression of cloned in ert in mammalian cell, the T7 and T3 promoter can be 
used for expression of cloned in erts in in vitro expre ion y tem or recombinant 
cell expressing the T7 or T3 polymera e . The plasmid carri an ampi illin 
antibiotic resi tance gene for selection of tran formed bacteria carr ing the pia mid 
during cloning and a neomycin pho photran fera e gene which i a lectab l 
marker in mammalian cell. A lso pre ent i the origin of repli alion of the 
filamentous phage f1 , a multicloning ite and following thi a V40 late poly 
ignal sequence allowing poly adenylation of cloned in eli . 
18 
Amp resistance gene 
BamHI 
-... 
5000 
\ I 
6000 
/' 
1000 
Gene11-PClneo 
6124 bps 
4000 
/' 
Synthetic poly(A) 
3000 
I 
2000 
-... 
Sacl 
Bbsl 
Bmll 
Nhel 
Xhol 
Gene segment 11 
Xbal 
~ _ ___ ---1 Accl 
Sail 
Sma I 
Xmal 
Noll 
SV40 enhancer and early promoter 
Appendix 2.2 Rota iru gene egment 11 cloned into the peIneo expre sion 
vector 
Rota irus gene egment II wa cloned into Xho I and Xba I re triction enzym ite 
of the multicloning ite of PClneo to generate gene II-PClneo. 
319 
Amp resistance gene 
"-
5000 
Bgill 
\ I 
6000 
/ 
1000 
NSP5-PClneo 
6102 bps 
2000 
Bbsl 
Bmll 
Nhel 
Xhol 
NSP50RF 
Xbal 
4000 
/' -;S:'----------i Aeel Sail 
Sma I 
Xmal 
Noll 
Appendix 2.3 
3000 
I 
SV40 Late poly(A) 
SV40 enhancer and early promoter 
P5 ORF cloned into the peIneo expres ion vector 
The P5 ORF wa cloned into Xho I and Xba I re triction enzyme itc of the 
multicloning ite of PClneo to generate P5-PClneo. 
320 
" 5000 
./ 
1000 
Sacl 
Xbal 
Acel Amp resistance gene 
NSP6-PClneo 
4000 5754 bps 
Io----------j Sail 
Sma I 
Xmal 
Noll 
Appendix 2.4 
Synthetic poly(A) 
8amHI 
3000 
I 
2000 SV40 Late poly(A) 
" 
SV40 enhancer and early promoter 
P6 ORF cloned into the PClneo expres ion vector 
The P6 ORF wa cloned into Xho 1 and Xba I restriction enzyme ite of th 
multicloning ite of PClneo to generate P6-P Ineo. 
"'2 1 
Amp resistance gene 
BgIII 
I I 
6000 
./ 
-... 1000 
5000 
gene11-PClneo ORF2 
ATG---+ACG 
6124 bps 2000 
4000 
/ 
Sacl 
Bbsl 
Bmtl 
Nhel 
)(hol 
Gene segment 11 
minus NSP6 
)(bal 
'~'--___ ---1 Accl 
Sail 
Sma I 
)(mal 
Notl 
SV40 enhancer and early promoter 
Appendix 2.5 ite directed mutagene i was used to generate PClneo-genell 
ORF2 ATG_A G 
ite directed mutagene i wa u ed to create a mutant gene II equence that c uld 
no longer expre the P6 protein generating gene II t23c-PClneo, 
322 
Amp resistance gene 
8amHI 
\ 
6000 
/ 
1000 
- 5000 NSP2-PClneo 
6533 bps 2000 
4000 
/ 3000 
\ 
Sacl 
Xbal 
fI3-""-----------1 Accl 
Sail 
Sma I 
Xmal 
Noll 
SV40 enhancer and early promoter 
Appendix 2.6 Rotaviru gene egment 7 cloned into the PIneo expre ion 
vector 
Rota iru gene egment 7 was cloned into Xho I and Xba I re triclion nzymc ilc 
of the multicloning ite of Pineo to generate P2-PClneo. 
32 
BfrBI 
Nsil 
pUC origin 
pCMV 
4000 
phrGFP-N1 
-1000 
3000 4262 bps 
Seal 
Eael 
2000 
\ T7 promotor 
SV40 Poly A 
LoxP 
Ahdl 
f1-ori 
Mlul 
Dralll 
Appendix 2.7 phr FP- 1 vector 
Bmtl 
Nhel 
Aiel 
Sbfl 
Pmll 
8bel 
Kasl 
Narl 
Sfol 
Bpu101 
EcoNI 
BseRI 
Xcml 
BsrGI 
Ed13611 
Sacl 
Acelll 
8gll1 
Xhol 
Hindlll 
S'~----j 8stBI 
EcoRI 
Acel 
Sail 
Sacll 
Smal 
Xmal 
BamHI 
Xbal 
phrG FP- I ( tratagene) has the hrGFP gene under the control of the MY promoter 
and a multicloning ite down tream of the hrGFP gene which i followed by a Y40 
polyadenylation ignal. When ORF's are ubcloned into thi vector in fram hrGFP 
fu ion protein are xpre ed. The vector al 0 contain an ampicillin antibiotic 
re istance gene and a LoxP equence. 
24 
"-
Seal 
Eael 
Pcil 
BfrBI 
Nsil 
Ndel 
SnaBI 
pUC origin pCMV 
4000 
GFP-NSP5 
4859 bps 
3000 
/ 2000 
\ 
1000 
f1-ori T7 promolor 
SV40 Poly A 
Bmtl 
Nhel 
Aiel 
Sbfl 
Pmll 
Bbel 
Kasl 
Narl 
Sfol 
Bpu101 
Sacl 
Hind'" 
'----------1 BslBI 
Appendix 2.8 P5 ORF cloned into the phrGFP-NI expre sion vector 
EcoRI 
Accl 
Sail 
Sacll 
Smal 
Xmal 
BamHI 
Xba l 
The P5 ORF \ as cloned into Sac I and Hind III restriction enzyme ites of the 
multicloning ite of Pelneo to generate GF P- P5. 
325 
Seal 
Eael 
Mdl 
pUC origin 
"-
4000 
8fr81 
Nsil 
pCMV 
Ndel 
Sna81 
-1000 
Am ~FP-NSP5 ORF2 ATG--+ACG 
p 4859 bps 
LoxP 
3000 
/ 2000 
\ 
NSP5 t23c 
f1-ori T7 promotor 
SV40 Poly A 
8mU 
Nhel 
Aiel 
Sbfl 
Pmll 
8bel 
Kasl 
Narl 
Sfol 
8pu101 
Hindlll 
'---------18sI81 
EcoRI 
Accl 
Sail 
Sac II 
Sma I 
Xmal 
8amHI 
Xbal 
Appendix 2.9 ite directed mutagene i wa u ed to generate GFP-N P50RF2 
TG- G 
ite directed mutagene i wa u ed to create a mutant gene II equence that cou ld 
no longer expre the P6 protein generating GFP- P5 t23c. 
326 
Seal 
AmpR 
Eael 
AMI 
BfrBI 
Nsil 
pUC origin pCMV 
LoxP 
4000 
GFP-NSP6 1000 
4559 bps 
3000 
2000 
\ 
T7 promotor 
SV40 Poly A 
f1-ori 
Mlul 
Bmtl 
Nhel 
Aiel 
Sbfl 
Pmll 
Bbel 
Kasl 
Narl 
Sfol 
Bpu101 
)(cml 
BsrGI 
FspAI 
Sapl 
Hindlll 
f0"''-------IBst81 
EcoRI 
Accl 
Sail 
Sadl 
Sma I 
)(mal 
BamHI 
)(bal 
ppendix 2.10 P5 ORF cloned into the PClneo expres ion vector 
The P6 RF \-\as cloned into ac I and Hind III re triction enzyme it of th 
multicloning ite of PClneo to generate GFP- P6. 
327 
Appendix 3 - Results Chapter 6 
\ I 
7000 
Actin-PClneo 
5000 721 8 bps 
SV40 enhancer and early promoter 
4000 
/ 
3000 
\ 
f1 ori iXba, ___ Acel Sail Sm I Xm I Noll 
Appendix 3.1 The Actin gene wa cion d into th e P In co xprc . ion vcctor 
The Actin gene was cloned inlo he I and Xho I r Iri Ii n 111 me si t ~ or III 
multicloning ite of PIneo to gen rate clin-P Ine . 
BamHI 
..... 
6QOO 
\ I 
?OOO 
/ 
1000 
Actin-gene11-PClneo 
7182 bps 2000 
5000 
4000 
I 
3000 
\ Gene 11 
T3 promoter 
SV40 enhancer and early promoter 
Appendix 3.2 The Actin gene wa cloned into the P Inco-g ne ll , pI' ss i n 
vector 
The Actin gene wa cloned into Nhe I and ' /70 I r tri lion 
t11ulticloning site ofgene ll -P Ineo to generat tin-gcn 11 -1 
tV Ill' si l 's or th ' 
In '(), 
"-
6000 
8911 
\ I 
7000 
/ 
1000 
Actin-Gene11 t23c-PClneo 
7182 bps 2000 
5000 
8amHI 
4000 
I 
SV40 enhancer and early promoter 
3000 
\ 
f1 ori i b l Acel II m l Xm I Noll 
Appendix 3.3 Site directed mutagene i wa u ed to g II rnt P III -A ·tin-
genetl t23c 
ite direcled mulagene is wa u ed Lo cr aL a l11 utati 
ORF of gene II making it non-functionall g nerat 
n at Ih 'start ( I 11 )r th ' fir ... t 
ctill -g'Ill: 11 t_ ' I' ' 111 '). 
() 
8amHI 
..... 
\ I 
6000 
,.. 
1000 
5000 
,.. 
CAT-PClneo 
6117 bps 
4000 
3000 
Synthetic poly(A) I 
Sacl 
Bbsl 
Bmtl 
Nh I 
)(hol 
SV40 enhancer and early promot r 
Appendix 3.4 CAT reporter gene cloned into th P Inco xpr ssioll' ctol' 
The AT reporter gene cloned it f th multi 
CAT-PC lneo wa provided by Dr A .. Marriott, 
r P In '0 W g 'n 'nlk' 
11'\\ i ' I-. . 
-- 5000 
Bgil 
\ I 
6000 
,/ 
1000 
Gen 11 CAT 
gene11-CAT-PClneo 
4000 
,/ 
6196 bps 
3000 
\ 
2000 
..... 
SV40 enhancer and early promo! r 
Appendix 3.5 Genell -CAT fu ion cloned into the P (nco ' prcssi tl, e ' (or 
equentia l PCR wa u ed to 
gene II fused to the 5' of the 
and Xba I re triction enzyme 
gene II -CAT-PC lneo. 
generate a n lru I' til' lirs! 80 IlU ' k: HI I ' " of 
T gene R , lhi nSlru t \\ % cit Il' I illl \ /to I 
ite or the multi I ning sit' )1' P ' In I )' 'n 'ral 
..... 
5000 
\ I 
6000 
,-
1000 
NSP5-CAT -PClneo 
6196 bps 
4000 
/ 
3000 
\ 
2000 
..... 
Sacl 
NSP5-CAl 
SV40 enhancer and early promol r 
Appendix 3.6 NSPS-CA T fus ion cloned into the p r n 0 xprc ion v tor 
Sequential PCR was used to generate a n tru t r th fir ' t 
NSP5 ORF fused to the 5' of the CAT g ne R ·, thi n lru 
I and Xba I restriction enzyme ite of the multi loning it 
NSP5-CA T -PCIneo. 
nu ' l olid's or Ill· 
BamHI 
5000 
\ I 
6000 
./ 
1000 
gene11-CAT a22g-PClneo 
6196 bps 
2000 
4000 
,/ 
Synthetic poly(A) 3000 \ 
Sacl 
Bbsl 
Bmll 
Nh I 
Xhol 
Gen 11 -CA T 22 
SV40 enhancer and early promot r 
Appendix 3.7 Site directed mutagene i wa u d to g n rat P l -gl'II (\ II - AT 
a22g 
ite directed mutagenes i was u ed to create a mutati n I Ih slllrt '( I n of'thl: fir,,! 
ORF making it non-functional to generate g n 11 - T _2g-P In ' ). 
BamHI 
-... 
5000 
\ I 
6000 
..-
1000 
gene11-CAT g19a a20c 
g21 c t25g-PClneo 
2000 
./ 
4000 6196 bps -... 
3000 
Synthetic poly(A) I 
Bbsl 
Bmll 
Nhel 
Xhol 
Gene11-CAT 9 19 
a20cg21ct25g 
bl 
;!i: ____ -;Accl 
1\ 
Sm I 
Xm I 
NOll 
SV40 enhancer and early promoter 
Appendix 3.8 ite directed mutagene i wa used to gcncra t P I-g n J J- AT 
g19a a20c g2 1c t2Sg 
ite di rected mutagene i wa u ed to creat a mutant 
con ensus equence urrounding the tart odon o f th III' t 
AT g 19a a20c g2 1 c t2Sg-PC lneo. 
ith an Impr c I 1\.01 \J... 
R t g n(;I"I\ ' 1;;(;111: I 1-
-- 5000 
9911 
\ 1 
6000 
;' 
1000 
gene11-CAT t25g-PClneo 
6196 bps 
2000 
4000 
", 
3000 
\ i b' Acel S II Sm 1 ml II 
f10n 
SV40 enhancer nd rty promot r 
ppendix 3.9 ite direct d mutag n , n u d to gCIl nlt I ' In o-g 1\ lI -
T t2Sg 
it directed mutagenc i wa u ed t rcat ' a mutant \\ ith all impr 1\ • \ ,,"o/uk 
con ensu equence at the +4 p sition or th' start '( d( n r th 'lirst I \. t) I 'n 'I ill 
gene 11 - AT t25g-P Inco. 
